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Muscles contain a relatively high concentration of ammonia,
which they produce as part of their normal metabolism and release
into the bloodstream. The present study is an investigation into
the production and metabolism of ammonia by the isolated perfused
rat heart.
Ammonia is produced by rat heart perfused with media to which
none is added; conversely, ammonia added to the perfusing fluid
is taken up and metabolized by the heart. In the first case an
equilibrium is reached in which the concentration of ammonia in the
intracellular fluid is approximately twenty times that in the perfusate.
A similar ratio obtains in the rat heart In vivo, as measured by
other authors. Variation of the ammonia concentiation in the
perfusing fluid alters the distribution ratio in a way that is
inconsistent with widely-held views that ammonia is freely diffusible
throughout the tissue, and that its distribution is controlled solely
by passive diffusion across the plasma membrane. It is proposed that
the anomalously high internal concentration is maintaii.ed in parr
by an ammonia pump.
The existence of an ammonia pump is supported by experiments with
■'"'N-labelled ammonia, which show that relatively more ammonia enters
the heart at low external concentrations than would be expected on
the basis of observations at high external concentrations. Labelling
of tiusue ammonia in these experiments is much less than expected:
there appear to bo two ammonia pools in rat heart, only one of which
exchanges rapidl) ith the perfusate. Possible locations of these
pools are suggested
X.
The intracellular location of some enzymes connected with the
metabolism of ammonia and amino acids i:. rat heart is also investigated,
and the relationship of erzyme distribution to the comx^artmentation of
ammonia and related metabolites is discussed.
An attempt is made to relate the formation and disappearance of
ammonia to amino acid metabolism in perfused rat heart. Glutamine
is the most likely precursor of the ammonia produced by the heart.
It was not possible however to demonstrate the fate of ammonia nitrogen
taken up by the heart.
The ammonia concentration in the intracellular fluid is maintained
within comparatively narrow limits despite a tenfold variation in
perfusate ammonia concentration. Three processes may be involved in
control of the intracellular ammonia concentration: synthesis or
metabolism of ammonia within the tissue; active uptake of ammonia
from the extracellular fluid; and intracellular compartmentation of
ammonia. Possible functions of ammonia in rat heart are suggested,
including enzyme regulation and the mobilization of weak acid substrates.
CHAPTER 1
GENERAL INTRODUCTION
Chapter 1. General Introduction.
Ammonia is present in all muscle tissue. Some representative
concentrations are shown in Chapter 3, Table 3.1. The first
extensive investigations into its formation in skeletal muscle
were performed many years ago (Embden and Zimmermann, 1927; Parnas
and Mozolowsky, 1927), and although a number of reports of ammonia
production have appeared since (see below), relatively little
is known about the formation and fate of ammonia in other types
of muscle, nor about the kinetics of its metabolism. Although
the concentration of ammonia in muscle tissues is much higher than
that in plasma (see Chapter 3, Section 3.1), mechanisms responsible
for maintaining this concentration difference have never been
satisfactorily elucidated. The possible functions of such a high
concentration in the muscle cell have never been adequately
discussed; indeed, ammonia has generally been considered a highly
toxic substance (see Section 1.3 below).
A series of early studies on frog skeletal muscle described
the magnitude and kinetics of ammonia production under various
conditions, and the relation of ammonia to adenine nucleotide
metabolism (Embden and Wassermeyer, 1928a,b; Embden et_ al_., 1928a,b
Parnas, 1929, 1932; Parnas and Lewinsky, 1935; Parnas and
Mozolowsky, 1927; Parnas et al., 1927, 1934). The production of
ammonia by rabbit muscle (Embden and Wassermeyer, 1928b; Embden
et ad^., 1928a) and human forearm (Parnas et_ ad., 1927) was also
reported. The relation of ammonia production to muscle metabolism
and activity was discussed in a revi ;.w by Parnas (1935).
More recently, ammonia production by a wide range of muscle
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tissues has been described, including rat leg muscle (Brown et al.,
1957; Gerez and Kirsten, 1965; C'liosa and Busneag, 1971;
Lowenstein, 1971, 1972), dog leg muscle (Duchene-Marullaz et al.,
1964a), human forearm (Allen and Conn, 1960; Duchene-Marullaz
et al., 1964a), stomach muscles from various vertebrate species
(Silakova and Bekir-Zade, 1967), and locust muscles (Gerez and
Kirsten, 1965). Early experiments with heart muscle showed that
ammonia was released by beating frog heart (Ostern, 1930) and by a
mammalian heart-lung preparation (Cruikshank and McClure, 1936).
More recent research on heart has centred mainly on the clinical
and diagnostic importance of myocardial ammonia metabolism.
Ammonia production has been described in perfused rabbit heart
(Feinberg and Alma, 1960), rabbit heart slices (Trush, 1963a),
rabbit heart in vivo (Kato, 1968; Watanabe, 1968; Watanabe et al.,
1969, dog heart (Duchene-Marullaz et_ al^., 1966; Kobayashi, 1967;
Aviado et al., 1968) and human heart (Keul et a^., 1964, 1966).
1.1 Precursors of Ammonia in Muscle.
Early investigators realized that ammonia was formed in
vertebrate skeletal muscle by the breakdown of AMP. This may not
be the case in other muscle types such as heart (see Chapter 5).
Embden made the first preparation of AMP from rabbit skeletal
muscle, established its identity, and proposed it as the precursor
of ammonia in this tissue (Embden and Zimmermann, 1927). He showed
that frog muscle whicli was "traumatized" by grinding it in a pestle
and inortar liberated ammonia from ax Ted adenine nucleotides
(Embden et_ al., 1928a). The quantity of ammonia produced by
4.
traumatized muscle was stoicheicmetrically equivalent to vhe
extent of conversion of adenine nucleotides to hypoxanthine
nucleotides (Embden and Wassermeyer, 1928b; Parnas, 1929). More
recently, conversion of adenine nucleotides to hypoxanthine nucleotides
was observed in active frog muscle by Lange (1955) and by Wajzer
et al., (1956), and in rabbit muscle by Bendall and Davey (1957).
Some workers have suggested that ammonia is formed from adenine
nucleotides in rabbit heart (Trush, 1963a; Watanabe, 1968;
Watanabe et al., 1969; Kato, 1968), although none of these
investigators measured hypoxanthine nucleotides. The discovery of
AMP deaminase (Schmidt, 1928) provided an enzymic bar.is for ammonia
production in skeletal muscle:
AMP + H20 > IMP + NH4+.
The enzyme has since been purified (Kalckar, 1947), crystallized
(Lee, 1957; Smiley et al., 1967), and its physical and kinetic
properties have been extensively studied (Conway and Cooke, 1939b;
Setlow and Lowenstein, 1967, 19o»; Lee and iVang, 1968; Ronca et al.,
1968).
In traumatized or hypoxic muscle ammonia and hypoxanthine
nucleotides are produced in equivalent amounts (Embden and
Wassermeyer, 1928b; Parnas, 1929). The adenine nucleotide content
of adequately oxygenated muscle on the other hand is not significantly
diminished by activity, although ammonia production continues
(Parnas, 1932, 1935); indeed the amount of ammonia produced in
24 hours by an isolated beating frog heart can rise to five times
the original adenine nucleotide content (Ostern, 1930). It was
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therefore postulated that the aerobic muscle could synthesize
adenine nucleotides from IMP (Parnas and Lewinsky, 1935). Parnas
believed that the amino donor in this reaction was not free ammonia,
which diffused out of the cell on production and was carried away
by the bloodstream, but was probably an organic amino compound such
as an amino acid (Parnas, 1935). The identity of the amino compound
remained unknown until Newton and Perry (1960) demonstrated the
incorporation of isotope from ^ N-aspartate into the 6-amino group
of the adenine nucleotides of rabbit muscle. They isolated an
intermediate which they tentatively identified as adenylosuccinic
acid, already familiar as an intermediate of adenine nucleotide
synthesis in yeast (Carter and Cohen, 1955). Two enzymes are
involved in the conversion of IMP to AMP: adenylosuccinate synthetase
and adenylosuccinate lyase. The synthetase requires aspartate as
amino donor, and GTP provides the energy for the reaction (Davey, 1961).
In aerobic skeletal muscle resynthesis of AMP follows deamination in
a cyclic process; this has been termed the purine nucleotide cycle
and has been studied in detail in rat muscle homogenates (Lowenstein,
1971, 1972, Tornheim and Lowenstein, 1972). The cycle is shown
diagrammatically in Fig 1.1. It may function in the regulation of the
ammonia concentration in the cell, or in the deamination of amino
acids which can transfer their amino groups ultimately to aspartate
(Lowenstein, 1972). Its suggested relationship with energy
metabolism is outlined in section 1.4 below.
AMP is not the only precursor of ammonia in muscles. Certain
insect muscles reportedly lack AMP deaminase (Gilmour and Calaby,










Fig 1.1. The Purine Nucleotide Cycle
(after Lowonstein, 1972).
activity
2 ATP » 2 ADP
ATP <y
Adenylate kinase
> AMP -> IMP + NH.
AMP deaminase
Fig 1.2. The actions of adenylate kinase and AMP
deaminase in working skeletal muscle.
Tissue AMP-deaminase activity Ammonia concentration
ymoles/g fresh wt./min ymoles/g fresh wt.
After Lowenstein (1972). (Chapter 3, Table 3.1).
Rat leg muscle 127 0.410
Rat heart muscle 1.6 - 4.4 0.430
Table 1.1 Showing the lack of correlation between AMP-deaminar<
levels and ammonia concentration in skeletal and cardiac muscle.
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(Gerez and Kirsten, 1965). Furthermore, large differences in AMP
deaminase activity between tissues, for example between rat heart and
skeletal muscle (Lowenstcin, 1972), are not parallelled by differences
in tissue ammonia concentration (Table 1.1). In the hypoxic heart,
the deamination of adenosine occurs in preference to the deamination
of AMP (Gerlach est al., 1963; Richman and Wyborny, 1964; Baer e^t al^. ,
1966), but this is not the source of the ammonia produced by
adequately oxygenated heart (see Chapter 5, Section 5.1).
Glutamine has been established as the precursor of ammonia in
the kidney (Van Slyke et^ al., 1943; Pitts est al_., 1965) and as a
storage form of amino nitrogen (Braunstein, 1947). Decreases in
the glutamine content of perfused rat heart (Hicks and Kerly, 1960;
Ottaway, 1969a) and guinea pig heart (Gailis and Benmouyal, 1973)
have been observed, and have been attributed to the action of
glutaminase (Ottaway, 1969b). Glutamine is thus a possible precursor
of ammonia in heart.
Deamination of glutamate couiu in theory give rise to ammonia.
In the mitochondria, where the NAD+/NADH ratio is much lower than
in the cytoplasm (Veech et al., 1969), the equilibrium constant of
glutamate dehydrogenase (Frieden, 1963; Bergmeyer, 1965) suggests
that this reaction is of greater importance in the fixation of
free ammonia than in its procaction. Nevertheless, some form of
compartmentation may be required to keep the ammonia concentration
low in the neighbourhood of glutamate dehydrogenase (see below, Section
1.3), and under these conditions thrc enzyme could catalyze a slow
production of ammonia from glutamate. The possibility of intra-
mitochondrial compartmentation with respect to glutamate metabolism
9.
has been discussed by Tager (19C6).
The massive release of ammonia on trauma or hypoxia (Parnas
and Mozolowsky, 1927) must be distinguished from the normal synthesis
of ammonia under physiological conditions. Traumatic ammonia
production in all tissues results from the degradation of adenine
nucleotides. Parnas believed that breakdown of the muscle structure
destroyed some form of intracellular compartmentation which had
hitherto rendered AMP inaccessible to its deaminase (Parnas, 1935).
It is equally possible that trauma damages the oxygen supply to
the muscle. The low intracellular oxygen tension reduces the
activity of the electron transport chain which is responsible for
the oxidative phosphorylation of ADP. Under these conditions the
requirement for ATP is met by the action of adenylate kinase, which
catalyzes the dismutation of ADP to produce ATP and AMP:
2 ADP > ATP + AMP
The yield of ATP is increased if AMP is removed by deamination; this
results in the "traumatic" ammonia release. Since the concentration
of GTP is also reduced in hypoxia (Gerlach et_ al., 1963) the
reamination of IMP by aspartate is inhibited (Lowenstein, 1971, 1972).
In contrast, under physiological conditions the precursor of ammonia
differs between tissues: in sxeletal muscle it may be AMP; in
other tissues, ammonia may derive from some other amino compound,
such as glutamate or glutamine.
1.2 TheMetabolic Fate of Ammonia in Muscle.
The question whether the converse process, namely ammonia
fixation, took place in skeletal muscle was the subject of fierce
argument in the early literature. Parnas believed that ammonia,
once formed, was never re-utilized by the muscle, but was carried
away by the bloodstream (Parnas, 1930, 1935; Parnas and Lewinsky,
1935). His results were supported more recently by those of
Chiosa and Busneag (1971), who failed to show any utilization of
ammonia by rat leg muscle homogenates. However, a substantial body
of evidence suggested that ammonia produced by active muscles, name
frog muscle (Embden and Wassermeyer, 1928a; Embden et al., 1928b),
rat leg muscle (Gerez and Kirsten, 1965) and a rat heart-lung
preparation (Cruickshank and McClure, 1936), could be re-used
during the recovery of the muscle.
Three systems are known to be concerned with ammonia fixation
in vertebrate metabolism: glutamate dehydrogenase, glutamic
synthetase and carbamyl phosphate synthetase (Langendorf, 1969).
The equilibrium constant of glutamate dehydrogenase renders it
suitable for the assimilation of ammonia into glutamate:
NH4+ + ccOG + NADH > ri20 + Glu + NAD+
This reaction is available in all tissues which possess glutamate
dehydrogenase; the enzyme is more active in heart than it is in
skeletal muscle (Lowenstein, 1972). The hydrogen donor can be
isocitrate, succinate or malate (Tager, 1966); or it can be
^-oxoglutarate itself, by a dismutatlon process (Kiebs and Cohen,
1939; Hunter and Hixon, 1949; Worcel and Erecinska, 1962). The
coenzyme may be NADPH rather than NADH (Tager, 196j). If this
reaction were allowed to proceed uncontrolled the high ammonia
concentration in muscle would soon lead to depletion of
^-oxoglutarate and failure of energy metabolism in the tissue. The
necessity for control of the reaction at a low rate, possibly
by means of permeability barriers limiting access of the ammonia
to the enzyme, suggests that it can only operate slowly in the
fixation of ammonia.
Glutamine synthesis is only available as a method of ammonia
fixation in tissues that possess glutamine synthetase. This enzyme,
though present in avian heart (Gothoskar et al., 1960; Wu, i963;
Patel and Ramakrishnan, 1969) has only once been reported in rat
heart (Trush, 1963b); other attempts to measure it directly in
mammalian heart have failed (Wu, 1963; Iqbai and Ottaway, 1970),
although similar techniques showed that the enzyme was present in
rat skeletal muscle (Iqbal and Ottaway, 1970).
Less direct evidence for the occurrence of glutamine synthetase
in muscle was provided by experiments in which ammonia administration
caused an increase in tissue glutamine concentration. Raising the
blood ammonia concentration (by ammonia infusion or by hepatectomy)
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increased the glutamine contenv of/skeletal muscles (Flock et al.,
void
1953; Stabenau et al., 1959) andj(heart (Tigerman and McVicar, 1951;
Kato, 1968) and increased the output of glutamine by skeletal muscle
(Hills et al. , 1972; Rudermm and Lund, 1972). Administration of
^N-label led ammonium ion to live animals led to the recovery of
isotope in glutamine of skeletal muscle ^Duda and Handler, 1958;
Silakova and Trush, 1962; Ferdman et al., 19o3) and heart (Duda
and Handler, 1958; Ferdman et al., 1963), glutamine was more
highly labelled in heart than in any other tissue studied (Duda and
Handler, 1958). This is not in itself a conclusive demonstration
that glutamine synthetase occurs in heart or muscle. These tissues
could take up from the blood glutamine synthesized by other organs
such as brain (Flock et al., 1953; Clark and Eiseman, 1958;
Monder, 1965), or liver (Lueck and Miller, 1970), or even by gut
bacteria (Kosharov et_ al_., 1967). The demonstration of glutamine
synthetase is much more conclusive if glutamine production can be
localized by a suitable technique to a particular organ, such as
human heart (Keul et_ aJ., 1964, 1966). It is even more convincing
if an isolated tissue or organ preparation is used. Rabbit heart
slices produced glutamine in response to added ammonia (Trush, 1963a).
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Synthesis of labelled glutamine from C-glutamate occurred in
perfused rabbit heart (Doell and Felts, 1959) and perfused guinea
pig heart (Asano, 1968). Perfused guinea pig heart also synthesized
14
C-glutamine from other labelled precursors: glucose (Davis and
Quastel, 1964; Gailis and Benmouyal, 1973), lactate (Davis and
Quastel, 1964), acetate and pyruvate (Asano, 1968; Watanabe, 1968;
Gailis and Benmouyal, 1973). Incorporation of isotope from acetate
and pyruvate into glutamine was increased when ammonia was also added
to tne perfusing fluid (Watanao0, 1968), Asano (1968) however found
that ammonia increased the incorporation of label from pyruvate,
but not from acetate.
These experiments provide strong evidence that glutamine can
be synthesized by the human, rabbit or guinea pig hearts studied.
Attempts made in this laboratory to reproduce the experiments of
Trush (1963b) did not demonstrate any glutamine synthesis in
rat heart (Iqbal and Ottaway, 1970) . The existence of glutamine
synthetase in rat heart thus remains in some doub*-.
1.3 Ammonia Toxicity.
The concentration of ammonia in muscle is high (Chapter 3,
Table 3.1). Three problems associated with the high concentration
are immediately raised. Firstly, ammonia is often regarded as
a toxic substance. Secondly, does the high concentration serve
any function in the cell? Thirdly, what mechanisms are responsible
for maintaining a concentration which is so much higher than that
in plasma?
Failure of urea synthesis, as in hepatic failure, leads to
an increase in blood ammonia (Bessman and Bessman, 1955; Fenton,
1962; Williams et al., 1972) which may be one of the causes of
cerebral symptoms found in such cases (Fenton et_ aJ_., 1966) . Ammonia
decreases the aerobic metabolism of carbohydrates in brain, even
though the rate of glycolysis may be increased (James et aj^. , 1972).
The increase in the proportion of glucose metabolized anaerobically
implies a lesion either in the Krebs cycle or in the electron-
transport system. It is usually held that ammonia combines with
01-oxoglutarate to form glutamato, with consequent depletion of
-oxoglutarate and other Krebs cycle intermediates in the cell
(Bessman and Bessman, 1955; Worcel and Erecinska, 1962; Chow
et al., 1970; Clifford et al., 1972). Further conversion of
glutamate to glutamine may exacerbate this effect, particularly
in brain (Clark and Eiseman, 1958; Warren and Schenker, 1964;
Williams et al., 1972). The brain is tnus peculiarly susceptible to
ammonia poisoning, and convulsions usually accompany ammonia
intoxication. Alternatively, the primary cause of the decreased
oxidative metabolism may be a depletion of NADH and consequent
impairment of cellular respiration. Glutamate dehydrogenase may
compete with the respiratory chain for NADH (Worcel and Erecinska,
1962), or there may be a specific activation by ammo..ia of MADH
oxidases (Katunuma et al., 1966).
Ammonia forms complexes with certain metabolically important
inorganic ions. The formation of magnesium ammonium phosphate
and calcium ammonium phosphate has been suggested. These compounds
are treated as waste products by the body, and are excreted in the
urine (Chow et al., 1971). Thus ammonia interferes with the metabolism
of calcium, magnesium and phosphate in the body: it hinders the
absorption of calcium and phosphate from the duodenum, and decreases
the incorporation of these ions into bone (Chow et al., 1971, 1972).
It has been proposed that blood ammonia is maintained at a low
level by the action of glutamine synthetase in skeletal muscle
(Bessman and Bessman, 1955; Bessman and Bradley, 1955; Langendorf,
1969). The disorder of familial protein intolerance, in which
dietary amino acids and proteins cause a rise in blood ammonia not
seen in normal individuals, may involve a lesion in glutamine
metabolism (Malmquist e^t al_., 1971) . The function of these
detoxification mechanisms is to prevent the toxic effects of ammonia
on the brain (Bessman and Bessman, 1955).
Both skeletal and cardiac muscles possess glutamate dehydrogenase
(Lowenstein, 1972) and its equilibrium constant (Frieden, .1963;
Bergmeyer, 1965) suggests that even small amounts of ammonia would
be removed by combination with «-oxoglutarate. One may wonder
therefore why the high concentration of ammonia which exists in
muscle (Chapter 3, Table 3.1) is not toxic to the tissue. The
most logical explanation is to assume that permeability barriers
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in the cell prevent the bulk of the ammonia from reaching the
glutamate dehydrogenase. The ammonia concentration in the
neighbourhood of the enzyme would thus be kept lew and fixation
of ammonia by glutamate dehydrogenase would be slow.
1.4 Ammonia and Energy Metabolism.
Ammonia is produced continuously by resting muscle (Parnas,
1935) . Production is increased by trauma (Parnas and Mozolcwsky,
1927; Embden et_ a^., 1928a), death (Bendall and Davey, 1957),
and by increasing the ambient temperature of cold-blooded animals
(Embden and Wassermeyer, 1928a; Parnas and Lewinsky, 1935). The
increase of greatest importance to homeothermic animals occurs in
response to muscular activity, Aut" has been observed in frog leg
muscle (Parnas and Mozolowsky, 1927; Embden et al., 1928a; Busneag
a.A<4
and Chiosa, 1971),^insect muscle (Gerez and Kirsten, 1965), as weW. »s A\ r*t
leg muscle (Brown et al., 1957; Gerez and Kirsten, 1965; Chiosa
ana Busneag, 1971), dog leg muscle (Duchene-Marullaz et al., 1964a),
human forearm (Parnas et al., 1927; Allen and Conn, I960; Duch^ne-
Marullaz et al., 1964a), rabbit heart (Feinberg and Alma, 1960;
Kato, 1968; Watanabe, 1968; Watanabe et al., 1969), dog heart
(Duchene-Marullaz et ad^., 1966; Kobayashi, 1967) and human heart
(Keul et al ., 1966). Increases in blood ammonia due to general
muscular activity have been noted in dogs (Schwartz et al_., 1958;
Duchene-Marullaz et al,, 1964b) and in humans (Schwartz et al., 1958;
Keul et al,, I96a). Despite the increase in ammonis production
during activity, ecily investigators realized that ammonia formation
had no direct connection with the process of muscular contraction.
Ammonia produced by frog muscle showed no correlation with lactate
produced during activity (Enbden and Wassermeyer, 1928a). Similar
amounts of exercise resulted in different rates of ammonia
production under different conditions (Parnas and Lewinsky, 1935).
Leg muscles of rats accustomed to regular bouts of strenuous
i
activity showed no increase in ammonia output on stimulation
(Chiosa and Busneag, 1972).
Parnas saw the function of adenylate deaminase in skeletal
muscle as a means of destroying AMP formed during periods of
muscular activity, believing that excess free AMP could exert
harmful effects on the muscle and on neighbouring tissue, whereas
IMP was harmless (Parnas, 1935). Modern views are summarized
by Lowenstein (1971, 1972). Muscular activity produces ADP.
In strenuous activity, oxidative phosphorylation of ADP may be
insufficient to keep pace with ATP demands. Under these conditions,
as in hypoxia, the ATP requirement is met by adenylate kinase,
which catalyzes the production of ATP and AMP from ADP. The
function of AMP deaminase is to remove AMP, upsetting the adenylate
kinase equilibrium and making more ATP available for th = short-term
needs of the muscle (Fig 1.2). This cannot continue for long
periods without severely depleting the muscle's adenine nucleotide
reserves. Resynthesis of AMP and ATP from IMP must therefore occur
during the recovery of the muscle.
Some insect muscles lack adenylate deaminase (Gilmour and
Calaby, 1953; Gerez and Kirsten, 1965); other muscles, such as
rat heart, possess the enzyme in much lower activity (Lcwenstein,
1972). In fact it is unlikely that the Lowenstein purine nucleotide
cycle is of great metabolic importance in rat heart (see Chapter 5,
Section 5.1). Such muscles do not differ greatly from skeletal
muscle in respect of their ammonia concentration (Chapter 3, Table 3.1).
It is probable therefore that ammonia has a distinct function in
the field of muscle metabolism, other than being merely a by-product
of the purine nucleotide cycle. Its function may include enzyme
regulation (Lowenstein, 1972).
1.5 Ammonia and Enzyme Activity.
Experiments in^ vitro have shown that ammonia has an activating
effect on the membrane sodium and potassium transporting ATPase
of erythrocytes (Post et_ al., 1960) and kidney (Klahr ert al., 1970),
on heart myosin ATPase (Hjalmarson et al., 1970; Rovetto et al.,
1972), on lipoprotein lipase of rat heart (Korn and Quigley, 1955;
Whr.yne and Felts, 1971), and on fructose diphosphatase (Black et. al.,
1972), pyruvate kinase (Kayne, 1971) and AMP deaminase (Ashman and
Atwell, 1972) from rabbit muscle. However, the ammonia concentrations
required to produce activation are always far in excess of that
f^und in tbQ cell, and the effect of ammonia is likely to be
insignificant in comparison with the effects of other intracellular
cations such as potassium.
However, physiological concentrations of ammonia may have a
regulatory effect in decreasing the flux through the Krebs cycle
(Katunuma et^ al_., 1966), increasing flux through the pentose phosphate
shunt in yeast (Holzer and Witt, 1960) and in erythrocytes
(de Loecker, 196-'), and increasing the rate of Embden-Meyerhof
glycolysis in yeast (Holzer and Witt, 1958), E. co 1 i (Ilolzer and
Grunicke, 1961), erythrocytes (de Loecker, 1964; Kloppick et al.,
1967) and brain (James et al., 1972). The most detailed investi¬
gation of the activation of a specific enzyme by ammonia concerns
phosphofructokinase. The acceleration by ammonia of erythrocyte
glycolysis was traced to an effect on this enzyme (Kloppick et al.,
1967). Phosphofructokinase from mouse brain (Passonneau and
Lowry, 1964), rabbit liver (Kemp, 1971) and rabbit muscle (Abrahams
ard Younathan, 1971) is activated by ammonia. Half-maximal
activation of the rabbit muscle enzyme occurs around the
physiological ammonia concentration (Chapter 3) of 0.3 mmol/1
(Abrahams and Younathan, 1971); thus changes in muscle ammonia
concentration around this value should have a profound effect on
the rate of glycolysis, although the effects of other proposed
phosphofructokinase effectors must not be disregarded (Randle et_ al_.,
1968). An increase in ammonia concentration on muscular activity
would cause an increase in the rate of glycolysis: hence the
change in ammonia concentration on activity reinforces the effects
of changes in ATP, ADP, AMP and inorganic phosphate in the mediation
of the Pasteur effect.
1.6 Transport of Ammonia across Membranes.
Transport of ammonia across cell membranes has been a subject
of contention in the literature for many years. Ammonia crosses
most membranes rapidly, but it is by no means certain whether the
permeant species is unionized ammonia (NH^) (Cooper and Osterhout,
1930; Jacobs and Parpart, 1938; Jacobs. 1940) or ammonium ion
(Fenn et al., 1945).
The proportion of ammonia in the uncharged form depends on
the equilibrium: NII^+ NH^ + H+, which depends on the pH
of the solution. Although the pK& for the dissociation of NH^+ is
relatively unaffected by the presence of other solutes, it is
markedly temperature-dependent (Bank and Schwartz, 1960); under
physiological conditions it is 9.03 (Klocke et_ aK, 1972). Changes
in pH around the "physiological" value of 7.4 will thus cause
large variations in the NH^ concentration, without greatly affecting
the NH^+ concentration, since at pH 7.4 the ratio of NH^+ to NII^
is 43 to 1. Proof that NH^ is the permeant species has rested largely
on the demonstration of a pH-dependent distribution of ammonia across
membranes. NH^ diffuses from the more alkaline side of a membrane,
where its concentration is higher, to the more acid side. Equilibrium
is reached when the NH^ concentration on both sides is the same. The
+
NH^ concentration at equilibrium is greater on the acid side. The
passage of NH^ has the effect of rendering the acid side more alkaline
diffusion of NH^ in one direction is equivalent to the passage of
pjotons in the opposite direction (see Fig 1.3; see also Henderson,
1971). Tnis phenomenon could easily be mistaken for direct exchange
+ +
of NH for H . It leads to dissipation of the original pH gradient
unless H is returned, possibly in exchange for Ma or some other
cation (Fig 1.4), by a carrier mechanism. The overall picture could
be mistaken for a direct exchange of NH^ for Na+, except that
in the former case the primary event depends on pH rather than
on Na+ concentration.
Cooper and Osterhout (1930) described a pH-dependent ammonia
equilibrium in cells of Valonia macrophysa. The entry of NH7
caused alkalization of the interior, and was accompanied by K+
efflux. Similarly, human erythrocytes were permeable to NH^
(Jacobs and Parpart, 1938; Klocke et al., 1972) and a mathematical
prediction of the pH-dependent distribution was possible (Jacobs,
1940). Stabenau and co-workers (1959) observed a pH-dependent
equilibrium indicative of NH^ diffusion between blood and muscle,
blood and brain and blood and cerebrospinal fluid in dogs. Bessman
et al., (1961) found on the other hand that the uptake of ammonia
from blood depended solely on the arterial concentration, and not on
pH. The pH-dependent diffusion of NH^ has been demonstrated in
sheep rumen (Mooney and O'Donovan, 1970), rat intestine (Swales
et al., 1970) and human colon (Castell and Moore, 1971), though
not in hamster ileum (Mossberg, 1967). Langendorf (1969) showed
that the toxicity of ammonium salts increased with their alkalinity.
NHg diffusion also occurs in kidney tubules (White et a^., 1973).
NH^ diffusion has . lso been postulated for ammonia uptake by chloro-
plasts (Crofts, 1967; Schuldiner and Avron, 1971) and mitochondria
(Chappell and Haarhoff, 1967; Papa et al., 1969; Van Dam and
Meyer, 1971). The necessity for concomitant proton movements is
obviated if a weak acid crosses the membrane at the same time, the
membrane being permeable to the uudissociated form of the weak acid
(Fig 1.5). Thus the uptake of ammonium acetate is faster than the
uptake of ammonium chloride, for example in rat brain synaptosomes
(Keen and White, 1971).
As indicated above (see Fig 1.4), pH-dependent NH^ diffusion
can be accompanied by cation movements. Ammonia uptake accompanied
by egress of cations, as described by Albano and Francavilla (1971)
in rat erythrocytes, is therefore not in itself a proof of NH^+
transport. On the other hand, non-dependence of the ammonia
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Fig 1.3. The diffusion of NH3 from right to left is




Fig 1.4. Exchange of protons for sodium ions. Overall events are
equivalent to an exchange of ammonium for sodium.
1.5. Diffusion of ammonia is accelerated by
the presence of the weak acid anion, A".
non-existent or operating in the reverse direction, does suggest
that the permeant species is not uncharged ammonia.
Fenn est al., (1945) found that the uptake of ammonia by frog
muscle was accompanied by an efflux of K+. Freshwater animals require
to excrete a large quantity of ammonia yet need to maintain osmotic
balance. It has been proposed that ammonium ion is exchanged for
Na+ or possibly H+ by frogs (Garcia-Romeu, 1971) and freshwater fish
(Maetz and Garcia-Romeu, 1964; Kerstetter est al., 1970). The effect
of pH was not investigated. Excretion of ammonia by toad bladder
is independent of pH (Frazier and Vanatta, 1971), though it is also
unaffected by abolition of the trans-membrane potential difference,
which would also seem to rule out simple electrophoretic diffusion of
NH^+. Simple electrophoretic diffusion of NH^+ across the human colon
from a positive serosal to a negative mucosal surface was claimed
by Wolpert et_ al., (1970). This is at variance with the results of
Castell and Moore (1971) cited above, although the passage of ammonia
in Wolpert's experiments is in the opposite direction and may well
require a different mechanism.
Most of the proposed mechanisms involve a passive distribution
of ammonium ion according to a pre-existing Nernst equilibrium,
controlled mainly by the K+ distribution. On the other hand NH^+
transport can be the primary event, as suggested by the finding of a
specific NH^+ permease in a Penicillium species (Hackette et_ al., 1970).
A temperature-dependent NH -concentrating system, possibly a
permease, has been described in an alga (Pribil and Kotyk, 1970).
The uptake of NH^+ against a concentration gradient requires energy.
Post and Jolly (1957) have shown that NH^+ can be transported into
-f" . "f*
human erythrocytes by the Na /K -dependent ATPase, in place of K ;
external NH^+ can also substitute for K+ in the activation of Na+
efflux. It cannot however replace sodium. Activation of ATPase
by ammonium ion can be shown in purified preparations of the enzyme
(Post et_ ad_., I960; Post and Sen, 1967). Sachs (1967) however
■f +
suggested that NH^ could bind to the ATPase and .nhibit K influx
but could not be carried by it, ammonia entering the cells only in the
+ +
uncharged NH^ form. Na /K transport ATPases of beef heart (Yoda
and Hokin, 1972) and rabbit kidney (Klahr et_ aH., 1970) can also
bind ammonium ion.
Our understanding of ammonia transport is therefore by no means
complete. There seems to be a general pattern of NH^+ diffusion
in lower organisms and of NH^ diffusion in higher animals. The
transport of ammonia across the membranes of mammalian muscle has
never been investigated in detail, and no studies have been undertaken
in heart muscle.
1.7 Amino Acid Metabolism in Heart Muscle.
Amino acids in the intracellular pool of heart muscle derive
both from plasma and from the breakdown of cellular proteins. The
concentration of free amino acids in rat heart has been measured by
several workers (Manchester and Wool, 1963; Scharff and Wool, 1965a;
Herbert et. sl1_. , 1966; Kuttner and Lorincz, 1969; Morgan et al. , 1971).
Their results are summarised in Table 5.5 of Chapter 5. Many of these
amino acids can be formed or degraded within the heart by transamina¬
tion with glutamate or other amino acids. C^mmarata and Cohen
(1950) list those amino uids which can transaminate with glutamate
in heart. Those which cannot be metabolized in this way are gained
and lost solely by across the membrane, and by synthesis
or degradation of proteins. Transport of amino acids across
the membrane is an active process and is insulin-dependent
(Scharff and Wooi, 1965a,b, 1966; Manchester, 1970).
The role of amino acids in protein synthesis in muscle is well
documented (see Manchester and Young, 1959; Manchester and Wool,
1963; Morgan et_ aCL, 1971). Incorporation of amino acids into
protein is increased by insulin (Manchester and Young, 1959, 1961;
Manchester and Wool, 1963; London, 1972). It is possible that
protein synthesis is the function of a small, metabolically active
fraction of the total tissue free amino acids, at least in skeletal
muscle (Hider et al., 1969, 1971) and diaphragm (Kipnis et_ aH., 1961);
this pool is in rapid equilibrium with the ECF and it may be located
in the T-tubules or in the sarcoplasmic reticulum (Hider et al., 1971).
The oxidation of amino acids provides a relatively small fraction
of the heart's energy requirements under normal circumstances
(Keul et_ al_., 1964, 1965, 1966). This fraction probably increases
when other substrates are in short supply (Clarke, 1957), as in
starvation. Oxidation of amino acids involves the detachment of
the amino group from the ca?'bon skeleton by transamination, followed
by the oxidation of the resultant oxo-acid to yield energy. Thus
oxidation is limited to those amino acids for which transaminases
occur (Cammarata and Cohen, 1950) and whose corresponding oxo-acids
can be metabolized by the heart. Quantitatively the most important
are those which are present in the highest concentration, and which
are directly related to Intermediates of energy metabolism, namely
alanine, glutamine, aspartate and glutamate. Glycine (Lorber and
Olsen, 1946; Coulson and Hernandez, 1968) and lysine (Felig and
Wahren, 1971; Felig, 1973; are not oxidized by the heart, although
they are also present in relatively high concentration.
Glutamate is the direct product of the transamination of amino
acids with oc-oxoglutarate, and of the hydrolysis of glutamine by
glutaminase (Ottaway, 1969a,b). However, there is no net output
of glutamate by the heart (Keul et al., 1966) and it must therefore
be metabolized further in this tissue. Oxidative deamin^'ion catalyzed
by glutamate dehydrogenase produces cc~oxoglutarate and ammonia. This
reaction has already been discussed (p. 8 ). Alternatively, reaction
of the glutamate with pyruvate produced in glycolysis yields oc-oxoglutarate
and alanine. Studies have shown that both ammonia (Feinberg and
Alma, 1960; Keul et al., 1964, 1966) and alanine (Carlsten et al.,
1961; Ottaway, 1969a) are produced by heart. These represent
mechanisms for ridding the tissue of unwanted amino nitrogen without
involving such a serious loss of carbon skeletons as would be the
case if glutamate itself were released. There is also a net. output
of glutamine in hearts of some species (see Keul et aK, 1964). The
interpretation of this as a method for disposal of amino nitrogen is
less clear as there is some doubt about the existence or glutamine
synthetase in rat heart (Trush, 1963b; Iqbal and Ottaway, 1970).
This aspect of glutamine metabolism has already been discussed (p. 11 ).
Heart takes up glutamate and glucose, and releases alanine and
ammonia into the plasma. Skeletal muscle displays a similar amino
acid balance. This phenomenon has led some workers to postulate
an "alanine cycle" (see Felig, 1973, for a review). The cycle is
completed in the liver, where alanine is converted to glucose by
gluconeogenesis (Ishikawa et al., 1972) and the nitrogen is released
into the plasma as glutamate or disposed of as urea. This cycle will
be discussed in greater detail in Chapter 5 (Section 5.3.3) where a
review of the literature will be presented.
1.8 The Structure of Cardiac Muscle.
Cardiac muscle differs from skeletal muscle in a number of
respects. The fibre orientation is more haphazard, and the
cross-striation of the fibrils is less regular (see Chapter 6).
The structure of cardiac muscle is described in detail by Bloom and
Fawcett (1968), pp. 285-297, where a diagram is presented. Fundamenta¬
lly the tissue consists, as does skeletal muscle, of actomyosin fibres
embedded in an aqueous sarcoplasm containing enzymes, substrates and
other essential substances. Mitochondria fill the interfibrillar
spaces in a columnar pattern (Klingenberg, 1964). There are more
mitochondria in cardiac than in skeletal muscle, and they are larger
(Klingenberg, op. cit.); this reflects the importance to cardiac
muscle of a constant energy supply. The complete fibre is surrounded
by a membrane, the sarcolemma, which has two properties. Firstly,
it is excitable and can carry an electrical impulse along the fibre
from the motor nerve ending. Secondly, it is a semipermeable
membrane which regulates the passage of substrates, cofactors and
other small molecules into the sarcoplasm.
The heart muscle syncytium is large in comparison with most
cells of the body. Thus both functions of the membrane are rendered
more efficient by prolongations into the sarcoplasm which increase
the surface area of the membrane. These form two distinct tubular
systems in both skeletal and cardiac muscle which are known as the
transverse (T-) tubules and -the longitudinal (L-) tubules or
sarcoplasmic reticulum (Huxley, 1964). The T-tubules originate
as invaginations of the sarcolemma (Ishikawa, 1968). Extracellular
ferritin diffuses read:i ly into the T-tubules of skeletal muscle
(Huxley, 1964; Ishikawa, 1968) and cardiac muscle (Forssmann and
Girardier, 1966), where it can be seen in electron-micrographed sections.
Horseradish peroxidase also enters the T-tubules of rat heart muscle
(Forssmann and Girardier, 1L70) where it can be localized by staining
with diaminobenzidine. These experiments suggest that the lumen
of the T-tubules is continuous with the extracellular space. The
apertures of the T-tubules on the surface of the sarcolemma have
been visualized in guinea pig heart muscle by a freeze-etching
technique (Rayns and Simpson, 1967).
The T- and L-tubules however are not themselves continuous;
neither ferritin (Huxley, 1964; Forssmann and Girardier, 1966;
Ishikawa, 1968) nor horseradish peroxidase (Forssmann and Girardier,
1970) can enter the L-tubules of heart or skeletal muscle. However,
there is evidence that small molecules in the ECF such as sucro?p can
penetrate the L-system and cause swelling (Birks and Davey, 1969).
Thus at certain points the T- and r-systems are in contact, but the
lumina of the two systems are distinct. These juxtapositions or
triads are very regular in skeletal muscle (Kelly, 1969); the
T-system forms a flattened sac flanked on either side by a terminal
lacuna of the L-system. In cardiac muscle similar connections
exist but they are less regular in appearance (Forssmann and Girardier,
1966). The T-tubules are tortuous and can make contact with the
L-system at any point (Forssmann and Girardier, 1970). The L-system
tubules appear to be continuous with the outer mitochondrial membrane
(Forssmann and Girardier, 1966). Postulated functions of the T- and
29.
L-systems are firstly, transmission of the electrical impulse from
the nerve ending throughout the fibre so that all the fibrils
contract in phase (Huxley, 1964; Forssmann and Girardier, 1966, 1970)
and secondly, conveyance of substrates such as free fatty acids
from the ECF directly to ihe mitochondria to maintain the energy
supply required for continual contraction (Forssmann and Girardier,
1966, 1970). These membrane systems will be considered in relation
to the handling of ammonia and amino acids by the tissue (Chapter 3;
Chapter 7).
Conclusion.
It is clear from the foregoing presentation that there is a
need for a study of the metabolism of ammonia in muscle tissues.
The investigation to be reported in the following pages shows
that ammonia is produced by the isolated perfused rat heart, and
attempts to clarify some aspects of its metabolism in this organ;





Chapter 2. Materials and Methods.
2.1 Materials.
2.1.1 Laboratory Chemicals
All inorganic chemicals used in research in Edinburgh were
products of B.D.H. Biochemicals Ltd., Poole, Dorset, England. Those
used in enzyme location studies in Konstanz were products of E. Merck,
Darmstadt, W. Germany. All were analytical grade. The following
organic chemicals were also obtained from B.D.H. Biochemicals:
Glucose, o-dianisidine dihydrochloride, INT, Phenol, disodium EDTA,
ninhydrin, hydrindantin, nitron, glycerol, glycine, aspartic acid,
monosodium glutamate, alanine and glutamine. The following were
products of Sigma (London) Ltd: phenazlne methosulphate, nitro-blue
tetrazolium, diaminobenzidine tetrahydrochloride, agarose, glycerol-
gelatine, D-sorbitol and dimethyloxazolidinedione. <*-oxoglutarate
was obtained from Boehringer and Soehne GmbH, Mannheim, IV. Germany,
as were sodium lactate, sodium succinate, aspartic acid and monosodium
glutamate used as substrates in histochemical enzyme localization.
Bovine serum albumin was a product of Armour Pharmaceutical Co. Ltd.,
14
Eastbourne, England. C-sorbitol was obtained from the Radiochemical
Company Ltd., Amersham, England and ^N-ammonium chloride from
Prochem (The British Oxygen Co. Ltd.). Dioxane-based scintillant
14
for measurement of C-sorbitol was a product of Koch-Light
Laboratories Ltd, Colnbrook, Bucks, England. Analytical grade diethyl
ether was obtained from McFarlane Smith Ltd, riinburgh. Glass-
distilled water was used throughout the study.
2.1.2 Fine Chemicals and Enzymes
NAD+, NADP+, the disodium salts of NADH and ADP, and cytochrome
were obtained from Boehringer and Soehne, as were all enzymes, with
the following exceptions: lyophilized alcohol dehydrogenase was
obtained from B.D.H. Biochemicals; glucose oxidase ("Fermcozyme")
and peroxidase from Hughes ^nd Hughes Ltd, Romford, Essex, England;
and catalase from Koch-Light Laboratories. All enzymes from
Boehringer and Soehne were bought as crystalline suspensions in
ammonium sulphate, with the exception of glutamate dehydrogenase,
which was a solution in 50% glycerol.
2.1.5 Abbreviations






EDTA ethylenediamine tetraacetic acid
Glu DH glutamate dehydrogenase
GOT glutamate oxaloacetate transaminase



















Specific optical assays which involved the enzymic production
or utilization of NADH were carried out in 1cm glass cuvettes, test
volume 1.0 ml, at 37 C. The change in absorbance at 340 nm was
monitored continuously by an SP 800 spectrophotometer (Pye-Unicam,
Cambridge). An SP 825 cuvette changer enabled four reactions to be
carried out simultaneously, and an SP 850 scale expander connected
to a Servoscribe recorder provided a record of absorbance changes.
In all cases the reaction was started by adding enzyme to the mixture
of the other components pre-warmed to 37°C. The Berthelot method
for ammonia estimation (Section 2.2.7), the tetrazolium method for
glutamate assay (Section 2.2.8.1), and the assays for glucose and
total ninhydrin-reactive material (Sections 2.2.1 and 2.2.4) required
absorbance measurement at the end of a specified period and comparison
with a standard curve. Absorbance was measured at the appropriate
wavelength in a Coleman Junior II Spectrophotometer.
2.2.1 Glucose
Glucose was assayed by the method of Huggett and Nixon (1957),
using glucose oxidase ("Fermcozyme") and peroxidase with dianisidine
as the colour reagent. Absorbance at 440 nm was linearly related to
concentration from 0 to 0.3 y moles of glucose per assay .(Fig 2.1).
2.2.2 Lactate
Lactate was a.c^ayed using lactate dehydrogenase and NAD+ in
glycine-hydrazine buffer at pH 9.0 (Hohorst, 1965). The increase in
35.
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Fig. 2.2 Standard curve of total ninhydrin-reactive material by the
method of Moore and Stein (1954b). Curves are shown for
alanine and glutamine.
37.
absorbance due to NADH was recorded at 340 nm.
2.2.3 Pyruvate
Pyruvate was assayed using lactate dehydrogenase and NADH in
If
phosphate buffer at pH 7.0 (Bucher et aj_., 19o5), recording the
absorbance decrease. Pyruvate estimations were carried out on the
day of perfusion, pyruvate in perchlorate extracts being determined
r'mmediately after neutralization of the extract, since pyruvate ion
is unstable.
2.2.4 Total Ninhydrin-Reactive Material
The method used was that of Moore and Stein (1954b). Prior to
use, the methyl-celiosolve solvent was tested for peroxides by
adding it to 4% aqueous potassium iodide. In every case a pale straw
colour resulted, indicative of a low peroxide content. Fresh
reagent was made up for each set of determinations. Standard curves
were plotted for alanine and glutamine, which did not differ greatly,
and were linear from 0 to 0.3 pinoles of ^-amino nitrogen per assay
(Fig 2.2). Under the conditions of assay 0.1 y moles of alanine gave
an absorbance of 0.291 at 570 nm.
2.2.5 Aspartate
Transamination of aspartate with 01 -oxoglutarate using GOT was
coupled to reduction of oxaloacetate by malate dehydrogenase and NADH




Alanine was measured in an analogous manner to aspartate, by
coupling transamination to pyruvate reduction:
GPT
-» Pyruvate + glutamate
> Lactate + NAD+
Alanine + ^-oxoglutsrate
Pyruvate + NADH + H+
The composition of the assay mixture was as follows:
Phosphate buffer, pH 7.2, 0.2 mol/1 0.500 ml
^-oxoglutarate, 150 m mol/1 (neutralized) 0.050 ml
NADH, 8.5 mg/ml 0.020 ml
LDH, 0.1 mg/ml 0.010 ml
GPT, 10 mg/ml 0.005 ml
Distilled water to a total volume of 1.000 ml
Up to 0.4 ml of sample could be assayed; reaction was started by
addition of GPT.
Two difficulties were encountered in the development of this
assay. Firstly, if commercial LDH suspension (10 mg/ml) was used
without dilution, the absorbance decreased rapidly prior to addition
of GPT. This was traced to a lack of specificity of the LDH. which
also catalyzed the reduction of ^-oxoglutarate by NADH. ^-oxoglutarate
reduction was proportional to the LDH concentration and was not
abolished by dialysis of the LDH before use. The ratio of the rate
of ^-oxoglutarate reduction to the rate of pyruvate reduction varied
with pH or enzyme dialysis, but not with enzyme concentration:
Conditions
Undialyzed enzyme, pH 7.6
Undialyzed enzyme, pH 7.2
Dialyzed enzyme, pH 7.2








Dilution of the LDH 100-fold before use abolished all appreciable
interference from ^-oxoglutarate reduction without increasing the
time required for alanine assay.
Secondly, the reaction is slow in coming to completion owing
to the high Km of GPT for alanine: the value as measured by Segal
etal., (1962) is 17.5 mmol/1. It was decided not to use the Kinetic
assay advocated by Pfleidert-r (1965a) since a large number of substances
in heart extract are potentially capable of influencing the reaction
rate (for example metal ions and glutathione). However, using the
assay described above, reaction of a standard quantity (50 n moles)
of alanine was complete in 20 min. Measurement of alanine in heart
extracts required 35 min, presumably because of the presence of
inhibitors (such as perchlorate ion). The rate of reaction was
unaffected by the addition of pyridoxal phosphate. Economy in
the use of sample was effected by measurement of aspartate and
alanine in the same cuvette, by sequential addition of the appropriate
enzymes.
2.2.7 The Ammonia Assay
Direct measurement of ammonia in biological materials by
colorimetric methods is subject to interference from naturally-
occurring amides and amines (Mondzac et al., 1965). Earlier workers
freed the ammonia from interfering substances by microdiffusion
from an alkaline sample to an acid recipient (Conway and Cooke,
1939a). Ammonia was measured in the recipient by titration (Reif,
1960), Nessler's reagent (Seligson and Hirahara, 1957), or by the
Berthelot or phenol-hypochlorite reaction (Brown ef al., 1959). The
alkaline medium required for microdiffusion could cause ammonia
liberation from alkali-labile proteins and peptides (Reif, 1960),
though not from glutam;ne in physiological concentrations (Brown
et al., 1957). More recently, ammonia has been adsorbed on to an
ion-exchange resin which was separated and washed before determination
of the adsorbed ammonia by the Berthelot reaction (Fenton, 1962;
Fenton and Williams, 1968; Kingsley and Tager, 1970). Ammonia has
also been measured by ion-specific electrode (Park and Fenton, 1973).
The effects of interfering substances are likewise reduced if
a more specific assay method is used, such as the reaction with
0(1 -oxoglutarate catalyzed by glutamate dehydrogenase. The decrease in
the absorbance of NADH is generally measured (Kirsten et a.1. , 1963;
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Mondzac et al., 1965; Muting «rt al., 1968). Variations in the
technique include measurement of the rate of reaction in the presence
of excess GluDH (Kaltwasser and Schlegel, 1966) and fluorimetric
measurement of NADH disappearance (Rubin and Knott, 1967). In the
present investigation, ammonia was measured by one of two methods: by
direct application of the Berthelot reaction, or by the use of
glutamate dehydrogenase, which is more sensitive, as well as Being
less subject to interference.
(a) The chemical method. This method is based on the Berthelot
reaction (as described by Chaney and Marbach, 1962; Kaplan, 1965).
To an aliquot of sample diluted to 1 ml were added 1 ml of phenol-
nitroprusside solution (Phenol, 50 g/1; Sodium nitroprusside,
0.25 g/1) and 1 ml of alkaline hypochlorite solution (Sodium hydroxide.
25 g/1; sodium hypochlorite, 40 ml of 5% w/v solution/i). The
absorbance was read at 628 nm after incubation for 5 mins at 37°C withou
further dilution. Under these conditions absorbance was linearly
related to concentration over the range 0 to 0.2ymoles of ammonia,
with an absorbance of 3-86 perymole of ammonia (Fig 2.3a). The
method was not sensitive enough to measure an ammonia concentration
of less than 0.02ymoles of ammonia per assay.
(b) The enzymic method. An enzymic method based on that of
Kirsten et_ al., (1963) was used in all determinations of ammonia in
heart perfusate samples and perchlorate extracts. The reaction is
shown below:
GluDH
NH^ + NADH + cc-oxoglutarate > H^O + NAD + Glutamate.
Usually sample aliquots containing 20-30 n moles of ammonia were
assayed in 1 ml of test solution; reactions seldom required more
than 20 min to come to completion. A standard curve using ammonium
sulphate showed that reaction was complete over the range 0 to 80
n moles of ammonia per assay (Fig 2.3b). ADP was added to the
reaction mixture as an activator of glutamate dehydrogenase. The
assay mixture was as follows:
K^HPO., 0.2 mol/1, neutralized to pH 7.0 with HC1 0.200 ml
NADH, 8.5 mg/ml 0.010 ml
cx-oxoglutarate, 150 m mol/1, pH 7.0 0.030 ml
ADP, 100 m mol/1 0.010 ml
GluDH, 10 mg/ml in 50% glycerol 0.010 ml
Distilled water to a total of 1.000 ml
The reaction was started by the addition of glutamate dehydrogenase,
and the absorbance decrease due to NADH disappearance was recorded




fJ&L2. 3a Standard curve of ammonia assayed by t-he chemical method.
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Fig. 2.3b Standard curve of ammonia assayed by the enzymic method.
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were performed with every batch of estimations. Blank values
reflected the presence of ammonia in reagents or adsorbed to
glassware.
Since the quantities of ammonia to be measured are generally
small (20-30 n moles per assay), contamination by exogenous ammonia
had to be avoided. It derives from several possible sources:
1. Glassware. All glassware was washed in 0.1 mol/1 HC1 prior
to use in ammonia experiments. Cuvettes were a common source of
contaminating ammonia: if they had previously held reaction mixtures
containing enzymes in ammonium sulphate suspension, they usually
retained a considerable quantity of adsorbed ammonium ion. A set
of cuvettes and stirrers was therefore kept specifically for
ammonia estimations, and was soaked in 0.1 mol/1 HC1 for 30 minutes
be core use.
2. Distilled water. Since all reagents were prepared with
distilled water, the separate contribution of this source towards
the ammonia contamination is difficult to assess. It accounts for
the blank dbsorbance decrease remaining when the contributions of all
other sources have been accounted for. Glass-distilled water was
used throughout the present study.
3. Laboratory air. Ammonia in laboratory air could come from
rats temporarily caged in the vicinity prior to use in experiments,
or from experiments producing ammonia in neighbouring laboratories.
The ammonia content of laboratory air was tested by aspirating 50
iitres of air overnight through 18 m mol/1 sulphuric acid in a Dreschel
bottle. Since this procedure caused no increase in the measured ammonia
content of the acid, it was inferred that ammonia contamination from
atmospheric sources was negligible.
4. Reagents. Several of the reagents used in the ammonia assay
contained ammonia which contributed to the absorbance decrease of
blank tests. The individual ammonia contents found by varying the
quantity of each reagent in the cuvette are shown in Tab1"? 2.1.
Routine assays involved the measurement of 20-30 n moles of ammonia.
The ammonia contamination introduced in the buffer was minimized
(1) by using potassium rather than sodium phosphate and (2) by
using dipotassium phosphate, which was adjusted to pH 7.0 with dilute
HC1 freshly prepared from the concentrated acid.
Loss of ammonia gas from solutions. If ammonia is lost from
solution as NH^ gas, measurements of ammonia changes during for
example prolonged perfusion will be inaccurate. A trial experiment,
however, showed that no such loss occurred under experimental
conditions. Standard heart Krebs Ringer (250 ml, pH 7.4, 37°C)
containing 4.6 mmol/1 ammonia was gassed vigorously with oxygen-5%
C0 gas mi :ture for 2 hours, during which time no ammonia was lost
from the solution. It can therefore be assumed that the ammonia in
the water phase does not enter the gas phase during closed-circuit
perfusion. Furthermore, it is unlikely that any loss of ammonia
occurs during overnight storage of samples at -15°C.
2.2.8 Glutamate and Glutamine
Chemical methods for assay of these compounds in biological
materials are neither reliable nor specific. Although specificity
can be increased by separating the compounds on an ion-exchange column
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before measuring them (Bessrvan «rt al., 1948; Moore and Stein, 1954a,b),
most of the techniques which have been reported depend on the use of
specific enzymes.
★
The estimation of glutamate using glutamate dehydrogenase
is complicated by the unfavourable equilibrium constant of the reaction
under physiological conditions, so that special steps are necessary
in order to ensure that the reaction proceeds to completion.
Sowerby and Ottaway (1966) removed the NADH formed by coupling it
to tetrazolium reduction. Holzer et_ al^., (1965) used the expensive
3-acetylpyridine analogue of NAD* which has a more favourable redox
potential than NAD* but reacts more slowly and requires a higher enzyme
concentration. Raising the pH alters the equilibrium so as to increase
glutamate oxidation; this is enhanced by the use of a ketone reagent
such as hydroxylamine (Albers _et al., 1961) or hydrazine (Bernt and
Bergmeyer, 1965) to remove the cc-oxoglutarate formed in the reaction.
Glutamine cyclizes to ammonium pyrrolidone-carboxylate when
heat<=d in solution at neutral pH. Hence the decrease in ninhydrin-
liberated CO^ after this treatment, measured manometrically, has been
used as a measure of glutamine concentration (Hamilton, i94u).
Glutamine has also been determined directly using glutamine amino¬
transferase (Kupchik and Knox, 1970). It is more usual to measure
glutamine by first hydrolysing it to glutamate and ammonia.^ Acid
hydrolysis is simple (Segal and Wyngaarden, 1955; Balis, 1971), though
* + GluDH
Glutamate + NAD+ and H^O > <x-oxoglutarate + NADH + NH^
^ Glutamine s- 1^0 » Glutamate + NH^
enzymic hydrolysis is more specific. Asparaginase has been used in
a cwo-step procedure (Cooney et_ al_., 1971): a small quantity of the
enzyme is used to hydrolyse asparagine, after which a large amount
is added to hydrolyse glutamine. The procedure is ra+her expensive.
Glutaminase, however, is the enzyme of choice, and has been used
in glutamine determination for some years (Archibald, 1944a,b; Segal
and Wyngaarden, 1955; Sowerby and Ottaway, 1966; Ottaway, 1969a;
Nahorski, 1971; Williams et_ aJ., 1972). Commercial enzyme
preparations are unstable but a less pure laboratory preparation is
more stable and perfectly satisfactory (Sowerby and Ottaway, 1966).
Hydrolysis of glutamine is followed by measurement of ammonia
(Archibald, 1944a; Segal and Wyngaarden, 1955) or glutamate
(Sowerby and Ottaway, 1966; Ottaway, 1969a; Nahorski, 1971;
Williams et_ al., 1972). Older methods for the estimation of glutamate
and glutamine were reviewed by Archibald (1945); more modern methods
have been reviewed by Balis (1971).
2.2 S.l Laboratory Procedure - Glutamate
(?) The t?trazolium method (Sowerby and Ottaway, 1966). Glutamate
oxidation was coupled to the reduction of INT using phenazine
methosulphate. The formazan produced was dissolved by adding acetone
and dilute hydrochloric acid and its absorbance was measured at
460 nm. Absorbance was linearly related to concentration from
0 to 0.25 ymoles of glutamate, giving an extinction coefficient of
2.12 perymole.
The method had several disadvantages. Firstly, it was not
sufficiently sensitlce to detect the low glutamate concentrations
in a rat heart perfusate. Secondly, variation between batches of
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Table 2.3 The effect of hydroxy1amine and ammonia concentration
on the equilibrium of the glutamate dehydrogenase reaction usea
in glutamate assay.
A standard aliquot of glutamate (0.050 ymoles) was assayed
using the hydroxylamine technique (see text). The hydroxylamine
concentration in the assay mixture was varied, or ammonium sulphate
solution was added to the cuvette, to produce the conditions shown.
100% oxidation of glutamate occurred when 0.050 ymoles of dADH
were generated in the reaction, as measured by absorbance ai 340 nm.
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INT resulted in different absorbance coefficients (see Sowerby and
Ottaway, 1966). Thirdly, the method was unsuitable for assay of
perchlorate acid extracts. The small amount of perch]orate remaining
after neutralization formed an insoluble salt with the tetrazolium
cation, reduction of which was impaired. Perchlorate can be removed
by the addition of nitron acetate, since nitron forms an insoluble
perchlorate which can be ce.-.trifuged down before addition of INT.
Excess nitron itself impaired tetrazolium reduction (Table 2.2),
and the difficulty of achieving exact stoicheiometry of nitron
addition rendered the technique impracticable.
(b) High pH and Ketone Reagent
1. Hydroxylamine (Albers et_ aK, 1961). The assay mixture was
as follows:
Hydroxylamine, 0.3 mol/1, pH 8.0 0.5 ml
NAD+, 100 m mol/1 0.020 ml
Glutamate dehydrogenase (10 mg/ml solution n 1
in 50% glycerol) ' J m
Distilled H^O to a total of 1.000 ml
The increase in NADU absorbance was complete in 20 minutes at
37°C, corresponding to complete oxidation of the glutamate added.
The rate of reaction was not increased by the addition of ADP, an
activator of glutamate dehydrogenase in the reverse reaction. The
percentage of glutamate oxidized was affected by the hydroxylamine
concentration in the cuvette, but not by the addition of ammonia
(Table 2.3). It was therefore concluded that the generation of
ammonia during the reaction would hate no detrimental effect on the
measurement of glutamate.
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The hydroxylamine method was a simple and reliable technique,
used when glutamate was to be assayed without concomitant measurement
of glutamine.
2. Hydrazine (Bernt and Bergmeyer, 1965). The buffer used in
this method contained glycine (0.9 mo1/1) and hydrazine (0.72 mol/1)
at pH 9.0. The rate of reaction was rather slower than that in the
hydroxylamine technique, but hydrazine was the only method which could
be used when glutamine was also to be assayed (see below).
Some assays were affected by a sharp increase in absorbance
beginning about 10 minutes after enzyme addition, which was unconnected
with NADH production. It occurred in cuvettes containing only
glutamate dehydrogenase and buffer, and the solution then exhibited
a "pearly" turbidity. It was concluded that enzyme was denatured and
precipitated by the hydrazine or by the high pH. The effect was more
pronounced at lower buffer concentrations, suggesting that glycine
might have a protective effect on the enzyme. It did not occur if
glutaminase preparation had been added, suggesting that the protein
in this preparation might likewise protect the enzyme. Consequent
experiments showed that defatted bovine serum albumin completely
abolished the spurious rise in absorbance, and this was inaludc-d in
all assay mixtures (5 mg per ml of reaction mixture). The composition
of the assay mixture was as follows:
Glycine/Hydrazine buffer (see above), pH 9.0
NAD+, 100 m mol/1
Bovine serum albumin (10% in water)
GluDH, 10 mg/ml in 50% glycerol







(a) Acid hydrolysis (Adapted from Balis, 1971). Aliquots of sample,
containing 20 to 100 n moles of glutamine, were pipetted into 1 ml
Eppendorf microbeakers and heated in 2 mol/1 HC1 for 15 minutes at
100°C. Ammonia was measured in the hydrolysate after neutralization
with a calculated amount oT NaOH. The glutamine content was found by
subtracting the ammonia concentration measured in the unhydrolysed
sample from that measured in the hydrolysate. If ammonia greatly
exceeded glutamine in the sample, as it did in perfusate to which
ammonia had been added, it was more accurate to measure glutamate
in the hydrolysate, using the hydroxylamine method (2.2.8.1). Acid
hydrolysis was used in order to avoid the lengthy preparation of
glutaminase when only a small number of samples required to be
analysed.
(b) Enzymic hydrolysis. Hydrolysis of glutamine by glutaminase,
being more specific than acid hydrolysis, was used whenever practicable
The method of Sowerby and Ottaway (1966) based on that of Klingman
and Handler (1958) yields a glutaminase preparation which is stable
on storage and is effective in the measurement of glutamine. A
specimen preparation is appended (Appendix 2.1). It was possible to
couple glutamine hydrolysis directly to oxidation of the g.'utamate
formed, recording the absortance increase due to NADH produced in
the GluDH reaction.
Glutaminase was inhibited by both ketone reagents used in
glutamate measurement, and also by the perchlorate ion present
in tissue extracts. Inhibition in all cases increased with the
time for which the enzyme was in contact with the inhibitor. These
Relativer tofglutaminhyd olysisingivenbuff r


























Table2.4heinhibitionofglutaminasbyhydr xylami e, hydrazineandperchloratio .
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Fig. 2.4 Inhibition of glutaminase by substances present in the assay
mixture for glutamine.
The graph shows the decrease in the initial rate of glutamine hydrolysis
as the time increases for which glutaminase is incubated with the inhibitor
at 37 C. The units of the relative reaction rate, and the experimental
method,are explained in the legend to table 2.4.
The nature of the inhibitor in the reaction medium is as follows:
A = glycine-hydrazine buffer, pH 9.0.
B = glycine-hydrazine buffer + 0.1 ml neutralized HCIO , 1 mol/1.
C = glycine-hydrazine buffer + 0.4 ml neutralized HCIO , 1 mol/1.4
D = hydroxyiamine, pH 8.0.
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Time of preincubation with inhibitor (min)
56.
nmol glutamate
Fig. 2.5a Standard curve of glutamate measured by the use of glutamate
dehydrogenase in glycine-hydrazine buffer.
57.
nmol glufamine
Fig. 2.5b Standard curve of glutamine measured using glutaminase in
glycine-hydrazine buffer after prior determination of
glutamate.
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effects are shown in Table 2.4 and Fig 2.4. Glycine-hydrazine buffer
was used in routine glutfinine assay in preference to hydroxylamine,
and the amount of perchlorate added was kept to a minimum: 50 yl of
extract was sufficient for glutamine determination. Phosphate was
added as an activator of glutaminase (Klingman and Handler, 1958;
Sowerby and Ottaway, 1966).
2.2.8.5 The determination of glutamate and glutamine in the same
cuvette
Glutamate and glutamine were determined in the same cuvette, using
the following assay mixture:
Buffer: Glycine 0.9 mol/1, hydrazine 0.72 mol/1,
pH 9.0
Potassium phosphate, 1 mol/1, pH 9 (approx)
Bovine serum albumin, 10% in ^0
NAD* 100 m mol/1
Sample aliquot
GluDH, 10 mg/ml in 50% glycerol
Glutaminase in 50% glycero] (Appendix I)
Distilled water to a total of
All the adducts except the two enzymes were mixed m tne
test cuvette. A blank from which sample was omitted was placed in
the reference beam of the spectrophotometer. The addition of glutamate
dehydrogenase to sample and reference cuvettes caused a rise in
absorbance equivalent to the glutamate content of the mixture,
complete in 15-20 minutes; on addition of glutaminase, the further
rise indicated glutamine and was complete in a further 35 minutes.
Standard curves were drawn for glutamate and glutamine. The








using this technique was 6.08 and that due to lymole of glutamine
was 5.52 (Fig 2.5).
2.2.9 Total Amino-acid Analysis
In a small number of hearts, amino acids in tissue and perfusate
were measured using a Locarte amino acid analyzer (see Moore and
Stein, 1954a,b). By this method a large number of amino acids can be
■■measured in a single sample, although glutamine elutes with threonine
and cannot be distinguished from it. Ammonia cannot be measured
accurately by this method: the heavy contamination of the reagents
by ammonia always gives a large peak. Samples for analysis must
contain no amino acid in excess of 0.6 ymoles; and a pH of 2.2 is
necessary to ensure that all amino acids adhere to the resin. Samples
were prepared as follows:
An appropriate aliquot of solution (3-5 ml of perfusate samples,
or 0.2 ml of tissue extracts) was acidified to pll 2 (Johnson Universal
Indicator Paper) with hydrochloiic acid, lyophilized and stored at
-15°C. When required for analysis, the dry powder was dissolved
completely in 0.5 ml of citrate buffer, 0.2 mol/1, pH 2.2. A measured
aliquot (0.36 - 0.41 ml) was applied to the column and eluted with
successive changes of buffer in a standard procedure. Eluted amino
acids were reacted automatically with ninhydrin and recorded as peaks
on a chart recorder. The area under each peak was measured and the
amount of each amino acid present was calculated with reference to
known standards. Glutamine, taurine and glutathione standards were
run independently in order to determine their eJution time and
absorbance in the ninhydrin reaction.
Figure 2.6
The apparatus used in perfusion of
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The animals used in the present study were female albino rats
of a local strain. They were maintained on a standard rat-cake
diet (Oxoid 41B) with free access to water. Food, but not water,
was withdrawn 18 hours prior to killing. The animals used weighed
150 - 200 g.
2.3.2 Perfusion Technique
2.3.2.1 The perfusion apparatus. The apparatus was based on that
of O'Brien (1969) and was exactly as described in detail by Mowbray
(1969), with two additions: the perfusion pressure could be
measured directly by a manometer connected at the level of the cannula
tip; and the sample chamber was modified in some experiments so
as to accommodate a pH electrode (dual type micro-electrode, E.I.L.,
England). The apparatus is shown diagrammatically in Fig 2.6.
2.3.2.2 The perfusion medium. The medium was based on that of
Krebs and Henseleit (1932). The concentrations of calcium chloride and
magnesium sulphate were reduced by half, since in the live rat about
half the circulating calcium and magnesium is protein-bound and
thus not directly available to the tissue (see Fisher and 0 Brien,
1972; Mowbray, 1969). Calcium in stock solutions was measured by
the oxalate titration method of Kramer and Tisdall (1921).
The pH of the medium thus constituted from Analar reagents
was 7.57. The difference in pH from that quoted by Krebs and
Henseleit (1932) was partly due to the reduction in the concentration
of the acidic calcium and magnesium salts. Replacing one-third
of the bicarbonate with sodium chloride yielded a medium of p'l
7.39. Bicarbonate was well gassed with oxygen-5% CO^ (British
Oxygen Company) before the addition of the other components in order
to avoid the precipitation of calcium and magnesium salts (Krebs and
Henseleit, 1932) due to high pH. When medium of pH 7.57 was
required, the original bicarbonate concentration of Krebs and Henseleit
was used. Some experiments required a medium in which the standard
potassium concentration was reduced to 60%, achieved by replacing
half the potassium chloride with sodium chloride. All perfusion
media contained 1 mg per ml glucose (5.56 mmol/1).
About 200 ml of the medium was poured into the reservoir of
the preperfusion system, and allowed to run to the bottom of the
system without gathering air-bubbles. 50 ml was poured into the
perfusate chamber, and both portions of medium were gassed continuously.
The cannula was attached to the bottom of the preperfusion system
and filled to the tip with fluid, again excluding air-bubbles.
The pump was started, circulating the medium in the closed system.
When the temperature of the medium had reached 37°C and its pH
had become steady, it was ready for the attachment of the heut.
2.3.2.3 Preparation of the heart. Rats were anaesthetized in
an ether-air mixture. The beating heart was removed as quickly as
possible, avoiding injury to it, leaving the aortic arch intact. It
was placed in ice-cooled saline (0.9%, containing 0.1 mmol/1 EDTA to
reduce blood clotting) until it had become quite cold. It was then
cleaned, and all adhering tissue was removed. The aorta was cut
just on the proximal side of the first branch. The heart was blotted
and transferred to a tared beaker containing about 30 ml of ice-cold
Krebs medium and weighed. The end of the aorta was then slipped
over the tip of the cannula, connected to the preperfusion system,
ensuring that no air-bubbles entered during the process. The aorta
was tied on to the cannula with silk thread, and the lower tap on
the preperfusion system was opened to allow medium to flow through
the heart. Heart beat was often irregular at first. Hearts which
were not beating satisfactorily after 5 minuces or which showed
ratches of myocardium from which blood had not cleared, were rejected
2.3.2.4 Perfusion and sampling. The heart was washed out in the
preperfusion system for ten minutes. It was then transferred as
rapidly as possible to the closed system without allowing any air-
bubbles to pass through the organ. In general hearts were perfused
for a period of 75 minutes, although if required, a viable
preparation could be maintained for up to 2 hours.
Samples were taken by hypodermic syringe from a chamber
(Fig 2.6), fitted with a "suba-seal" rubber cap. In most experiments
1 ml of perfusate was withdrawn every 15 minutes. Samples were
heated to 90°C for 5 minutes to inactivate enzymes released by the
heart; if this was not done the presence of glutamate dehydrogenise
interfered with the ammonia assay, and LDH interfered with pyruvate
measurement. No loss of added glutamine (500 ymol/1) due to this
step was seen. Samples were stored at -15°C.
The values of some physical and metabolic parameters in rat
hearts perfused under the conditions described arc shown in Table 2.5
The pH of the perfusing fluid remained almost constant throughout
perfusion, falling during 75 minutes by 0.01-0.02 pH units.
Heartrate Oxygenconsumption(controlperf si ) "(+300ymol/1NH4+) Tissuelactate/pyruvatratio(6he rts) Perfusatelactate/pyruvateratio(7he rts) Glucoseptak(10hearts) Lactateproduction(11hear s) Temperature(inh artch mb r) pHofperfusate Perfusionpressure(atcannulati )
170-200beats/min 3.6ymol/min/heart 4.5 12.1+4.5(meanS.E.M.) 13.3+7.6 32.5+13 7ymol/g/hour 24.4+10.0" 37°C 7.39or.57 70cmof^
Table2.5Someparametersfthperfus drheart.
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2.3.2.5 Preparation of tissue extracts. At the end of perfusion,
the heart was removed from the heart chamber anc rapidly crushed in
a Wollenberger clamp pre-cooled in liquid nitrogen. Perfusate flow
was maintained until the heart was frozen. The frozen tissue was
transferred without delay to 1 ml of 1 mol/1 perchloric acid in 20%
v/v ethanol, pre-cooled in an ice-salt mixture, homogenized
(Lbtraturrax Homogenizer, Janke and Kunkel) and centrifuged. The
soluble extract obtained was neutralized with potassium carbonate
and cooled to freezing point, and the potassium perchlorate precipitated
was spun down. Extracts were stored in glass vials at -15°C. If
storage of unhomogenized tissue was unavoidable, it was stored
immersed in liquid nitrogen. Control hearts, described hereafter as
"unperfused", were analyzed after 10 min preperfusioti.
2.3.3 Perfusate Contamination of Tissue Extracts
When a perfused heart is freeze-clamped in the manner described
in the foregoing section, the extracellular fluid and any perfusate
circulating through the heart are frozen in addition to the intra¬
cellular fluid. These cannot be entirely excluded from the tissue
extract. If a metabolite to be determined in the ICF is also
present, in the ECF and perfusate, then the total volume of this
extracellular material must be known in order that an appropriate
correction may be applied. The phrase "perfusate contamination" is
used here to denote this volume. It was measured by one of the
procedures described below.
(a) Chloride estimation. The titrametric method of White
(1961), applied to perfused rat heart by Mowbray (1969), was
employed. A correction was required since chloride is also present
in the intracellular fluid, where its concentration is assumed to
be 25% of that in the perfusate (Mowbray, op. c.t.). However, this
concentration ratio may be affected by altering the concentration
of other ions in the perfusion medium, for example, by adding
ammonium ion (see Lux, 1971). In the present study, two hearts
perfused with medium containing 360 ymol/l ammonia showed high
internal chloride concentrations as measured by this method.
Furthermore, unexplained low titres were given rspeatably by certain
perfusate samples, and it was considered that more accurate results
could be obtained by the use of a labelled extracellular marker.
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(b) C-sorbitol as an extracellular marker (Morgan et al.,
1961). Sorbitol is confined to the extracellular space. 1 yC of
14
U- C-sorbitol and 25 mg of unlabelled sorbitol carrier were added
to the 50 ml of perfusion fluid. At the end of the perfusion, radio¬
activity was measured by scintillation counting, both in the perfusate
and in the perchlorate extract (Packard Tri-Carb liquid scintillation
counter). Hence the perfusate contamination of the extract was simply
and directly determined.
2.3.4 Extracellular pH
Extracellular pH was measured by incorporating a "dual" pH
electrode, specially made for measuring pH in small volumes, in
the main perfusion system. The electrode was connected to a pH
meter: both meter and electrode wert products of E.I.L. Instruments,
England The meter output was fed into a Servoseribe recorder, and
adjusted so that a pH change of 1 unit (7.0 to 8.0) gave a full
scale deflection (20 cm) on the recorder. A 500 yF capacitor was
connected across the recorder terminals to reduce noise caused by the
operation of the perfusate pump. The recorder chart was set in
motion at 12 cm per hour, and the external pH was recorded throughout
the perfusion.
2.3,5 Intracellular pH
Intracellular pH was investigated by the method of Waddell
and Butler (1959). 5,5-dimethyl-2,4-oxazolidinedione (DMO) is
a weak acid; in solution it exists in undissociated (HDMO) and
dissociated (DMO ) forms, which are in equilibrium. The proportion
of HDMO is increased by decreasing the pH:
It is assumed that the cell membrane is permeable to HDMO but
not to DMO , and that the rate of diffusion of HDMO across the
membrane is proportional to its concentration. Thus the ratio of
DMO concentration between the two sides of the membrane depends
on the pH gradient across it, and the internal pH can be calculated
if the external pH and the internal and external DMO concentrations
are measured. They are related by the equation
(Waddell and Butler, 1959), in which pHi and pHe are the internal
and external pH, pK is the acid dissociation constant of DMO
(= 6.13), Ce and Ct are the DMO concentrations in the ECF and
total tissue water respectively, and Ve and Vi ar^ the volumes of
the extracellular and intracellular compartments. If the concentration
H+ + DMO ^ HDMO
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of DMO in the ICF ca 1 be determined directly, as it can in the
perfused rat heart by application of the "perfusate contamination"
correction (Section 2.3.3), the equation reduces to fne following:
where Ci is the DMO concentration in the ICF, Vi is the intra¬
cellular volume per g tissue, T is the weight of DMO per g tissue
(T = Vp x Cp), and P is the DMO concentration in the blood or perfusate.
It is assumed that P and Ce are equal. The internal pH of perfused
rat heart was calculated from measurements of perfusate pH, and of
DMO concentration in the perfusate (P) and in the tissue (T).
Laboratory Procedure
DMO was added to perfusion media before the start of perfusion
(12.5 mg per 50 ml of medium). After perfusion its concentration
was determined both in the perfusate and in the tissue, as follows:
0.5 ml alj-quots of perchlorate extract or perfusate were mixed with
2 ml of 5 mol/1 NaFLPO^ and shaken with 12.5 ml of ether which had been
purified according to Giotti and Maynert (1951) and saturated with
water. 10 ml of the ether phase was withdrawn and extracted with
2.5 ml of ether-saturated borate buffer (0.05 mol/1, pH 9.0), 1 ml
of the buffer phase was taken and diluted in the case of perfusate
samples with 3 ml of fresh borate buffer. An ultraviolet absorbance
spectrum was recorded and the absorbance was read at the peak
wavelength of 210 nm. Perchlorate extracts were treated identically
except that 1 ml of the buffer phase was diluted with only 2 ml of
fresh buffer, and a second 1 ml portion of the buffer phase was
diluted with 2 ml of 0.1 mol/1 HC1. The absorbance at 210 nm in
acid solution was subtracted from the absorbance in pH 9 buffer
in order to correct for the effects of interfering substances present
in the tissue. The absorbance of a 1 m mol/1 solution of DM0 at pH 9.
in a 1 cm quartz cuvette was 11.0. To obtain the true intracellular
DM0 concentration (T), an allowance was made for DM0 in the EOF
and in perfusate frozen with the tissue, by applying the "perfusate
contamination" correction (Section 2.3.3).
The internal pH measured by this method was independent of the
external pH at the two values of external pH used:
External pH 7.39 + 0.01 7.57 + 0.03
Internal pH 7.07 + 0.08 7.06 + 0.11
(No. of hearts) (7) (8)
Va.'ues are means + S.E.M.
2,3.6 Isotopic labelling of Myocardial Ammonia
Isotopically-labelled ammonia was added to the perfusion medium
as ^N-ammonium chloride ("Prochem", the British Oxygen Company Ltd:
95.9% enrichment). Three concentrations were used:
(1) 10 pmol/1 ammonia, 80% enrichment
(2) 160pmol/l ammonia, 33% enrichment
(3) 360 pmol/1 ammonia, 19% enrichment
labelled ammonia was present from the start of perfusion. Hearts
were freeze-clamped after 15 minutes perfusion, and perchlorate
extracts were made in the usual way (Section 2.3.2.5). Since
facilities for stable isotope measurement were not available within
the Biochemistry Department, the number of hearts which could be
investigated by this technique was limited.
2.3.6.1 ^N-ammonia measurement
Ammonia must be removed from substances in the sample which
might interfere with the measurement of its labelling; it must
also be collected in as small a volume as possible. This was
achieved by passing the sample through a cation-exchange resin
column (Fenton, 1962). The direct action of alkaline sodium hypo-
bromite on the resin eluted the ammonia and converted it to nitrogen
gas (Rittenberg £t al., 1939), whose content was determined
by mass spectroscopy. No ammonia was eluted from unused resin by
strong alkali in a "blank" reaction.
Adsorption of ammonia. The resin (Bio-Rad AG 50W-X4, 100-200
mesii) was activated by washing with alkali followed by acid, as
described by Kingsley and Tager (1970), and stored under water at 2°C
until required.
Resins have been used by several workers to adsorb plasma ammonia
CFenton, 1962; Fenton and Williams, 1968; Hutchison and Labby, 1962;
Miller and Rice, 1963; Forman, 1964). All authors apart from the
first simplv shook a convenient volume of sample with the resin,
usually 1 volume of resin to 2 of sample. Using this technique,
however, it was not possible to adsorb more than 60% of an ammonia
sample containing 500 yg of nitrogen on to 1 ml of resin (Table 2.6).
Absorption at pH 7.0 was little different from that at pH 2.2.
+
pHofsolutionT talN ^inlution,H4adsorbedt%ofadded4 ygNH^-Nresin,^-adsorbedtresin 2.25.010 108.9 2517.972 10053.3 250147.759 5002837 1000532 7.0108.3
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Table2.6Adsorptionfammoniatresiinheest-tube. 1mlofactivatedc tion-exchangeresi(ste )wasshakenfor
1minwith5lofsolution,bufferedapH2.2(80m ol/1citra e)o pH7.0(8mmol/1phosphate),containingvaryiamountsofam niumchl ride. Residualammoniawass yedinthesupernata taft rcentrifug ti ni i g theenzymicmethod.
Total ammonia added to column = 508 ]ig NH^-N
Ammonia unadsorbed on first passage through column = 1.8 "
Ammonia eluted in 10 ml wash of column = 2.2 "
Hence ammonia adsorbed to resin = 504 "
Percentage of added ammon.ia adsorbed = 99.2%
Table 2.7 Adsorption of ammonia to resin in a column.
To a perchlorate extract of a rat heart, prepared as in section
2.3.2.5 of this chapter, was added ammonium chloride equivalent to
500 yg of ammonia nitrogen, giving a total of 508 yg of ammonia
nitrogen in a total volume of 6.0 ml. The solution was filtered
and added to 1.0 ml of activated resin in a column, 0.7 cm diameter.
The eluate was collected and ammonia was measured in it by the enzymic
method. The column was washed with 10 ml of water, and ammonia was
measured in the washing.
95.4% of the adsorbed ammonia (482 yg of ammonia nitrogen) was









Table 2.8 Glutamate oxidation coupled to
reduction of dissolved oxygen.
Reactions were carried out at 37°C in the dark, in a
total volume of 10 ml. Concentrations of NAD, FDTA, GluDH
and PMS were as given in the text. Initial concentrations
of glutamate in the reaction mixtures were as shown. The
extent of reaction was determined after 30 and 60 minutes
by measurement of the ammonia formed (phenol-hypochlorite
method). Solutions were not aerated during the reaction.
1^0 + Glutamate . /^P®red \ + ^+
NH^ + cc-oxoglutarate NADH V—PMSox
Figure 2.7 Redox events in glutamate oxidation coupled to
reduction of dissolved oxygen.
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However, if 1 ml of resin was poured into a column (Fenton, 1962),
99.2% of an ammonia sample containing 300 pg of nitrogen at pH 7.0
could be adsorbed on to the resin (Table 2.7).
Adsorbed ammonia could be quantitatively eluted with 4 mol/1
sodium chloride, but in order to keep the volume to a minimum the
resin was treated directly with alkaline hypobromite in the Rittenberg
tube.
2.3.6.2 ^N-Glutamate Measurement
Isotope incorporation into glutamate was determined in samples
from which the ammonia had been removed by the resin technique
described (Section 2.3.6.1). Glutamate nitrogen in the column eluate
was liberated as ammonia by the action of glutamate dehydrogenase.
The deamination of glutamate was made irreversible by the
addition of PMS to catalyse the oxidation of NADH formed in the
reaction (Sowerby, 1964) by oxygen dissolved in the medium (Fig 2.7).
Since the solubility of oxygen in air-saturated water at 37°C is only
0.205 m mol/1 or 0.410 m-g-atoms/1, glutamate present in excess of
0.4 m mol/1 cannot be completely oxidized by this method. In fact,
a concentration as low as 0.12 m mol/1 glutamate was necessary in order
to allow complete oxidation (Table 2.8). Dilution of samples to give
a suitable glutamate concentration was therefore necessary Aeration
of samples, whether carried out before or during the reaction, had
no effect on the extent of glutamate oxidation. The progress of the
reaction was monitored by assaying ammonia in aliquots of reaction
mixture by the Berthelot method (Kaplan, 1965). The enzymic method
could not be used owing to the presence of PMS, which would oxidize
added NADH.
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Once sufficient glutamate had been converted, the ammonia formed
was adsorbed on a second resin column and treated for mass spectrometry
as described in Section 2.3.6-1.
2.3.6.3 Laboratory Procedure for Determination of Labelling of Glutamate
and Ammonia in the Same Sample
The mass spectrometer used required a minimum of 500 yg of nitrogen
gas for operation, whereas samples contained between 2 and 60 yg of
nitrogen as ammonia. Therefore 500 yg of unlabelled nitrogen (as
ammonium chloride) was added to all samples before adsorption to the
column, the extent of isotope dilution at this stage being known
accurately.
Samples of perfusate and extract were prepared in the usual way
(Section2.3.2), andthe concentrations of ammonia and glutamate in
them were determined accurately. An appropriate volume of each was
14
taken, ammonium chloride solution containing 500 yg of N was added,
and the pH was adjusted to between 5 and 6 using Johnson Universal
Indicator paper. At this pH glutamate does not adsorb to the
resin (Fig 2.8). The sample was run on to a column containing 1 ml
of resin, 0.7 cm diameter at a rate of 1 ml per minute. The column
was washed once with 10 ml of distilled water. The resin was washed
quantitatively into a sample tube, and excess water was carefully
pipetted off after settling. No detectible ammonia was eluted from
the resin by this procedure. Resin samples were stored at -15°C
until required.
15If the sample was also required for N-glutamate measurement, the
eluate from the first column was retained. Its volume was Kept as














































E F G fraction
I7l glutamaf? □ a mmonia
Fig. 2.8 The separation of air monia and glutamate using a cation-
exchange resin.
To a rat heart perchlorate e.>: tract were added ammonium chloride
and sodium glutamate corresponding each tc 500 j»g of nitrogen. The
pH was adjusted to 6.0 (Johnson Universal Indicator Paper) and the solution
(volume 5 ml) was added to the column. The resin was washed once
with 10 ml. water and then with 5 ml of 4 moi/1 sodium chloride. The
diagram shows that all the ammonium i m is adsorbed, ana can be eluted
vith sodium chloride, whereas all the glutamate pa tees through the column
without adsorption. Volumes of fractions are as follows: A, 9.0 ml;
B, 6.0 ml; C - G, 1.0 ml. A and B were collected before NaCl was added
to the column; C - G represent elution of the column with 4 mol/1 NaCl.
Ammonia was measured using the enzymic method and glutamate using
the hydroxylamine technique.
to 7.0 (indicator paper), and 2.0 ml of potassium phosphate buffer,
pH 7.0, 0.2 mol/1 was added, followed by:
NAD+ (100 m mol/1) 0.020 ml
EDTA (8.7 m mol/1) 0.040 ml
GluDH C10 mg/ml in
glycerol)
PMS (0.1%) 0.040 ml
The volume was adjusted to 10 ml with water, and the mixture was
incubated in the dark for 45 minutes at 37°C.
At the end of the incubation, tubes were rapidly frozen in an
ice-ethanol mixture to prevent further reaction and ammonia determined
(Berthelot method) in an aliquot taken before freezing, to determine
the extent of reaction. Tubes were heated to 90°C for 5 minutes
to destroy glutamate dehydrogenase, ammonium chlc ide solution
14
containing 500 yg of N was added, and the pH was readjusted to
6.0. The mixture was run through a second column to adsorb the
ammonia, the technique being exactly the same as that employed in
the first pdsorption.
For mass spectrometry each resin sample was washed mvo
one leg of a Rittenberg tube. To the other leg was added 2 ml
of alkaline sodium hypobromite. This was made by adding bromine
dropwise to 10 mol/1 NaOH until no more dissolved (Van Slyke, 1927).
After evacuation of the tube the contents were mixed and the nitrogen
evolved was measured in a mass spectrometer (A.E.I.). Enrichments
14
were calculated by comparison with blanks consisting of N-ammonia
equivalent to 500 yg of nitrogen, adsorbed to 1 ml of resin.
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2.4 Enzyme Localization in Rat Heart
2.4.1 Histochemical localization of enzymes
The localization of enzymes in thin sections of rat heart follows
the methods described by Pette and Brandau (1966), Brandau and Pette
(1966) and Sigel and Pette (1969).
2.4.1.1 Preparation of Tissue Sections
Rats were maintained on a standard laboratory diet and killed
by cervical fracture and exsanguination without prior fasting. The
heart was removed as quickly as possible and transferred to isotonic
potassium chloride solution at 0°C; when contraction ceased the heart
remained in a relaxed state. The ventricular muscle was cut into
strips of 2 mm cross-section which were soaked for a further
1 minute in the KC1, rapidly blotted with filter paper, and
transferred to isopentane cooled in liquid nitrogen. In one
experiment a heart was perfused with ice-cold buffered KC1 through
the coronary system, but the tissue sections prepared from this
specimen presented an identical microscopic appearance to those
prepared by the standard method. The pieces of frozen tissue were
mounted on a cryostat block at -20°C, and 10 ysections were cut with
a microtome (Cryostat and microtome were products of W. Dittes,
Heidelberg, W. Germany). The sections were allowed to fall on to
a microscope slide and thawed by pressing a finger to the underside
of the glass. They were stained as described below by the immediate
application of a staining gel mounted on a cover-slip. Sections
were cut, stained, fixed and mounted on the same day as removal of
the heart from the rat.
2.4.1.2 Preparation of Gel-films
Bright daylight was avoided throughout the preparation of the
staining media in order to minimize the decomposition of PMS. Gel-
film staining systems (Pette and Brandau, 1966) were used in the
localization of all enzymes with the exception of cytochrome oxidase
(Section 2.4.1.5). Agarose powder (60 mg) was mixed with 1 ml of
double-distilled water and 1 ml of reaction buffer (see Section 2.4.1.4).
The mixture was heated in a boiling water-bath with thorough mixing
until it formed a clear solution, which was kept liquid at 42°C until
required. 1 ml of the solution was withdrawn using a pre-warmed
pipette with a wide orifice, and mixed with 1 ml of medium, also at
42°C, containing all the staining reagents in double concentration.
The final agarose concentration was thus 1.5%.
Glass cover-slips were arranged on a metal plate heated by
circulation of water at 42°C, and a 0.2 mm spacer consisting of a
loop of chrome-vanadium wire wc^ placed cn each. A drop of liquid
staining gel was pipetted on to the certre of each cover-slip, and
a second cover-slip was placed on top of the gel and covered with a
5 g weight. The plate was cooled by passing tap-water through it,
and the solidified gels were stored in a light-proof box in which
water provided a humid atmosphere. Gel-slices thus prepared and
stored could be used on the day of preparation, but were not kept
overnight.
2.4.1.3 Staining
A suitable tissue section, containing fibre.- cut in longitudinal
section, was selected by viewing in the phase-contrast microscope.
After removal of one of the cover-slips and the wire loop, a staining
gel was inverted and placed on the tissue section on its microscope
slide. The system was incubated at 3 7°C, observing colour development
microscopically until sufficient staining had occurred. Then the
gel-slice was carefully removed and the section was fixed in 4%
formaldehyde and mounted iii situ in glycerol-gelatine. The stained
sections were photographed on the following day.
2.4.1,4 Composition of Staining Media
Test staining gels for lactate, glutamate and succinate
dehydrogenases were based on the tetrazolium system of Pette and
Brandau (1966); the GOT gel was developed after spectrophotometry
tests in liquid media to determine the optimal reagent concentrations.
In the GOT test, transamination was coupled to glutamate reduction:
GOT
cc-oxoglutarate + aspartate > Glutamate + oxaloacetate
GluDH
Glutamate + NADP+ + l^O —> °c-.^oglutarate + NH^+ + NADPH
Since a-oxoglutarate is proeuced in the GluDH reaction, high
concentrations added to the gel inhibit staining. The optimum
concentration was 1.5 mmol/1. NADP+ was used as the coenzyme in
the auxiliary reaction since NADH is reoxidized by oxaloacetate and
endogenous malate dehydrogenase. Glutamate dehydrogenase used
as the auxiliary enzyme wasfreedfrom ammonium sulphate by overnight
dialysis against 2 changes of 200 mmol/1 imidazole buffer containing
5 mmol/1 EDTA, pH 7.6.
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The composition of the staining gels is set out beiow; for
each enzyme control gels without substrate werci also prepared.
•k
Lactate dehydrogenase. TEA = 50 mrnol/1, pH 7.6; EDTA = 1 mmol/1;
Nitro-BT = 1.5 mmol/1; NAD+ 2.3 mmol/1; L-lactate = 24 mmol/1;
DMS = 0.3 mmol/1; agarose = 1.5% (w/v).
Glutamate dehydrogenase. TEA = 50 mmol/1, pH 7.6; EDTA = 5 mmol/1;
Nitro-BT = 1.5 mmol/1; NAD+ = 2.3 mmol/1; L-glutamate = 50 mmol/1;
ADP = 2 mmol/1; PMS = 0.15 mmol/1; agarose = 1.5%.
Succinate dehydrogenase. Phosphate buffer = 100 mmol/1, pH 7.6;
EDTA = 5 mmol/1; Nitro-BT = 1.5 mmol/1; PMS = 0.15 mmol/1;
succinate = 80 mmol/1; KCN = 1 mmol/1; agarose = 1.5%.
Glutamate-oxaloacetate transaminase. TEA = 50 m mo1/1, pH 7.6;
EDTA = 5 mmol/1; Nitro-BT = 1.5 mmol/1; NADP+ = 5 mmol/1;
cc-oxoglutarate = 1.5 mmol/1; L-aspartate = 50 mmol/1; GluDH = 100
units/ml; ADP = 2 mmol/1; PMS = 0.2 mmol/1; agarose = 1.5%.
2.4.1.5 Cytochrome Oxidase
Cytochrome oxidase was localized using the diaminobenzidine
(DAB) technique of Seligman et al_., (1968). A liquid staining medium
was used, composed as follow^:
Sodium phosphate = 0.05 mol/1, pH 7.4; DAB = 0.5 mg/ml;
catalase = 2 yg/ml; cytochrome c = 1 mg/ml; sucrose = 75 mg/ml
(= 0.22 mol/1); total volume - 5 ml.
DAB was obtained as the tstranydrochloride which was neutralized before
use. Control gels contained in addition 10 mmol/'l potassium cyanide
:k
A list of abbreviations can be found on p. 32,
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to inhibit cytochrome oxidase. Colour development in control sections
was not completely prevented unless tissue slices were preincubated
in a medium containing buffer, 75 mg/ml sue rose and 10 mmol/1 KCN
(Nir and Seligman, 1971).
Sections were prepared on microscope slides as described in
Section 2.4.1.1, and 100-200 yl of staining medium was pipetted on
to each. After 40 minutes incubation at 25°C the section was carefully
blotted, fixed in 5% acetic acid, dried and mounted in glycerol-gelatine.
2.4.1.6 Exogenous Alcohol Dehydrogenase
In experiments in which the possible adsorption of exogenous
alcohol dehydrogenase to the muscle fibres was studied, a section
was prepared by the standard technique (Section 2.4.1.1) and a 5 yl
drop of a test solution was placed upon it by pipette. Two test
solutions and two control solutions were used:
1. Alcohol dehydrogenase, 10 mg/ml in 0.8 mo1/1 ammonium sulphate.
2. Control: 0.8 mol/1 ammonium sulphate
3. Alcohol dehydrogenase, 10 mg/ml in 2 mmol/1 phosphate, pH 7.0.
4. Distilled water control.
Alcohol dehydrogenase was obtained as a 30 mg/ml suspension in
2.4 mol/1 ammonium sulphate; solution (1) was prepared from it by
dilution, and solution (3) by dialysis against 2 mmol/1 phosphate
buffer followed by volume adjustment.
After 3 minutes at room temperature, excess liquid was carefully
soaked away from the tissue section with filter paper and a
staining gel was applied. Colour development war sufficient after
5 minutes incubation at 37°C. Sections were photographed immediately,
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w:th the gel-slice in position, since the ADH incubation technique
loosens the tissue from the slide and renders removal of the gel
impossible. In a further control experiment a 5 yl drop of 15 mmol/1
NADH solution was applied to the tissue section, in an analogous
manner.
The gel-film staining media employed in these experiments had
the following composition:
Exogenous ADH: TEA = 50 mmol/1, pH 7.6; EDTA = 1 mmol/'l;
Nitro-BT = 1.5 mmol/1; NAD+ = 3.0 mmol/1; Ethanol = 44 mmol/1;
PMS = 0.15 mmol/1; agarose = 1.5%.
Exogenous NADH: TEA = 50 mmol/1, pH 7.6; EDTA = 5 mmol/1;
Nitro-BT = 1.5 mmol/1; PMS = 0.15 mmol/1; agarose = 1.5%.
2.4.2 Enzyme Localization in Disrupted Tissue
2.4.2.1 Fractional Extraction of Endogenous Enzymes
The technique used was that of Pette (1968). Rats were
maintained an a standard diet (Oxoid 41B), and were killed by
cervical fracture and exsanguination without prior fasting. The
heart was removed immediately, cut into small pieces and minced at
2°C in a specially-constructed micro-meat-mincer (B. Braun, Apparatebau,
Melsungen, W. Germany). 500 mg of minced tissue was weighed into
a 10 ml centrifuge tube and suspended in 9.5 ml of sucrose medium
(0.3 mol/1 sucrose, 10 mmol/1 triethanolamine hydrochloride, 2 mmol/1
EDTA, adjusted to pH 7.4). The suspension was stirred for ^5 minutes
in an ice-bath by ?. teflon plumper moving vertically at 80 cycles
per minute. The clearance between the plumper and the sides and
bottom of the tube was sufficiently wide that shearing forces in
the liquid, which might cause rupture of organelles, were avoided.
After 15 minutes the tube was centrifuged for 20 minutes at 140,000 g
(Spinco L50 ultracentrifuge, rotor type 50 Ti, 45,000 rpm) and
the clear supernatant was decanted and labelled S^. Resuspension
of the pellet in sucrose medium and repetition of the procedure
yielded supernatant S^. Fractions and represent the "washing
out" of the cytoplasmic compartment by a medium of low ionic strength
without liberating enzymes from mitochondria. The pellet was re-
suspended in phosphate buffer (0.1 mol/1, pH 7.2), "plumpered" for
15 minutes and recentrifuged to yield supernatant S^. This medium
causes swelling of the mitochondria and rupture of the outer
membrane with liberation of intermembranal enzymes such as adenylate
kinase from li/er mitochondria (Pette, 1966). The pellet was
homogenized in 2 ml of phosphate buffer (Polytron PT 10 homogenizer,
Kinematic, Luzern, Switzerland), diluted to 10 ml with phosphate buffer
and stirred for 10 minutes. Centrifugatiori yielded supernatant
and the pellet P, which was resuspended in 0.05 mol/1 phosphate, pH 7.2,
using a ground-glass hand-homogcnizer. 3^ contains enzymes soluble
in the intramitochondrial matrix; P contains membrane-bound enzymes.
Enzyme activities in all fractions were measured spectrophoto-
metrically at 25°C by standard reactions involving appearance or
M
disappearance of NADH (Bucher et al., 1964); succinate dehydrogenase
was measured by the reduction of cytochrome C by succinate in the
presence of cyanide. Enzymes in fractions containing mitochondrial
membranes (e.g. fraction P) were measured after inhibition of NADH
oxidase by the addition of rotenone (2 yl of a 0." m mol/1 solution in
ethanol) to the cuvette.
2.4.2.2 Adsorption ^est fo" ADH in a heart homogenate
A freshly-excised rat heart was washed for 10 minutes by
coronary perfusion with ice-cold Krebs medium (Krebs and Henseleit,
1932), the temperature effect on pH being overcome by altering the
bicarbonate concentration. 0.5 g of tissue was homogenized
(Ultraturrax homogenizer, Janke and Kunkel) in a medium cf low ionic
strength (0.3 mol/1 sucrose, 5 mmol/1 triethanolamine hydrochloride,
0.5 mmol/1 magnesium sulphate, pH = 7.2). Yeast alcohol dehydrogenase
was added (0.1 mg, having an activity of 8.40ymoles per minute
at 25°C as measured by the Racker (1950) assay), and the solution
was diluted to 10 ml with sucrose medium. The mixture was stirred at
0°C for 20 minutes to permit any adsorption to take place, and
centrifuged at 36,000 g for 25 minutes (Spinco L50 ultracentrifuge,
rotor type 40, 40,000 rpm) to yield the supernatant S^. The sediment
was resuspended and washed for 15 minutes with a second 10 ml portion
of sucrose medium to yield supernatant S^. The pellet from this
steF was resuspended and washed in a medium of high ionic strength
(0.1 mol/1 phosphate, pH 7.2), yielding supernatant and the pellet
P, which 'Was resuspended in phosphate buffer. Alcohol dehydrogenase
was measured in all fractions by the method of Racker (1950), with
the addition of semicarbazide and glutathione in the concentrations
recommended by Boehringer and Soehne (Biochimica catalogue).




A specimen preparation of Glutaminase from Pig's kidney
Klingman and Handler (1958)
Sowerby and Ottaway (1966)
Kidneys from freshly-killed pigs (slaughterhouse), total
227 g, were homogenized using a Waring blendor in 5 volumes (1,135 ml)
of 8.5% (w/v) sucrose, containing 0.02 mol/1 borate, pH 8.1. The
homogenate was centrifuged at 1,500 g for 15 minutes (3,000 rpm in
the 6 x 250 ml rotor r,f an MSE High Speed 18 centrifuge) and the
sediment was discarded. The supernatant was strained through two
layers of muslin and centrifuged to precipitate the mitochondria
(20,000 g, 20 min). The sediment was lyophilized.
The dried powder (14.23 g) was homogenized at -10°C for 2
minutes (Waring Blendor) in 504 ml of redistilled butanol, pre-
cocifcd to -10°C. The homogenate was sucked almost to dryness on a
Buchner funnel, rehomogenized for 30 seconds at -10°C in 229 ml of
acetone redistilled from potassium permanganate, and returned to the
suction funnel. Just before dryness, 50 ml of redistilled diethyl
ether was added to the powder in the funnel, which was then sucked
dry. The powder was dried overnight in a vacuum desiccator.
To prepare a soluble extract containing the enzyme, the dry
powder (weight 11.92 g) was stirred for 1 hour in 286 ml of 0.01 mol/1
borate, pH 8.1 at 4°C. The suspension was centrifuged at 29,000 g
for 15 minutes (MSE High Speed 18, 6 x 100 ml rotor, 15,000 rpm).
119 ml of cold 4 mol/1 potassium phosphate, pH 8.0, was added to the
supernatant dropwise over a 30 minute period, stirring continuously.
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The suspension was stirred for a further 15 minutes and centrifuged
at 29,000 g, and the precipitate was dissolved in 47.6 ml of 0.01 mol/1
borate, pH 8.1. The enzyme was precipitated a second time with
23.8 ml of 4 mol/1 phosphate, spun down and redissolved in the minimum
volume (18 ml) of a buffer containing 0.03 mol/1 borate and 0.02 mol/1
phosphate, pH 8.1. The solution was dialyzed overnight against 2 litres
of the same buffer, changing the buffer once, to remove protein-bound
glutamate. A precipitate formed during dialysis, which was not
observed by Sowerby and Ottaway (1966). After centrifugation, however,
virtually all the enzyme activity remained in the soluble supernatant,
which was dispensed in 2\ ml portions into glass vials and stored
at -15°C. The frozen enzyme was stable for 6 months without serious
loss of activity, but was rapidly inactivated by repeated freezing
and thawing. Enzyme solution in regular use was therefore diluted
with an equal volume of Analar glycerol and stored at -15°C. Under
these conditions the enzyme remained active for at least one month.
The enzyme was assayed during its preparation. The ra.te of
production of ammonia from glutamine by the enzyme was measured
using excess glutamate dehydrogenase in tne following mixture:
Sodium phosphate buffer, 0.2 mol/1, pH 7.2
NADH, 8.5 mg/ml
oc-Oxoglutarate, 150 m mol/1'
GluDH, Boehringer solution in glycerol
(10 mg/ml)
Aliquot of glutaminase preparation
Glutamine, 0.2 mol/1
Distilled water to a total volume of
All adaucts except glutamine were mixed in the cuvette. Once all








was added and the initial rate of absorbance decrease was recorded.
Table 2.? shows the progress of the glutaminast purification. The
protein content of the solution was estimated by measuring the
absorbance at 28G nm and 260 nm (Warburg and Christian, 1941) using
an SP 500 spectrophotometer (Pye-Unicam, Cambridge). The glutaminase
preparation contained, finally, 24 mg of protein per ml, or 12 mg/ml





Specificact vity, ymol/min/gpr tein
Mitochondrialprecipitate beforelyophilization Extractedbut nol powder Final4mol/1phosphate precipitate,before dialysis Ditto,afterdialysis Supernatantafter centrifugingdialysate Pelletaft r centrifugingdialysate
190 300
18 28.5 25.0 8.9
76.3 82.8 181.1 338.0 371.0 15.1
8.89 3.59 0.62 0.62 0.61
Notmeasured
86 231 292. 546 603
Table2.9hctivityofglutaminaseduri gpreparation. Activitywasmeasuredadescribeinthext.Tpp r nt
increasetheot lglutaminaseactivityduri gp eparations theremovalofsubstancesinhibitingtas y.
CHAPTER 3
SOME KINETIC STUDIES ON AMMONIA IN PERFUSED
RAT HEART
Chapter 3. Some Kinetic Studxes on Ammonia in Perfused Rat Heart.
3.1 Ammonia in Animal Tissues.
It was suggested (Chapter 1, Section 1.4) that the relatively
high ammonia concentration in tissues such as muscle may be of
physiological importance. The concentration of ammonia was
measured in three tissues of the rat and compared with values
reported by other authors (Table 3.1). The concentration of ammonia
is similar in all the tissues shown in Table 3.1. Some workers
reported values higher than these, which can usually be attributed
to one of two causes. Early workers (e.g. Meyerhof et al., 1925;
Embden et_ al., 1928b) did not appreciate that dying or traumatized
tissue produces large amounts of ammonia (Parnas and Mozolowsky, 1927),
and allowed too long a time to elapse between removal of the tissue
and making the extract. Some more recent workers, who are primarily
concerned with amino acid concentrations (e.g. Manchester and Wool,
1963; Scharff and Wool, 1965a), quote a value corresponding to the
ammonia peak eluted by an amino acid analyzer, which is generally
high owing to the presence of ammonium salts in the reagents used.
The concentration of ammonia in plasma is much lower than that
in muscle tissue. Representative data are given in Table 3.2.
Larger values than these are probably again due to less specific
methods of analysis (Chapter 2, Section 2.2.7). Concentrations in
whole blood show greater variation than do plasma concentrations.
Erythrocytes have a high internal ammonia concentration (Seligson
and Hirahara, 1957). Furthermore, erythrocytes possess adenylate
deaminase (Dimond, 1955; Lowenstein, 1972). Act:on of this enzyme
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Tissue Ammonia concentration, Reference and Notes
ymol/g fresh weight
Present Study
Rat liver 0.632, 0.470 ") Single determinations,
Rat leg muscle 0.410 J chemical method
Rat heart 0.430 + 0.030 ( Enzymic method,






Rabbit leg muscle 0.250
Rat leg muscle 0.274
Pigeon breast muscle 0.342
Locust leg muscle 0.455
Locust flight muscle 0, 282
Rat heart 0.419
Embden et al., 1928b
Parnas and Mozolowski, 1927
Gerez and Kirsten, 1965
Stewart et al., 1969













































Table3.2Concentrationfmmoniaimam ablood,s givenbyvariousauth rs.
oo
on AMP is probably responsible for the rapid increase in the
ammonia content of whole blood after drawing (Scudder and Smith,
1940; Reif, 1960; Mondzac et al., 1965). Inhibition of the enzyme
by heparin may result in the lower values characteristic of heparinized
blood (Dimond, 1965). The failure of some workers to demonstrate
any ammonia in the blood of rested, fasting humans (Kirsten et al.,
1963) is at variance with the majority of authors. The ammonia
concentration in rat blood is 0.03 mmol/1 (Astakhova and Golubev, 1967).
A concentration of ammonia inside a muscle cell is thus 20
to 30 times greater than that in the plasma. It will be shown
(Section 3.1.1) that n rat heart perfused with a medium of ammonia
concentration similar to that of plasma maintains a similar concentra¬
tion ratio. These results seem to conflict with the view that
ammonia is freely diffusible across membranes (cf Jacobs, 1940). In
the present chapter the kinetics of ammonia production and uptake by
the perfused rat heart are described, and possible mechanisms for
maintaining the high concentration ratio are discussed.
3,1.1 Ammonia in the Perfused Rat Heart
Table 3.3 shows the ammonia content of rat hearts, before and
after perfusion. Hearts were perfused for 75 minutes at 37°C and
prf 7.39 with Krebs-Henseleit medium supplemented with glucose (see
Chapter 2, Section 2.3.2.2). During this time, ammonia was produced
by the heart and released into the perfusate. After 75 minutes the
external ammonia concentration was similar to that in blood
(Astakhova and Golvbev, 1967), and the ratio of tissue concentration
to perfusate concentration resembled that found in vivo. There was
little net change in the concentration of ammonia in the tissue. This
situation could be maintained up to the end of 2 hours perfusion without
further change (Section 3.2.1).
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Ammonia concentration, mmol/1, Ratio
Tissue/Perfusate
Tissue Perfusate
Before perfusion 0.86 + 0.06 0.007 + 0.001
After perfusion 0.64 + 0.08 0.031 + 0.003 21
In vivo 0.86 + 0.06 0.03 (Blood) 29
Table 3.3 Ammonia concentrations in the perfused rat heart.
Concentrations of ammonia, measured in perfusate samples and in
percliorate extracts of tissue as described in the text, are means + S.E.M.
Tissue concentrations are calculated as mmol/1 intracellular water, assuming
the volume of the ICF is approximately C.5 ml/g tissue (Scharff and
Wool, 1965a). The ammonia concentration of rat blood is that given by
Astakhova and Golubev, 1967.
3.2 Changes in Ammonia Concentration on Perfusion of Rat Heart
3.2.1 The Metabolism of Ammonia by Perfused Rat Heart
It has been shown (Table 3.3) that hearts perfused at pH 7.39
with Krebs-Henseleit medium produce detectable traces of ammonia.
In order to determine whether a balance could be reached between
output and uptake of ammonia, hearts were perfused with media to
which increasing concentrations of ammonium chloride had been added.
Table 3.4 and Fig 3.1 show ammonia lost or gained by the whole system
during perfusion ("change in total ammonia"), which represents
ammonia synthesized or utilized in heart metabolism. The change in
perfusate ammonia accounts for the major part of the change in total
ammonia, the change in tissue ammonia being relatively small. Thus
the change in perfusate ammonia reflects the metabolism of ammonia by
the heart rather than a redistribution of ammonia across the membrane.
Net uptake of ammonia from media of standard pH and potassium
concentration did not occur unless the initial perfusate concentration
exceeded 210 ymol/1. The requirement for a high external concentration
before uptake will occur has also been shown in frog muscle, which
does not take up ammonia unless the external concentration exceeds
700 ymol/1 (Netter, 1934). Hearts were also perfused with media of
non-standard pH or potassium concentration in connection with investi¬
gations to be discussed later in this chapter. For simplicity the
metabolic events associated with these media will be presented here
alongside those results obtained with standard media. Net uptake
from media of high ammonia concentration was less if the pH of the
perfusate was increased to 7.57. However, reduction of the extra¬
cellular potassium concentration promoted ammonia uptake at
Conditions
InitialPerfus te ammonia concentration mmol/1






0.007+1 0.076+0 0.205+01 0.307+013
0.32+04 0.41+07 0.52+0 0.77+0
+1.560. 8 +2.040.49 +0.280.13 -3.87+0.38
+1.450.25(9) +2.020.56(4) +0.360.14(2) -3.54+0.32( )
Perfused, pH7.57 K+normal
0.009+1 0.076+04 0.136+018 0.184+.012 0.312+0 1
0.35 0.51 0.54 0.45 0.68
0.06 0.0.8 0.07 0.08 0.06
+1.560.504746(6) +1.050.41133(5) +1.691.0180(2) +1.461.07174(3) -0.18+0.742088(6)
Perfused, oH7.39
•K+x0.6
0.011+. 02 0.066+05 0.116+002 0.206+0 7 0.330+018
0.49+.0 0.15+02 0.33+0 0.43+07 0.56+08
+2.240.4 -2.35+0.5 -0.60+0.43 -0.641̂.65 +0.201 77
+2.29 -2.63+ -0.70+ -0.64+ +0.34
0.44 0.51 0.45 1.68 1.78
(4) (3) (3) (31 (4)
Table3.4Chang si mmoniaconcentrationperfusiofrahe r . Ammoniawasmeasuredintissuandperf s te,beforfterf on
describedinthext.Valuesrmeans+S.E.M.,w tht umb rofh a t parenthesis.Wh reo lytwohe rtanalyzed,valuisgivensm a+r g . Thetotalammoniachangeinsyst mco putedst uf reachh tf perfusatechang+tiss eg .T etiicalculatedthiss concentrationafterperfusionfoeachh —thmeanconc n rat ni unperf d heart(0.43ymol/g).
Fig. 3.1 Changes in ammonia concentration on perfusion of rat hoart
with media of varying initial ammonia concentration.
The graphs show the gain or loss of ammonia in the system (tissue +
perfusate) due to metabolism, as ymol/g fresh weight. The data are
tabulated in table 3.4. Crosses represent individual hearts; circles
are means of groups of hearts perfused with media of the same initial
ammonia concentration.
(a) pH 39, K+ normal
(b) pH 7.57, K+ normal




intermediate initial ammonia concentrations. The ammonia balance in
hearts perfused with low external potassium and high external ammonia
was not reproducible.
No irregularities in beating or outward appearance of the tissue
were observed in any heart at any time during perfusion with the
higher concentrations of ammonia, nor was any decrease in oxygen
consumption seen (Chapter 2, Table 2.5).
5.2.2 The Time-Course of Ammonia Changes in Perfusate
The efflux of ammonia into perfusing fluid to which no ammonia
has been added is shown in Fig 3.2. The initial concentration of
7.1 ymol/1 represents ammonium salts present as contaminants in the
components of the Krebs-Henseleit medium. Production is approximately
linear for the first 60 minutes, at a rate which is comparable to
the rate of output of alanine and glutamine (Chapter 5, Section 5.2.3.4).
The ammonia concentration in the perfusate reaches a maximum of
31 ymol/1 after 60 minutes, which is similar to the concentration in
blood (Astakhova and Golubev, 1967), and remains constant for a further
60 minutes of perfusion. There are two possible explanations for this
phenomenon. Ammonia synthesis in the tissue may cease altogether at
the end of 60 minutes. However, it seemed more likely thai a dynamic
equilibrium exists after 60 minutes in which the rate of ammonia
production equals the rate of its utilization. The finding that hearts
can take up ammonia from media of high ammonia concentration supports
the latter hypothesis, as do subsequent experiments with ^N-labelled
ammonia (Chapter 4). A similar maximum concentration was reached
in perfusion with the medium of pH 7.57, whereas efflux into the
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Time of perfusion ( min )
Fig. 3.3 The time-course of ammonia in perfusate, r>H 7. 39,K+ normal.
Ammonia was measured in serial samples of perfusate; the initial

























Time of perfusion ( min )
Fig. 3.4 The time-course of ammonia measured in perfusate,
pH 7.57, K normal.
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Fig. 3.5 The time-course of ammonia measured in perfusate,
pH7.39, K+ 0. 6 x normal.
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low-potassium medium continued throughout 75 minutes.
Changes in ammonia concentration at higher initial concentrations
are shown in Fig 3.3. If the initial concentration was above
150 ymol/1 it tended to fall during perfusion and vice versa. A
tendency of the ammonia concentration in the perfusate of some hearts
to rise in the final 15 minutes may signify incipient heart failure
due to the unphysiological ammonia concentration, and was not seen
in hearts perfused at pH 7.39 with concentrations of ammonia similar
to those of plasma (see Chapter 5, Section 5.3.5). Uptake from media
of high initial concentration was relatively slow, and there was no
net uptake after 60 minutes. The perfusate concentration never
actually fell to the plasma level.
The effects of high pH and low potassium on these time-courses
are shown in Figs 3.4 and 3.5.
3.2.3 The Time-Course of Ammonia Changes in Tissue
Tissue ammonia in routine perfusion was only measured at the
end of 75 minutes. However, a few hearts were perfused for different
periods, and the tissue ammonia concentration in these is given in
Table 3.5.
The data of Table 3.5 suggests that tissue ammonia rises in
the first 15 minutes of perfusion, falling later to a concentration
similar to that in the unperfused heart. However, the 15 minute
15
values were from the hearts used in JN-labelling studies, and it
is possible that the high tissue ammonia values measured in these
hearts are due to the effects of impurities in the ^N-ammonium
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chloride (see Chapter 4, Section 4.1). The data provide no evidence








Unperfused 0 0.43 + 0.03 (6)
0.007 15 0.89, 1.35
75 0.32 + 0.04 (9)
90 0.42
120 0.60, 0.30
0.310 15 2.25, 0.54
75 0.77 + 0.07 (3)
Table 3.5 Effect of perfusion time on tissue
ammonia concentration.
Ammonia was measured in the tissue, before and after perfusion.
Values are means + S.E.M., where the number of hearts appear? >n
parenthesis. Other values are the concentrations in individual hearts.
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5.3 The Distribution of Ammonia across the Heart Cell Membrane
It has been considered by many authors, whose opinions have
already been presented (Chapter 1, Section 1.6) that ammonia diffuses
freely across biological membranes of widely differing kinds, such as
those of erythrocytes, aquatic organisms, gut cells and mitochondria. In
general, investigations in higher animals suggest diffusion of
UAcAcxr^ec! ammonia rather than diffusion of ammonium cation. If
this were true also of the heart cell membrane, one would expect the
ammonia concentration inside the tissue to be approximately twice that
outside (Section 3.3.1.1). The measurement of ammonia concentrations
in rat heart and blood demonstrates the much higher ratio of 30 : 1,
and a ratio of 20 : 1 was found in the isolated perfused heart (Table 3.3).
In the present section possible mechanisms of ammonia transport are
investigated and discussed.
3.5.1 The Expected Ammonia Distribution
If ammonia diffuses freely across the heart cell membrane,
whether as uncharged ammonia or as ammonium cation, one wouli expect
the ratio of the ammonia concentration inside to that outside to
remain constant at all values of external concentration (Fig 3.6a).
Thus the internal ammonia concentration (Ci) should be directly
proportional to the external concentration (Ce), (Fig 3.6b).
It should theoretically be possible by further tests to distinguish
whether NH^ or NH^+ is the permeant species.
3.3.1.1 Free diffusion of uncharged ammonia
Since the proportion of free NH^ in a mixture of NH^ and NH^+
Fig. 3.6 The expected ammonia distribution.
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depends on the pH of the solution, the distribution of ammonia
in this case will depend on the pH gradient across the membrane
and can be predicted mathematically (Jacobs, 1940; Stabenau et al.,
1959) as follows:
where Ci and Ce are the concentrations of ammonia in the intracellular
and extracellular fluid respectively; pHe is the extracellular pH;
pHi is the intracellular pH; and pKa is the acid dissociation constant
of ammonium ion. Under physiological conditions pKa = 9.03 (Klocke
ert al., 1972); pHi = 7.07 at both values of perfusate pH tested
(Chapter 2, Section 2.3.5). Hence at a perfusate pH of 7.39,
Ci/Ce = 2.06 and at a perfusate pH of 7.57, Ci/Ce = 3.09. Thus the
ratio Ci/Ce will increase with the alkalinity of the perfusate
(Stabenau et. al. , 1959), as a result of the increase in the
concentration of uncharged ammonia in the external medium. Ci will
still be linearly related to Ce (Fig 3.7a).
3.3.1.2 Free diffusion of ammonium cation
Earlier authors assumed that the membrane potential was influenced
only by the potassium ion distribution, and that the distribution of
potassium and other ions was related to the membrane potential by




[k+] i _ [nH4+] i (2) (see Conway and Moore, 1945)
Fig. 3.7 Expected ammonia distribution,
(a) NHg permeant:
Solid line: normal pH
Dotted line: raised pH.
(b) NH^+ permeant:
Solid line: normal [K ]
Dotted line: decreased [K+],
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Hence the expected value for (or Ci/Ce), as for -
[h+] e
was
approximately 40. The value found for ammonia in frog muscle was
much lower than this (Conway and Moore, 1945; Netter, 1934).
It is now appreciated that the membrane potential is a function
of all permeant ions present (Goldman, 1944; Ginsberg, 1973), e.g.
Where is a permeability constant for the ion A with extra¬
cellular and intracellular concentrations (more correctly activities)
Ae and Ap respectively. Since the membrane is more permeable to
potassium than to other ions (Pjc> P^a' etc.), the membrane potential
is effectively determined by the ratio of potassium concentrations
across it. Since IC> Kg, the interior of the cell is negative with
respect to the exterior.
When the potassium concentration of the extracellular fluid is
reduced, some of the intracelljlar potassium tends to leak into
the ECF tending to restore the equilibrium. However, in vivo this
leakage is very slow (Fenn et al., 1945), requiring several days
(Muntwyler et. al., 1950; Sasslone and Muntwyler, 1965), and the
proportional reduction in the potassium concentration in the tissue
is never so great as that in the serum (Muntwyler et al., 1950). Hence
in a short-term experiment reduction of the perfusate potassium
concentration does not significantly affect the tissue potassium, and
is an effective means of increasing the membrane potential (Adrian, 1956).
If ammonia diffuses as NH^' cation, its distribution will depend
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on the membrane potential, but the ratio Ci/Ce need not have the
value of 40 as determined by the Nernst equation. The actual value
of the ratio cannot be predicted from equation (3) without accurate
knowledge of the value of and the membrane potential. More¬
over, a tissue such as heart muscle which exhibits continuous
electrical activity does not have a constant membrane potential.
Nevertheless, altering the membrane potential by decreasing Kg/K^ ought
to cause a decrease in the ratio NH./NH... Furthermore, NH. will4e 4i 4e
still be linearly related to NH^ (Fig 3.7b), provided that
NH..« P. K. and P,IIt..NH. « P, K ; these conditions are fulfilled in4i k i NH4 4e k e'
all the perfusions to be described.
5.3,1.3 Summary
Given the premise that one form of ammonia diffuses freely,
the following will be true. If uncharged ammonia is the permeant
species, raising the perfusate pH should cause an increase in Ci/Ce,
but altering the potassium concentration should have no effect
(Fig 3.7a). The simple picture of Fig 3.7a will only be adhered to
provided that ammonia diffusion does not alter the internal pH. If
ammonia cation is the permeant species, decreasing the extracellular
potassium concentration shoui-I bring about an increase in Ci/Ce,
whereas altering the pH should have no effect (Fig 3.7b).
3.3.2 The observed ammonia distribution in perfused rat heart
3.3.2.1 The effect of pcfusate ammonia concentration on the ammonia
distribution
The concentration of ammonia in tissue and perfusate was measured
in rat hearts after perfusion for 75 minutes with Krebs medium
in which the initial ammonia concentration was raried. The results
are shown in Table 3.6, Plotting tissue concentration (Ty moles
per g fresh weight) against perfusate concentration (P y moles per ml)
shows that T is linearly related to P, but that the best straight
line does not pass through the origin (Fig 3.8). The best straight
line was calculated by computer, using a method which allowed for
error of measurement in both T and P. The values of slope and
intercept were:
Intercept (A) = 0.25 y moles per g fresh weight
Slope (jn.) = 1.71 ml per g fresh weight
T y moles per g and P y moles per ml are the quantities measured
experimentally, T and P thus have different dimensions, but in
this way no premature assumptions are made with respect to the volume
accessible to the tissue ammonia. If this volume (v ml per g fresh
weight) is known, then the true ammonia concentration (Ci) in the
intracellular fluid is related to the measured quantity T as follows:
Ci = T/v y moles per ml
Assuming that there is no permeability barrier between the perfusate
and the extracellular fluid, ■he symbols P and Ce are interchangeable.
3 3.2.2. The effect of perfusate pH on the ammonia distribution
Dependence of the ammonia distribution on pH was tested by
altering the pH of the perfusing fluid. A medium of more alkaline
pH was chosen, nearer to the pKa of ammonia (Klockij et al., 1972), in
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order that a relatively small pH change might achieve the maximum
effect on the degree of dissociation of the ammonium ion. A
pH of 8 or higher tends to cause precipitation of calcium salts
(Krebs and Henseleit, 1932) and also affects glycolysis (Kloppick
et al., 1967), and was therefore avoided. A pH of 7.57 was used,
approximately 0.2 units above that of the standard medium. This
was achieved by increasing the bicarbonate concentration of the
perfusate (Krebs and Henseleit, 1932; see Chapter 2, Section 2.3.2.2).
Hearts perfused with this medium continued to beat normally
and showed no change in outward appearance. The initial concentration
of ammonia in the medium was varied and ammonia was measured in
tissue and perfusate at the end of perfusion (Table 3.7). Tissue
ammonia was plotted against perfusate ammonia concentration (Fig 3.9),
and a best straight line was drawn. The values of slope and intercept
were:
Intercept (A) = 0.36 y moles per g
Slope (m) = 1.02 ml per g
3.3.2.3 The effect of perfusate potassium concentration on the
ammonia distribution
Hearts were perfused with a medium in which the potassium
concentration had been reduced by 40%, by replacing half of the
potassium chloride of Krebs Ringer by sodium chloride. The hearts
continued to beat normally and showed no change in outward
appearance. The ammonia concentrations in tissue and perflate at
the end of perfusion are shown in Table 3. ft. Plotting tissue ammonia





(A) = 0.07 y moles per g
(ra) = 1.84 ml per g
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Legend to Tables 3.6 - 3.8
The ammonia concentration in tissue and perfusate wf each heart
was measured at the end of 75 minutes perfusion as described in
the text. Tables 3.6 - 3.8 show the values for individual hearts,
together with mean values (+ standard error of mean) for groups
of hearts perfused with media of the same initial ammonia concentration.
The initial ammonia concentration was varied by adding ammonium
chloride to the perfusing fluid. Values given in the table are
means of concentrations measured in the medium at the start of each
perfusion.
The pH and potassium concentration of the perfusing fluid























0.72 0.058 0.43 7.4
0.93 0.032 0.29 9.0
0.88 0.021 0.43 20.6
0.77 0.043 0.42 9.6
0.60 0.021 0.27 13.1
0.63 0.033 0.19 5.5
0.63 0.064 0.44 7.0
0.59 0.026 0.15 5.8
0.60 0.034 0.23 6.7
Mean + S.E.M. 0.031 + 0.005 0.32 + 0.04 9.4 +1.6
0.076 0.80 0.084 0.28 3.3
0.74 0.107 0.42 3.9
0.70 0.119 0.37 3.2
0.66 0.130 0.58 4.4
Mean + S.E.M. 0.110 + 0.010 0.41 + 0.07 3.7 + 0.3
0.124 0.64 0.159 0.23 1.4
0.66 0.250 0.37 1.5
Mean 0.204 0.30 1.5
0.205 0.72 0.235 0.53 2.3
0.63 0.197 0.50 2.5
Mean 0.216 0.52 2.4
0.307 0.67 0.272 0.84 3.1
0.76 0.286 0.63 2.2
0.65 0.240 0.83 3.5
Mean + S.E.M. 0.266 + 0.014 0.77 + 0.07 2.9 + 0.4
Table 3.6 Effect of perfusate ammonia concentration on ammonia distribution.
(pH = 7.39, K+ normal)
Mean initial Heart Final perfusate Final tissue Distribution
perfusate weight, ammonia ammonia ratio,
ammonia g concentration, concentration, ml/g
concentration, pmol/ml pmol/g
ymol/mi ^ ^ (T/P)
0.009 0.64 0.021 0.60 28.2
0.63 0.027 0.30 11.2
0.69 0.029 0.42 14.6
0.64 0.022 0.28 13.0
0.59 0.057 0.33 5.7
0.53 0.041 0.17 4.0
Mean + S.E.M. 0.033 + 0.006 0.35 + 0.06 12.8 + 3.5
0.076 0.65 0.107 0.68 6.4
0.67 0.089 0.70 8.0
0.73 0.115 0.30 2.6
0.97 0.096 0.38 4.0
0.55 0.071 0.51 7.1
Mean + S.E.M. 0.095 + 0.007 0.51 + 0.08 5.6 + 1.0
0.136 0.76 0.202 0.61 3.0
0.63 0.134 0.47 3.5
Mean 0.168 0.54 3.3
0.184 0.73 0.276 0.46 1.7
0.81 0.210 0.32 1.5
0.63 0.143 0.58 4.0
Mean + S.E.M. 0.210 + 0.038 0.45 + 0.08 2.4 + 0.8
0.312 0.74 0.308 0.57 1.8
0.65 0.314 0.46 1.5
0.83 0.354 0.81 2.3
0.83 0.296 0.67 2.3
0.79 0.314 0.82 2.6
0.70 0.326 0.77 2.3
Mean + S.E.M. 0.319 + 0.008 0.68 + 0.06 2.1 + 0.2
Table 3.7 Effect of high perfusate pH on ammonia distribution.






















0.67 0.041 0.67 16.5
0.64 0.053 0.54 10.2
0.74 0.034 0.50 14.7
0.69 0.042 0.23 5.5
0.043 + 0.004 0.49 + 0.09 11.7 +
0.066 0.51 0.045 0.15 3.4
0.50 0.037 0.18 4.9
0.56 0.050 0.11 2.2
Mean + S.E.M. 0.044 + 0.004 0.15 + 0.02 3.5 + 0.8
0.116 0.68 0.120 0.39 3.2
0.63 0.122 0.31 2.6
0.56 0.103 0.29 2.8
Mean + S.E.M. 0.115 + 0.006 0.33 + 0.03 2.9 + 0.2
0.206 0.76 0.165 0.50 3.0
0.70 0.185 0.29 1.6
0.70 0.269 0.51 1.9
Mean + S.E.M. 0.206 + 0.032 0.43 + 0.07 2.4 + 0.3
0.330 0.70 0.334 0.73 2.2
0.71 0.366 0.46 1.3
0.66 0.364 0.64 1.8
0.72 0.330 0.42 1.3
Mean + S.E.M. 0.349 + 0.009 0.56 + 0.08 1.7 + 0.2
Table 3.8 Effect of low perfusate potassium concentration on
ammonia distribution. (pH = 7.39, K+ = 0.6 x Normal).
Figs. 3.8 - 3.10: The observed ammonia distribution.
The quantity of ammonia in the heart tissue (T jxmol/g) is plotted
against the concentration of ammonia in the perfusate (P mmol/1).
Both quantities were measured after perfusion for 75 min. Crosses
represent individual hearts; circles are the means (iS.E. M., except
where mean of 2) of groups of hearts perfused with mecLa of the same
initial ammonia concentration. The line of best fit was calculated
by computer (see text); in this calculation the four hearts perfused
with low-potassium medium without addition of ammonia, which behaved
anomalously (see discussion), were omitted. The data are tabulated
in Tables 3.6 -3.8.
Fig.3.8Theobserveddistri utionfammoniabetweetissandperfusate,H7.39,Kn r l.
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3.4.1 The ammonia distribution
If one species of ammonia is freely diffusible, the expected
ratio of ammonia concentration inside the cell to that outside
(T/P) should be independent of the external concentration whether
the permeant species is uncharged ammonia or ammonium cation (Pig 3.6a).
Fig 3.11 shows that this is not the case in the perfused rat heart.
The ratio T/P, approximately 10 in the heart perfused without added
ammonia, falls to a limiting value of about 2.6 as the external
concentration rises. If it is assumed that the internal ammonia fills
the intracellular space irrespective of its concentration in the
extracellular fluid, these figures are equivalent to a fall in
Ci/Ce from 20 to the limiting value of 5 (assuming that the ICF
volume is 0.5 ml per g - see Scharff and Wool, 1965a). In this
connection it may be mentioned that similar findings have been
reoorted in frog skeletal muscle. The data of Netter (1934) show
an average T/P of 4.5 at higher external concentrations, rising to
9.6 at an external concentration of 160ymol/l, the lowest concentra¬
tion tested. Conway and Moore (1945) also described an increase in
T/P as the external concentration was decreased below 700 ymol/l.
These observations are inconsistent with the view that ammonia
is freely diffusible throughout the tissue, its distribution being
controlled solely by its diffusion across the plasma membrane. The
results suggest that the expected distribution is modified in some
way. There could he permeability barriers within the tissue which
limit the space accessible to the internal ammonia, or which prevent
a portion of the tissue ammonia from exchanging with the extracellular
Fig. 3.11 The variation of the ammonia distribution ratio with the
perfusate ammonia concentration.
The same data are used in this Figure as in Figs. 3.8 - 3.10, and
are tabulated in Tables 3.6 - 3.3. The ratio of tissue ammonia to
perfusate ammonia (T/P) is plotted against the perfusate ammonia
concentration (P). The symbols are explained in the legend to
Figs. 3.8 - 3.10.
(a) pH 7.39, K+ normal
(b) pH 7.57, K+normal
(c) pH7.39, K+0.6 x normal.
125.
P = Final perfusate ammonia concentration (mm.ol/l)
fluid. Or alternatively there may be no single process by which
ammonia crosses the membrane, the mechanism at high external
concentrations differing from that at low concentrations.
When the external ammonia concentration is low, the ratio Ci/Ce
in the intact rat (Section 3.1), and that reported for frog muscle
by Conway and Moore (1945), can approach the corresponding ratio for
potassium. This suggests that in these circumstances the ammoaia
distribution is controlled by the membrane potential (Conway and
Moore, 1945), which is itself effectively a function of the potassium
distribution. Therefore ammonium ion would be the permeant species
and would behave similarly to hydrogen ion (Sanslone and Muntwyler,
1965) and other monovalent ions such as rubidium and caesium (Hunter
and Monahan, 1971). However, the fall in the distribution ratio as
Ce is raised would suggest that some other process is involved at
higher external concentrations. Rapid metabolic removal of tissue
ammonia can be discounted since the net metabolic disappearance of
ammonia is slow under all conditions (Section 3.2). Alteration of
the membrane potential as the external concentration of ammonia rises
can likewise be excluded, since the highest concentration involved
is still very low in relation to the perfusate potassium concentration.
When no ammonium salt was added to the perfusate, reduction of
the perfusate potassium by 40% increased the ratio T/P from 9.4
to 11.7 (Tables 3.6 and 3.8). However, this is not in itself a
proof of dependence of the ratio on the membrane potential since at
all other values of Ce, produced by addition of NH^Cl, the effect
of reduced external potassium was a reduction, or little change, in
the ratio T/P. It is possible that the increase in T/P at the lowest
external concentration represents an effect of the decreased potassium
on ammonia metabolism, since, unlike the hearts perfused with the
standard medium, hearts perfused with reduced [k+] and low ammonia
concentrations did not attain a constant perfusate ammonia concentration
(Fig 3.2c). An excess of formation over disappearance within the
tissue could result in a high T/P.
The slope of the graph of T against P (Fig 3.10) is perhaps a
more reliable index of the way in which T varies with increasing P
than is the absolute value of T/P at any single value of P. This
slope is unaffected by the reduction in extracellular potassium
provided that the extracellular ammonia concentration at the start
of perfusion is greater than 60pmol/l. At lower concentrations the
sudden increase in T/P, already noted and possibly metabolic in
origin, occurs. It seems unlikely therefore that diffusion of NH^+,
controlled by the membrane potential, can account for the observed
ammonia distribution.
It remains to consider diffusion of uncharged ammonia. In this
case one would expect a value for the ratio Ci/Ce of 2.06 (Section
3.j>. 1.1), equivalent to a value of approximately 1.0 fov T/P. This
is certainly not the case when P is low, and even the limiting value
of T/P when P is high never falls as low as this. In practice, T/P
Sails to a limiting value of around 2.5 on perfusion with standard
medium (Fig 3.11). If the ammonia is distributed throughout the
intracellular volume of 0.5 ml per g (Scharff and Wool, 1965a), it
can be seen that Ci/Ce never falls below 5. Conversely, if ill the
internal ammonia is freely exchangeable with the external medium,
a ratio of 2.5 for T/P would require an "intracellular volume" of
1.2 ml per g of tis.sue in order to maintain a true concentration
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ratio (Ci/Ce) of 2.06. The internal concentration is thus too
high to be solely the consequence of pH-dependent diffusion of NH^.
3.4.2. Compartmentation of tissue ammonia
The anomalous dependence of T/P on P could be explained if it
is assumed that ammonia is not freely diffusible throughout the
tissue, but that a fraction of the tissue ammonia is prevented from
exchanging with the perfusate ammonia. Under these circumstances
a quantity of ammonia ("A" y moles per g) would remain in the tissue
even if the perfusate concentration were hypothetically reduced to
zero (Fig 3.12). The diffusion of this fraction might be restricted
either by intracellular permeability barriers (endoplasmic reticulum,
for example) or by binding to structural elements of the tissue. This
might be electrostatic attraction of NH^+ to some fixed anion, if the
NH^+ cannot readily be exchanged for another cation. The remainder
of the tissue ammonia ("mP" y moles per g) would be free to exchange
with the perfusate either as free ammonia or as ammonium ion. Tissue
ammonia as measured (T) would be the sum of two intracellular pools,
i.e. T = A + mP (Fig 12). Considering the distribution of ammonia
between the exchangeable pool (mP) and the perfusate should then
provide a clearer idea of the changes brought about by varying the
pH or the potassium concentration of the perfusate than can be
obtained by considering the tissue ammonia iii toto.
In general terms, if the exchangeable pool occupies a space
within the cell uf v ml per g, its concentration (Ci) is mP/vymoles
per ml. If ammonium cation diffuses between the exchangeable pool




Expected variation of tissue ammonia with perfusate ammonia:
compartmental model.
The total tissue ammonia (T jxmol/g) can be divided into two fractions:
a n on-exchangeable fraction (A pmol/g) which does not vary with perfusate
ammonia concentration (P ^mol/ml), and an exchangeable fraction,which





Fig. 3.13 Expected variation of tissue ammonia with perfusate ammonia:
active transport of ammonia.
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about an increase ii. Ci/'Ce (Section 3.3.1.2), hence, assuming that
v remains constan*:, the slope (m) of the graph of T against P should
increase. It has already been noted that this is not the case
experimentally.
If uncharged ammonia diffuses, the distribution between the
exchangeable pool and the ECF should behave as predicted above (Section
3.3.1.1) and Ci can be replaced by Ci/in equation (1):
Ci'
= ! + iQ (PKa - PHD
Ce
1 + io(pKa " pHe)
mD
Since Ci' = —, and Ce = P
v
m
_ 1 + - PHi>
V
1 + 10(pKa " pHe^
Assuming that v is unaffected by altering the external pH, and that
pHl, the pH of the space accessible to the exchangeable ammonia pool,
ic identical to the pHi measured by the DM0 distribution, equation (4)
predicts that an increase in pHe should bring about an increase in
the slope (m) of the graph of T against P.
The observed slope of the graph at pH 7.57 is 1.02 (Section
3.3.2.2). The calculated value of the expression on the right-hand
side of equation (4) at this pH is 3.09. Hence v = 0.33 ml per g.
This is rather less than the volume of the intracellular space
(Scharff and Wool, 1965a), but is not an unreasonable value. However,
at pH 7.39 the fit is less good. The slope (m) is 1.71 and the
calculated value of m/v is 2.06, giving a value for v of 0.85 ml per g,
131.
similar to the volume of the total tissue water. Such a value is
rot possible if the internal ammonia is confined within the plasma
membrane. Moreover, increasing pHe from 7.39 to 7.57 caused a
decrease in (m) from 1.71 to 1.02, rather than the increase which is
expected on theoretical grounds. These data would only fit the
pH-dependent model if perfusion with the more alkaline medium caused
a reduction in the volume accessible to the exchangeable pool. There
is no a. priori reason for supposing this to be true.
Although comparmentation into an exchangeable and a non-exchange¬
able pool cannot alone account for the observed ammonia distribution,
the concept of compart mentation need not be rejected altogether at
this stage. Experiments with labelled ammonia (Chapter 4) suggest
that some form of compartmentation of tissue ammonia does indeed
exist in heart muscle.
3.4.3 Active transport of ammonia
Specific ammonia-transporting systems have been described in
seme lower organisms (Hackette et al., 1970; Pribil and Kotyk,
1970); and transportation of ammonia by the Na+/K+-dependent
ATFase of erythrocytes has also been demonstrated (Post and Jolly, 1957).
It is not inconceivable therefore that such a process might occur in
heart, which also has an Na+/K+-transporting ATPase which is capable
of binding ammonia (Yoda and Hokin, 1972). An ammonia pump could
be bi-directional or unidirectional. If ammonia substituted for
potassium, as is the case with the erythrocyte ATPase (Post and
Jolly, 1957), a unidirectional pump carrying ammonia into the tissue
would result. This would tend to increase the distribution ratio Ci/Ce.
A carrier mechanism would display saturable kinetics. Let us
assume that saturation is approached at the higher external concent¬
rations used in these perfusion experiments (as is probably the
case : see Chapter 4, Section 4.2.2), and that passive diffusion of
ammonia also occurs. In this case the elevation of Ci/Ce would be
greatest at low external concentrations. As Ce increased, the rate
of passive influx would continue to increase proportionally whereas
the rate of active transport would rise to a maximum as the carrier
became saturated. Hence as Ce increased Ci/Ce would fall from an
initial value, enhanced by the effect of active transport, to a
limiting value characteristic of passive diffusion. The fall in
Ci/Ce is in accordance with experimental findings although the
limiting value of Ci/Ce does not closely correspond to diffusion
either of NH^ or of NH^+ as has already been shown (Section 3.4.1).
If the perfusate concentration were reduced to zero, the rate
of uptake due to active transport would also be zero and the tissue
concentration would depend on the rate at which ammonia was formed
in the tissue. If this rate is low, then the tissue concentration
could fall close to zero on account of the passive efflix of ammonia.
As the external concentration approached zero therefore, the internal
concentration would fall sharply (Fig 3.13). This is in contrast to
the two-compartment system (Fig 3.12), in which a finite tissue
concentration remained despite a perfusate concentration of zero.
The perfusate system used (Chapter 2, Section 2.3.2.1) did not allow
study of the heart at 75 minute perfusate concentrations less than
31ymol/l, since ammonia produced by the heart during perfusion could
not be removed from the system. Therefore the form of the lower part
of the curve of Fig 3.13 could not be established by experiment. A
curve similar to thac of Fig 3.13 was given by the ammonia distribution
across the cell membrane in an alga in which the presence of an
ammonia carrier was suspected (Pribil and Kotyk, 1970:.
The effects of changes in pH or potassium concentration on such
a carrier mechanism are difficult to predict. However, if
potassium and ammonia compete for the transport system, reduction of
the extracellular potassium should cause an increase in tr.e ratio
Ci/Ce for ammonia. Experimentally an increase was only observed at
low initial Ce, as would be expected if the relative importance of the
carrier became less as Ce increased. The possible role of metabolism
in producing this increase has already been noted (Section 3.4.1).
3.4.4. The metabolism of ammonia by perfused rat heart
The formation or disappearance of ammonia (Section 3.2) is slow
in comparison to other metabolic functions of the heart such as
oxygen uptake or lactate production (Table 2.5), but is comparable in
velocity to the amino acid changes described in Chapter 5. Alteration
of the external pH had little effect on the metabolism of ammonia
(Fig 3.1). There was no net metabolic utilization of ammonia in
either case until the external concentration exceeded 200 ymol/l. This
observation can be compared with that of Netter (1934) who showed
that frog muscle did not take up ammonia from media in which its
concentration was less than 710pmol/l. Presumably the formation or
disappearance of ammonia within the tissue is regulated by the tissue
ammonia concentration. In the unperfused heart (Section 3.1) and
m the heart in vivo (Stewart (rt aK , 1969) the internal ammonia
concentration is approximately 0.4 ymoles per g fresh weight. It
can be seen from the manner in which Ci varies with Ce on perfusion
(Tables 3.6 - 3.7; Figs 38 - 3.9) that the value of Ci does not
greatly exceed the in vivo value until the initial Ce is 200 ymol/l
or more. Hence there is a net disappearance of ammonia from the system
only when Ci exceeds the "physiological" concentration, and the
metabolic formation or disappearance of ammonia may be seen as a
mechanism for keeping the ammonia concentration in the heart within
defined limits. This mechanism is reinforced by the incomplete
dependence of Ci on Ce shown by the ammonia distribution (Fig 3.8 - 3.9),
which may be a result either of a non-exchangeable pool of ammonia in the
tissue, acting as an "ammonia store", or a result of the active
uptake of ammonia from media of low concentration by a "pump"
mechanism.
The behaviour of hearts perfused with a medium of reduced
potassium concentration was unexpected (Fig 3.1). Reduction of
the initial external concentration from 330 ymol/l to 120ymol/l had
little effect on the net metabolism of ammonia, which on average did
not differ significantly from zero over this range of concentrations.
However, reduction of the initial Ce below 100ymol/l resulted in an
anomalous disappearance of ammonia from tissue and perfusate, seen
in the fall in Ce during perfusion (Fig 3.5) and in the low internal
concentration at the end of perfusion (Table 3.8; Fig 3.10). However,
the heart does not appear to tolerate any further reduction in
tissue concentration, since a further decrease in the initial Ce trig¬
gered a metabolic production of ammonia which restored Ci to the
in vivo value (Table 3.8) and which was still continuing at the end
of perfusion (Fig 3.2c).
3.4.5. Summary
The data presented in this chapter cannot be used to distinguish
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conclusively between transport of NH^ and NH^+, since neithei
hypothesis fits the data. Furthermore, the wide biological variation
between hearts is bound to reduce the significance of any differences
reported between values of quantities such as slopes and intercepts
(Figs 3.8 - 3.10).
It is clear, however, that the involvement of ammonia in heart
metabolism is much more complex than is usually imagined. The
increase in the ratio Ci/Ce as Ce is reduced is in line with the
earlier findings of Netter (1934) and Conway and Moore (1945) in
frog muscle. This phenomenon may be a result of intracellular compart-
mentation of ammonia, or it may be a result of a different mechanism
of transport becoming important at low external concentrations. The
latter may involve an ammonia carrier.
In consequence the variation of Ci with Ce is less than would
be the case if Ci were directly proportional to Ce. Similarly,
metabolic synthesis or utilization of ammonia tends to restore the
tissue ammonia concentration to the fn vivo level. Hence a constant
ammonia concentration in the intracellular fluid may be of more
importance than is usually considered. The function of a constant
ammonia concentration is a matter for speculation. Ammonia is an
activator of phosphofructokinase (Abrahams and Younathan, 1971) and
of certain other enzymes (see Chapter 1, Section 1.5). However,
although a role in the activation of glycolysis in skeletal muscle
is feasible, since in this muscle both ammonia production and
glycolytic flux vary with activity (Chapter 1, Section 1.4), such
a role in heart is unlikely since the glycolytic flux in this tissue
is much more constant. Furthermore, the production of ammonia in
heart does not appear to be linked to nucleotide deamination and
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energy metabolism as it is in^muscle (Chapter 5, Section 5.1). It
is striking that concentrations of ammonia in the perfusate up
to 0.3 mmol/1 are not apparently toxic to the heart, despite the
widely held belief that tissue ammonia reacts rapidly with^-oxo-
glutarate, causing a depletion of the latter and a failure of energy
metabolism (Chapter 1, Section 1.3). This may be responsible for
the deleterious effects of ammonia on the brain (James ejt al. . 1972) .
However, the fact that heart muscle tolerates relatively high
intracellular ammonia concentrations without any decrease in oxygen
consumption (Table 2.5) may mean that ammonia is prevented from
reaching glutamate dehydrogenase, perhaps by permeability barriers
or by the presence of cation binding sites which preferentially bind
NH.+ and hinder its diffusion.
4
The net changes associated with the intracellular metabolism
of ammonia and its transport across the plasma membrane have been
measured and found to be small. It is the purpose of the following
chapter to measure the absolute fluxes of ammonia in both directions
across the membrane, to furnish further evidence for an ammonia
transport system, and to investigate the possible intracellular
compartmentation of ammonia.
CHAPTER 4
THE METABOLISM OF LABELLED AMMONIA IN
PERFUSED RAT HEART
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Chapter 4. The Metabolism of Labelled Ammonia in Perfused Rat Heart
Ammonia enriched with the stable isotope of nitrogen, ^ N, has
been available for many years (Urey et eQ. , 1937). Nevertheless,
relatively little use has been made of it in the study of ammonia
and amino acid metabolism in mammalian tissues. There has been a
preference for working with amino acids labelled with the radioactive
14 15
isotope of carbon, C, since it is easier to measure than N. It
is not surprising therefore that a great deal more is known about the
metabolism of the carbon skeletons of these compounds than about
that of the amino group. In the present chapter a preliminary
investigation into the uptake and metabolism of ^N-labelled ammonia
by rat heart is reported.
The use of in studies of nitrogen metabolism in mammalian
systems began not long after enriched ammonia became available
(Schoenheimer and Rittenberg, 1939). Methods similar to those used
in the present study (Chapter 2, Section 2.3.6) were developed for
the determination of isotope in organic nitrogen compounds and
ammonia by conversion to nitrogen (Ritte^berg et al., 1939), and
the preparation of labelled amino acids was described (Schoenheimer
and Ratner, 1939). The first metabolic studies involved the feeding
of ^N-ammonium citrate to rats (Foster et_ al., 1939; Schoenheimer,
1949). Analysis of amino acids in the carcass showed that the amide
nitrogen fraction was the most highly labelled, followed by glutamate
and aspartate. After injection of "^N-iabelled ammonia into rats
(Duda and Handler, 1958) or rabbits (Ferdman et al., 1963), glutamine
of high enrichment was found in all tissues, particularly in heart
muscle. The time-course of labelling was not investigated, since in
both studies all animals we.-e analyzed at a single time after injection.
Thus the data do not necessarily indicate synthesis of labelled
glutamine in the heart; glutamine synthesized in some distant organ
such as the liver could pass into the heart from the plasma. (Uptake
of glutamine by the perfused rat heart has been demonstrated in this
study (Chapter 5, Section 5.2.5.1)). has also been used in
studies on the incorporation of isotope from labelled ammcnia into
protein amide nitrogen (Vitti and Gaebler, 1963; Vitti ert al., 1964)
and in studies on the formation of ammonia from glutamine in the
kidney (Pitts et_ a^., 1965).
13
There is also a ladioactive isotope of nitrogen, N. Since this
isotope has a half-life of only 10 minutes, it is best suited to
experiments of short duration, or where a qualitative rather than a
quantitative interpretation is desired (e.g. Monahan et_ al^., 1972), and
it can only be used when facilities for its preparation are at hand.
13
Ammonia labelled with N has been used in studies in live dogs.
After injection, whole-body scanning showed that label became localized
in heart, brain, liver, kidneys and bladder (Hunter and Monahan,
1971; Monahan e_t al., 1972) . It was proposed that the heart took up
NH^+ cation by a mechanism similar to the physiological uptake of
potassium, or the uptake of rubidium or caesium used in myocardial
studies (Hunter and Monahan, 1971). The possibility that the
radioactivity found in the heart actually represented glutamine or
some other labelled compound synthesized in another organ and taken
up by the heart was discussed (Monahan et al., 1972), although the
results of Harper et al. (1972) showed that the uptake of label by
mouse heart was so anpid as to preclude this: nearly all the label
which entered the hoart did so on the first passage of the labelled
ammonia through the coronary circulation. 85% of the radio¬
activity of the blood disappeared from it in the first minute after
injection: it was probable that the greater part of this represented
uptake of ammonia by heart, lungs and possibly skeletal muscle
(Bessman and Bessman, 1955). Owing to the short half-life of the
isotope, its use in kinetic or metabolic studies is limited, and
it is likely to find its widest application as a diagnostic tool
in the visualization of myocardial disorders (Hoop et_ al_., 1973).
4.1 Metabolite Changes after 15 Minutes Perfusion
Perfusion with labelled ammonia permits a study of the system
in its approach to equilibrium. Therefore hearts must be perfused
for a sufficient length of time to allow measurable changes to take
place, yet not so long that the system reaches equilibrium. A
perfusion time of 15 minutes was used in the present investigation.
Hearts were perfused with the following media:
Serial No. of Initial perfusate „ . , Number of Voarts
r, 1 — vtu—i —c— Enrichment ,Hearts NH + concentiation perfuied
104, 106 10 ymol/1 80 atoms % excess 2
107 160 ymol/1 31 atoms % excess 1
105, 108 360 ymol/1 19 atoms % excess 2
The number of hearts studied was limited by the availability of
facilities for 1% determination (See Chapter 2, Section 2.3.6)
Ammonia was measured in the perfusate at the beginning and end
of perfusion, and in the tissue at the end of perfusion. Tissue
glutamate was measured in one heart at each ammonia concentration.
Values for all hearts are shown in Table 4.1. Concentrations of
ammonia and glutamate in the unperfused heart are taken from
Chapter 5, Table 5.6.
The tissue glutamate concentrations after 15 minutes are similar
to those measured at the end of 75 minutes, and demonstrate that
the decrease in heart glucamate on perfusion (Chapter 5, Section
5.3.4) is complete after 15 minutes. During this period ammonia
passes from the heart into media containing 10 ymol/1 ammonia, whereas
hearts perfused with the higher concentrations take it up. The
high concentrations of ammonia in the tissue after 15 minutes
deserve comment. The extent of ^N-labelling of the tissue ammonia
is very low in all hearts (Section 4.2 of this Chapter). Thus
the excess ammonia does not derive from the medium, even in hearts
perfused with media, containing high concentrations of ammonia. It
may be interpreted as an accumulation of ammonia in the tissue,
indicating that the rate of its production during the first 15 minutes
exceeds the rate at which it can diffuse out of the tissue. If this
is correct, J to | of the total ammonia (1.6 pinoles per g tissue
in 75 minutes) produced by hearts perfused with media of low ammonia
concentration is synthesized during the first 15 minutes of perfusion.
Diffusion out of the heart is then a slower process, and net outward
flux continues until a physiological tissue concentration is reached.
The increase in total ammonia is therefore roughly parallel to the
decrease in tissue glutamate. Alternatively, the high tissue ammonia
may be due to an artifact; this is suggested particularly by the
large variation, especially in the concentrations in the hearts
perfused with high-ammonia media. Some component of the commercial
*5N-ammonium chloride preparation may have been poisoning the heart,
Metabolite
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though the effect did not increase obviously with the concentration
of "^N-ammonia, and the ammonia content of the commercial material
as measured by the routine enzymic assay (Chapter 2, Section 2.2.7)
did not fall detectibly short of 100%. A further possibility is
contamination of reagents by ammonia, though extracts of tissue from
hearts 106-108 were made using fresh solutions of perchloric acid
and potassium carbonate without causing the tissue ammonia to return
to normal (except in heart 108).
4.2 The Labelling of Ammonia in Perfused Rat Heart - A Model System
Table 4.2 shows the effect of perfusion on the labelling of
ammonia in perfusate and tissue. Isotope in the perfusate of
hearts perfused with 10 ymol/1 ammonia was diluted to half its
initial concentration, whereas isotope in the perfusate of the
other hearts was not detectibly diluted. Thus no detectible endo¬
genous ammonia diffuses out of hearts perfused with 160 or 360 ymol/i
ammonia in the first 15 minutes of perfusion. The enrichment of
tissue ammonia is very lo1-: in comparison with that of perfusate
ammonia in all hearts. The low enrichment of 1.5 for heart 105
is associated with a high tissue ammonia concentration (Table 4.1),
and may reflect an abnormally large synthesis of unlabelle<^ ammonia
by this heart.
The data of Table 4.2 do not indicate how much isotope is
taken up by the heart from the perfusate, or how much disappears
in metabolism. However, the concentration of heavy ammonia in
tissue and perfusate can be calculat?d if the total ammonia concent¬
ration and the isotope enrichment are known. Increases and decreases
in the isotope content of tissue and perfusate can be calculated
from the data. Isotope concentrateonsshown in Table 3 are pinoles
^NH^+ per g tissue in excess of the quantity of "^NH^+ (0.36%)
present naturally in ammonia from all sources (Rittenberg et_ al^., 1939).
15 +
Table 4.3 shows that * NH^ disappears from systems perfused for
15 minutes either with high or with low concentrations of ammonia.
The disappearance represents metabolic utilization of ammonia. The
most important feature of the data is that ^N-ammonia is extensively
metabolized by the heart without the tissue ammonia becoming labelled
to any great extent. More than 25% of the isotope added to hearts 104
and 106 was metabolized by the tissue, although the enrichment of
the tissue ammonia at the end of perfusion was only 0.01 to 0.02
times that of the perfusate. (If the enrichment of the ICF ammonia
of heart 104 increased linearly from 0 to 0.78 atoms % excess during
15 minutes (Table 4.2), with an average value of 0.39, disappearance
of 0.17 ymoles of "^NH^+ from a single pool of this size would
represent metabolism of 0.17 x 100/0.39, or 43.6 ymoles of ammonia
per g tissue, which is not feasible). The data lend support to
the theory developed in Chapter 3 (Section 3.4.2), that two pools
of tissue ammonia exist in heart. One pool is free to exchange with
the perfusate, and it therefore becomes labelled by ammonia from the
perfusate; the other pool is prevented from exchanging and remains
unlabelled. The exchangeable pool alone is the source of the 0.17
y moles of ^NH^+ per g tissue metabolized by heart 104.
Let A denote the non-exchangeable pool, and x the exchangeable
pool; let X and Y represent undefined metabolites. A possible model
is that of Fig 4.1, diagram 1. If it is assumed that the enrichment
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Fig. 4.1 Possible models of ammonia pools in perfused rat heart.
P = perfusate pool; A = non-exchangeable pool; x = exchangeable pool;
X and Y = metabolites. Arrows (a) - (dj represent ammonia fluxes.
during 15 minutes, with an average value of 60, then the diffusion
of 0.18ymoles of ^NH^+ per g into the tissue (Table 4.3) is
equivalent to a passage of 0.18 x 100/60, or 0.30ymoles of ammonia
per g into the heart. This is represented by arrow (a) in Fig 4.1.
Since ammonia in the perfusate increases by 0.36ymoles per g on
perfusion (Table 4.1), there must be a balancing efflux of approximately
0.7ymoles per g from the heart (arrow (c)).
In order to explain the observed dilution of label in the
perfusate, this ammonia must be unlabelled and hence derive from the
non-exchangeable pool (diagram (3) of Fig 4.1), rather than the
exchangeable pool (diagram (2)), which ought rapidly to become
labelled to the same enrichment as the perfusate. If it is assumed
that the size of pool A is independent of the perfusate ammonia
concentration, and that flux (c) depends on the size of pool A, then
all hearts should release 0.7ymoles of unlabelled ammonia per g into
the perfusate in 15 minutes, irrespective of the ammonia concentration
in the medium. In the case of heart 105, IS.18y moles of ammonia
per g tissue are present in the perfusate at the end of perfusion
(Table 4.3). The presence of C.7ymoles of unlabelled ammonia in
this total would make little detectible difference to the enrichment
of the perfusate ammonia. Hence no dilution of the isotope in the
perfusate of this heart was c.etected experimentally. Pool A would
require to be replenished from some metabolic source X, which may
be glutamine (see Section 4.2.2). A simple model based on these
experimental observations is depicted in Fig 4.1, diagram (3).
4.2.1 The parameters of the model
In the model depicted in Fig (4.1), diagram (3), fluxes (b)
and (d) are enzymic processes, whereas fluxes (a) and (c) represent
transport of ammonia across the membrane. The rate of flux (b) is
dependent on the size rf the pool x; that of (c) on the size of
pool (A); and that of (a) on the concentration of ammonia in the
perfusate. The values of the parameters of the model (rate constants
and the size of pool x) can be calculated for heart 104 if it is
assumed that (c) is constant (for example if the size of A is constant
throughout perfusion) and that (a) and (b) are directly proportional
to the concentration of ammonia in the perfusate and in pool x
respectively. This situation is shown in Fig 4.2, and the calculation
(appendix 1) is based on this model. k^ and k^ are the rates of
fluxes (a) and (b), A^ and A^ are the corresponding rate constants,
and K is the constant rate of diffusion of ammonia from the non-exchange-
able pool into the perfusate. Flux (d) is ignored in the calculation.
The parameters A^, A2 and K calculated from the data of heart
104 are shown in Table 4.4. If the same parameters are calculated
from the data of heart 105 (a heart perfused with high ammonia medium),
different values are obtained which are also shown in Table 4.4. The
size of the exchangeable pool, and the concentration of ammonia in
the perfusate after equilibrium is reached, have been calculated using
the parameters and are likewise shown in Table 4.4. The calculated
equilibrium concentration in the perfusate of heart 104 is exactly
the same as that observed after 1 hour's perfusion.
The model thus provides an adequate explanation of the observa¬
tions in hearts perfused with low ammonia, but not in hearts
perfused with high ammonia concentrations. This is reflected by
the negative values of K and of the equilibrium perfusate concentra¬
tion and by the large value for the calculated size of the
150.
Perfusate Tissue Metabolite
Fig. 4.2 The preliminary model.
k^ and are the rates of ammonia fluxes (a) and (b), respectively;
K is the constant rate of efflux of ammonia from the non-exchangesole
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exchangeable pool: the model predicts that more ammonia enters
the heart than is observed experimentally. If the rate of influx
of ammonia (k^) from the perfusate to the exchangeable pool were
hyperbolically, rather than linearly, related to the perfusate
concentration (e.g. k, = „ , where V and K' are constants,^ 6 1 K + Sp' *
and Sp is the perfusate ammonia concentration, this error would be
reduced. Such would be the case if ammonia uptake were mediated
by a saturable carrier mechanism. Furthermore, the rate of efflux
from the non-exchangeable pool (A) to the perfusate may not be
constant if the size of A varies during perfusion. These possibilities
are considered below.
4.2.2 The Optimum Model
In the model depicted in Fig 4.3, fluxes (b) and (c) are
proportional to the size of pools A and x respectively; (a) is
a hyperbolic function and is saturated at high perfusate ammonia
concentrations; and (d) represents the enzymic breakdown of a
precursor. Since glutamine wa° the only amino acid tested which
significantly increased myocardial ammonia production (Chapter 5,
Section 5.2.5.1), flux (d) hss been taken to represent the action of
glutaminase on the large pool of glutamine in the heart; the kinetic
constants are those measured uy Ottaway (1969b) for rat heart
glutaminase. Flux (b) is also an enzymic reaction; if, however,
the concentration of ammonia in poo] (x) is low relative to the
Michaelis constant of the enzyme, as would presumably be the case if
this were glutamate dehydrogenase witli a Km of 3 2 mmol/1 (Frieden,





Fig. 4.3 The optimum model of the behaviour of ammonia in perfused
rat heart.
S^, S and Sp denote ammonia concentrations in tissue pools A and x,X
and in the perfusate, respectively. A0 and A, are rate constants for fluxes (c)
and (b). Flux (a) is a saturable proce is with kinetic constants K and V.
Flux (d) is assumed to represent the hydrolysis of glutamine with constants
as measured by Ottaway (1969b) for rat heart glutamir.i3e.
By computer, values of the parameters A , V, K, A^ ~nd (Sx)0 can
be chosen so as to produce the minimum deviation of the calculated
pool sizes from those measured experimentally in the five hearts
studied. The chosen values of the parameters are shown in Table 4.5,
and the calculated pool sizes at 0 and 15 minutes are compared
with those measured experimentally in Table 4.6. Calculated pool
sizes at 75 minutes are shown in Table 4.7 and compared with those
measured in hearts perfused for 75 minutes.
The fit of the model to the data is very good except for the
case of the tissue ammonia in hearts perfused with 360 ymol/l ammonia,
where the two hearts show wide variation. If the model is correct,
the size of the non-exchangeable pool (A) does not remain constant,
but increases at least during the first 15 minutes of perfusion.
The value of K = 4.16 ymol/heart (Table 4.5) for the uptake of ammonia
from the perfusate is equivalent to a perfusate ammonia concentration
of 83.2ymol/l. Thus one would expect the carrier mechanism to
become saturated at the higher perfusate ammonia concentrations
(e.g. 310ymol/l) used in the experiments described in Chapter 3.
This could account for the observed variation of tissue ammonia
concentration with perfusate ammonia concentration (see Chapter 3,
Section 3.4.3). Calculation of pool sizes at 75 minutes (Table 4.7)
shows that the calculated perfusate concentration reached in hearts
perfused with 10ymol/l ammonia (31ymol/l) is identical to that
measured experimentally, although the predicted 75 minute concentra¬
tion in the perfusate of hearts perfused with 160 or 360ymol/l
ammonia is lower than that observed experimentally. Furthermore, the
calculated amounts of ammonia in the tissue of hearts perfused with
all media are greater than those reported in Chapter 3, Section 3.3.2.1
V 2.41 ymol.heart
K 4.16 ymol.heart *
^0 0.040 heart ^.min ^
*2 1.41 heart *.min *
Wo 0.0031 ymol.heart *
Table 4.5 Parameters of the
optimum model.
The optimum model is depicted in figure 4.3,
where the meaning of V, K, A0 and A.2 is explained.
[Sx]o is the quantity of ammonia in the exchange¬
able pool at the start of perfusion. These five
quantities were chosen by computer so as to
produce the minimum deviation of calculated pool
sizes from those measured experimentally in the
five hearts studied.
Legend to Table 4.6
The sizes of all ammonia pools are shown as ymol ammonia/
heart. S refers to total ammonia + 1%H4+) • R refers to
1%H4+. Subscripts p, x and A denote the ammonia pools : perfusate,
exchangeable and non-exchangeable, respectively. Subscripts 0
and 15 denote the time of perfusion (min). Hence !~Rp] o -'■s
initial 1%H4+ content of the perfusate as ymol/heart, [Sa + SxJl5
is the total ammonia in both tissue pools after 15 min perfusion,
etc.
[Sa + Sx] o, the tissue ammonia before perfusion, is
calculated from the average value of 0.43 ymol/g in unperfused
hearts (Chapter 5, Table 5.6). Thus for a heart weighing an average
0.6 g, [Sa + SXJ0 = 0.43 x 0.6 = 0.26 ymol/heart. [SX]Q is the
value chosen by the computer as given in Table 4.5. Calculated
values for other initial pool sizes are the average of measured
results.
Using the above values for zero time pool sizes. 15 minute
pool sizes were calculated by computer using parameters (Table 4.5)
chosen to give the best fit. Table 4.6 shows the comparison between
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It is possible that the picture is distorted by the high 15 minute
tissue ammonias of hearts 104-108, on which the calculation is
based; these may after all be due to an artefact, and perhaps should
not be relied upon too heavily.
4.5 The Metabolic Fate of Ammonia
Although hearts perfused with 300 ymol/l ammonia metabolize
3.5 ymoles of ammonia per g heart during 75 minutes (Chapter 3,
Section 3.2.1), no significant increase in synthesis of any amino
acid by the heart was observed (Chapter 5, Section 5.2.4). There
are two reactions available in peripheral tissues for the fixation
of ammonia. Glutamine synthetase may not occur in rat heart (Iqbal
and Ottaway, 1970; see Chapter 1, Section 1.2). Glutamate
dehydrogenase on the other hand :s more active in heart than it is
in muscle (Lowenstein, 1972). If the primary event in the fixation of
ammonia is the synthesis of glutamate, it should be possible to
detect labelled glutamate in the tissue.
However, if isotope is measured in tissue glutamate (Chapter
2, Section 2.3.6.3), it is found that the enrichment is very low; in
Table 4.8 the measured ^N-glutamate is compared with the value
calculated by computer using the model of Section 4.2.2. (Fig 4.3),
assuming that glutamate is the first product formed from the ammonia
in the exchangeable pool. Thus the label disappearing from ammonia
is not found in glutamate, and there are two possible explanations
for this phenomenon. The first product formed from ammonia may not
in fact be glutamate. If it is glutamine, glutamine labelled in
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such a finding would demonstrate the existence of glutamine synthetase
in rat heart. Alternatively, glutamate may be formed first, but. may
rapidly transaminate to yield labelled aspartate or alanine, which
should also be measurable. If the second explanation is correct
it must be assumed that "^N enters and leaves heart glutamate without
the latter becoming highly labelled, as is the case with heart ammonia.
Hence tissue giutamate may also exist in two pools, only one cf which
is in equilibrium with the exchangeable ammonia pool and is labelled
from it. It is likely that the physical location of the labelled
glutamate pool is the same as that of the labelled ammonia pool.
This suggests a compartment concerned with the active metabolism of
several interrelated substances. The possible location of this
compartment is discussed in Chapter 6 on the basis of histochemical
studies. Such an arrangement would have the further advantage of
allowing a small portion of the tissue ammonia to react with glutamate
dehydrogenase, whilst the larger fraction (pool A) is prevented from
doing so, thereby preventing depletion of tissueoc-oxoglutarate and
wAicA
failure of energy metabolism, / occurs in brain (James et al., 1972).
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Appendix 4.1 Calculation of model parameters and pool sizes.
Perfusate Tissue Metabolite
k^, k: and K are the rates of the ammonia fluxes shown (as ^-mol.heart ^.min
K is a constant rate. A, and <}zare the rate constants corresponding to k^
and k .
Let isotope in perfusate = Rp ^mol/heart.'
Let enrichment = ap (= lOOap atoms % excess).
Let total ammonia in perfusate = Sp jl mol/heart.
Hence Rp/Sp = ap.
Similarly, let isotope in pool x = R ;
isotope in pool A = R^; etc.
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Consider isotope in perfusate pool P:
Rate of increase of Rp
dRp






lo®e^P = ~S^t+ °'
When t = 0, let Rp = [R^] .
Hence c = log^R^.
kl
1<^'eRP " 1 + loge[RP]o
RP
1Pge [Rp]0 s ' (1>
or Rp = [R^eV^.
From (1), [Rp]Q
^°^e ~R ~ s~ ^Rp
But since k /S = [Rp]1 P
1 og -p = A, t (2)
t
Consider heart no. 104:
[Rp]0 = 0.47; [Rp]15 = 0.34; t = 15.
\ -1 -l -1 -1
Substituting in (2), A, = 0.0216 heart .min = 0.0296 g ,min .
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Consider total ammonia in perfusate pool:
Rate of increase of Sp
= dSP = - kx + K.
dt
But k^ = X, Sp; K is constant.




>,t K \t te .dt = -t—. e + c.
X|
When t = 0, S = [S ] .
r L r o „
c - [Sp]o" T'/XI
S e*,t: = — e^'* + TS 1 — —.. Sp. e A( e + [Sp]o x
sp = T (1 " ®At> + [spVe~V (3)'S
In heart no. 104 at t = 15,
Sp = 0.35; X, = 0.0216; [S ] - 0.59.
Substituting in (3), K = 0.033 jtmol.heart \min ^.
When equilibrium is reached,
K = k = A,S .1 P
Sp = K/^( = 0.033/0.0216 = 1.53 moles.
Thus in a perfusate volume of 50 ml,
Concentration of ammonia in perfusate at equilibrium
= 1.53/50 x 103 = 31 mol/1.
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Consider isotope in exchangeable pool (x) of heart:
Rate of increase of R
x
dR
= _x = Klap - k2ax
k k
■ Sp-"p - S -Rxr x
= A,Rp - AzRx.
Since Rp = [Rp]o.e~X,t (see (1) above),
dRx + \r% = [Rp]0-e'X,t-
dt
Integrating, f x
Ve f - \ 1M -dt
irr iVo-^A)t + *
When t = 0, R^ = 0, hence c = — ^ ^ [Rp]Q»
V** - - *}
-^-[Rp^. (e~Xlt - e"°^) (4).R =
1 xl
In heart no. 104, when t=15, = 0.005. = 0.0216; [Rp]Q = 0. 47.
Substituting in (4),
At = 1.54 heart ,min .
Consider total ammonia in exchangeable pool:
Rate of increase of S
x
dS
— = k - k
dt 1 2
Integrating, ^ ^ K
S ,e z = —!— eXlt.dt + A,([Sp]o -y).le(Xl"^
.
. K_eJtt +fX,[S ]o - K |.e(>--Vt + c.
K-\
When t = 0, S = [S ] .
x L xJo
A, tsp]0 - KK 4,
: c = [S ] ~ ~T~ ~ T .xJ0 \ \A A 2. A,
Sx = [Sx]o-e"Xlt + f(1 ~ S~U) + (e^'-A') ..*3- 2- /
If e-^ is very small ( = e in heart 104),
K M^o " K -U
S — "y + / ° (e Xlt) (6)
— A)
In heart 104, \ = 0.0216; = 1.54; K = 0.033; [Sp] = 0.59
Substituting in (6), ^
Sx = 0.012 jrmol.heart .
Since heart no. 104 weighed 0.73g, S^ = 0.016 ^imol.g .
Since the total tissue ammonia at 15 minutes is 0.6-1 jimol.heart \
S is 2% of the total tissue ammonia,
x
CHAPTER 5
AMMONIA AND AMINO ACID METABOLISM IN PERFUSED
RAT HEART
Chapter 5 Ammonia and Amino Acid Metabolism in Perfused Rat Heart
It has been shown (Chapter 3, Table 3.4) that perfused rat heart
produces substantial quantities of ammonia, 1.5 ymoles per g fresh
weight in the first 60 minutes of perfusion. Keul and his group
(1964, 1966) have shown that amino acids do not contribute significantly
to the energy metabolism of the human heart in vivo. However,
results discussed in the latter half of this chapter show the extent
to which their oxidation does occur in the isolated perfused rat heart
(see also Buse et_ al., 1972). Deamination of amino acids results in
the production of ammonia. In this chapter three possible mechanisms
of ammonia production are discussed. Firstly, catalytic deamination
of aspartate, for example by the purine nucleotide cycle (Lowenstein,
1972); secondly, direct deamination of glutamate by glutamate dehydro¬
genase; thirdly, hydrolysis of glutamine (Ottaway, 1969a,b). The
overall result would be similar in the first two cases, but the direct
precursor of ammonia in the first case would be an adenine nucleotide
(or nucleoside), and in the second case, an amino acid.
5.1 Adenine Nucleotides and Ammonia
Anoxia in skeletal muscle leads to the production of large
quantities of ammonia (Parnas and Mozolowsky, 1927). This is due to
the accummulation of AMP, which is hydrolyzed to IMP and ammonia
(Schmidt, 1928). Under physiological, aerobic conditions a pathway
operates which reconverts IMP to AMP (Newton and Perry, 1960; Davey,
1961). The pathway requires energy in the form r2 GTP. These reactions
form a cycle in skeletal muscle, the net result of which is the
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Figure 5,2, The purine nucleoside cycle.
Pj = inorganic phosphate; PPj = inorganic pyrophosphate,
PRPP = 5-phosphoribosylpyrophosphate,
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Concentration in tissue (ymol/g fresh weight)
Ventricle after ischaemia for the
Control times shown (min)
Ventricle
5 10 20 30 45 60
ATP 4.28 3.39 2.70 0.46 0.24 0.14 0.08
ADP 1.05 1.75 1.78 0.90 0.85 0.70 0.45
AMP 0.16 0.42 0.69 2.74 2.67 2.38 2.25
Adenosine 0.00 0.02 0.13 0.50 0.48 0.32 0.25
IMP 0.00 0.03 0.03 0.08 0.13 0.22 0.28
Inosine 0.00 0.02 0.20 0.74 0.86 1.37 1.61
Adenine 0.00 0.00 0.02 0.03 0.08 0.05 0.04
Hypoxanthine 0.00 0.01 0.07 0.18 0.24 0.37 0.46
Total 5.49 5.64 5.62 5.63 5.55 5.55 5.42
Table 5.1 Concentrations of adenine and hypcxathine nucleotides in
rat hecrt during anoxia (reproduced from Gerlach et al., 1963).
The data show that much of the ATP and ADP which disappears during anoxia
*Ls converted to AMP and inosine. There is a transient peak in the concentra¬
tion of adenosine, suggesting that this, rather than IMP, is the intermediate
-Ln the conversion of AMP to inosine. The concentration of IMP does not
■Increase significantly until towards the end of the experiment.
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hydrolysis of aspartate to fumarate and ammonia (Fig 5.1). Thus
one of the suggested functions of the cycle (Lowenstein, 1972) is the
deamination of amino acids which can donate their amino-group, via
glutamate, to aspartate.
In hypoxic cardiac muscle on the other hand, deamination of AMP
is much less important than deamination of adenosine to inosine, as
is shown by the data of Geriach ert al_. (1963), reproduced in Table 5.1,
and confirmed by the data of Richman and Wyborny (1964). This is
due to two factors: firstly, the high activity of 5-nucleotidase of
heart muscle (Baer et al., 1966), which competes more successfully
for AMP than does AMP deaminase; and secondly, the presence of
cytoplasmic adenosine deaminase in this tissue. AMP deaminase in
heart is less active and chiefly found in the nucleus (Baer et al.,
1966), where it may be concerned in nucleic acid metabolism.
Under aerobic conditions inosine can be recoverted to adenine
nucleotides (Tsuboi and Buckley, 1965; Liu and Feinberg, 1971). The
pathway begins with conversion of inosine to hypoxanthine. The key
enzymes, purine nucleoside phosphorylase and hypoxanthine phosphoribo-
syltransferase, are present in heart (Maguire et al., 1972). Again
one can postulate a cyclic pathway in aerobic tissue (Fig 5.2). Like
the Lowenstein cycle, this cycle results in the deamination of
aspartate. It is, however, a very expensive process energetically,
and its primary functions are probably connected with salvage of
purine nucleotides (Maguire £t cQ., 1972) and regulation of the
concentration of adenosine, a physiological vasodilator of the
coronary system (Geriach <rt al., 1963).
Several lines of evidence suggest that this cycle does not operate
in perfused rat heart at a rate sufficient to account for the observed
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ammonia production. Although all the enzymes, when measured under
saturating conditions (Maguire et al., 1972), are sufficiently active
to account for the observed ammonia production, the intermediates
adenosine, inosine, hypoxanthine and IMP cannot be found in rat heart
tissue unless it is severely hypoxic (Gerlach £t al., 1963) nor in
rabbit heart unless it is hypoxic or uncoupled for 20 minutes or
longer (Richman and Wyborny, 1964). There is evidence that adenosine
given to perfused rabbit heart is converted to AMP (by adenosine kinase),
rather than to incsine (Liu and Feinberg, 1971). Finally, the cycle
implies turnover of the oc-phosphate of AMP, but Rossi et_ al. (1972)
found the rate of turnover to be only one twentieth of the rate of
ammonia production as measured in this study.
172.
5.2 Amino Acid Metabolism and Ammonia
Since adenine nucleotide breakdown is insufficient to account
for the observed ammonia production in perfused rat heart, alternative
precursors must be considered. Comparison of enzyme levels in
heart and skeletal muscle suggests that deamination of glutamate is
potentially more important than deamination of adenine compounds in
s/te(efo»l
heart, whereas the reverse is true in^muscle (Table 5.2)
Direct deamination of glutamate by glutamate dehydrogenase provides
a route for the deamination of amino acids linked to glutamate by
transamination. Glutamine is another possible precursor of ammonia
(Ottaway, 1969a,b), but is less important in the context of overall
amino group metabolism since it may not be formed from other amino
acids in heart (Iqbal and Ottaway, 1970).
In the present section, experimental results are presented which
attempt to relate ammonia production or utilization to myocardial
amino acid metabolism. The implication of the results, and
problems arising from them, will be discussed in the final section of
this chapter (Section 5.3).
5.2.1 Total Ninhydrin-Reactive Material
Definition "Total ninhydrin-vcactive material" is an unambiguous, if
cumbersome, phrase to indicate material which reacts with ninhydrin
under the conditions described in Chapter 2 (Section 2.2.4) to give
a colour absorbing light at 570 nm. It includes free amino acids,
compounds such as taurine, ammonia and small soluble peptides such as
glutathione. In this and subsequent chapters it •'ill be abbreviated to
NRM. Within this category it is possible to define amino nitrogen as
Rat leg muscle Rat heart
Glutamate dehydrogenase 1.3 11
AMP deaminase 127 1.6 - 4.4
Table 5.2 Concentration of ammonia-producing enzymes
in rat heart and skeletal muscle (data from
Lowenstein, 1972).
Units are ymol substrate converted per g tissue per
min at 37°C.
Treatment
Total NRM, ymol/g fresh weight
(mean + S.E.M.)
Unperfused, tissue 34.8 +1.9 (7 hearts)
Perfused, no added N source:
Tissue 24.8+2.3 (9 hearts)
Perfusate 14.9+1,5 (9 hearts)
Total 39.7 +3.1 (9 hearts)







Unperfused34.8+1.9(7) Perfused,noaddedNso rce24.8+.3(9)P<0.01 Perfused+300ymol/1NH4+ 2.71.9(4)•P>0.40 5<P<0.1 Perfused+500ymol/1gl tamine33.81.1(5)P> .6<0.02 Table5.4heffectontissueNRMfperf sionwithvariousm dia. ThenumberofheartsiwhichNRMameasuredsownparenth sis. SignificanceAreferstohdiffere ebetw enperfus da dunpe fused tissue;significanceBre erstohd fferenbetw ent ssperfus d withoutanddedn rogensourcethaperfusedwithammo iarglut mine. Differencesw rcompa dusingStud nt'st-t . v?rf:'-4;"Kg*53***5
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nitrogen covalently bound to carbon in the form of an amino group
(-NH,,). The phrase "total amino nitrogen" thus defined does not
include ammonia.
The NRM content of rat heart, before and after perfusion, is
shown in Table 5.3. In the absence of an added nitrogen source, the
heart lost NRM into the perfusing fluid. There was, however, a
net gain by the whole system of 4.9 ymoles per g. It was not possible
to demonstrate statistical significance of this increase (P>0.2),
though there was probably a real increase due largely to protein
degradation and reflecting the imbalance between protein breakdown and
synthesis (see Section 5.2.3.1). The hydrolysis of glutamine to
glutamate and ammonia would also result in an increase in NRM.
Loss of NRM from the perfused tissue was abolished if ammonia
or glutamine were added to the perfusing medium (lable 5.4). It was
not practicable to measure NRM in the perfusate under these conditions.
5.2.2. Myocardial Amino Acids
Table 5.3 shows that the unperfused rat heart contains 34.8ymoles
of ninhydrin-reactive material per g tissue. To determine the nature
of this material, perchlorate extracts from two hearts were analyzed
for amino acid composition (Moore and Stein, 1954a). The results are
shown in Table 5.5. With the exceptions given below, the data are
the means of values from the two hearts. Threonine, asparagine and
glutamine elute as a single peak in the procedure used; serine in
sufficient quantity appears as a shoulder on the side of this peak,
but was not seen in these analyses. Glutamine was measured enzymically:
the other three amino acids were not determined, but asparagine is present
Legend to Table 5.5
The table shows the content of free amino acids in rat
heart as measured by the techniques described in the text.
Figures in parenthesis are the number of hearts in which
analyses were carried out -'values are means + S.E.M.). Other
values are the means of two determinations by amino acid analyser.
Literature values are either taken directly from the source cited
or calculated from the data of the authors as ymol/g fresh weight.
*-These authors quote ammonia concentrations in the heart of
approximately 10 ymol/g. This almost certainly represents the
large ammonia peak found in all automatic analyses, which arises
from contamination of the reagents used.
(A) Herbert et_ al., 1966
(B) Kuttner and Lorincz, 1969
(C) Morgan et_ al. , 1971
(D) Scharff and Wool, 1965a
(E) Manchester and Wool, 1963
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Compound This Author, Literature values, ymol/g
ymol/g
(A) (B) (C) (D) (E)
Aspartate 1.14 + 0.10 (9) 0.56 1.47 0.55 3.02 2.68
Glutamine 5.49 + 0.66 (9) 5.99 7.61 5.83 - 5.29
Glutamate 4.46 + 0.24 (9) 4.45 7.76 4.63 4.24 4. 18
Alanine 0.99 + 0.12 (6) 1.92 1.15 0.62 2.32 3.61
Ammonia 0.43 + 0.03 (6) - - - * *
Glycine 0.82 0.76 0.47 0.35 0.68 1.53
Lysine 1.07 0.83 0.89 0.52 0.61 1.09
Arginine 0.33 0.13 0.29 0.13 0.27 1.19
Valine 0.050 0.15 0.12 0.08 0.11 0.77
Methionine 0.024 0.08 0.06 0.03 0.06 0.53
Isoleucine 0.034 0.08 0.08 0.04 0.06 0.70
Leucine 0.033 0.18 0.14 0.06 0.12 1.23
Tyrosine 0.018 0.09 0.06 0.04 0.08 0.39
Phenylalanine 0.028 0.07 0.05 0.03 0.05 0.50
Histidine 0.045 0.17 0.05 0.11 0.11 0.55
Proline 0.040 - - - - 1.01
Tryptophan 0.006 - - - 0.02 -
Taurine 11.75 24.5 35.4 7.54
"Peak (1)" 4.52 - - - - -
Glutathione 2.27 - - - 4.11 -
Unidentified 0.27 - - - - -
Total (calculated) 33.8 . _ _ . _
Total NRM (measured) 34.8 + 1.9 (7) — — — —
Nutritional status
Fasted Fasted Fasted Fasted Fed Fed
of rats
Table 5.5 The Free Amino Acid Content of Rat Heart, before Perfusion.
only in low concentration in heart (Ottaway, 1972). Data for
aspartate., glutamine, glutamate, alanine and amnonia are the means
(+ standard error) of enzymic measurements. Obviously much more
weight can be placed on these values than on the remainder. Examples
of analyses taken from the literature are shown in comparison.
Nine amino acids (valine to tryptophan in the Table) constitute
a very small proportion of the total (0.28ymoles per g altogether,
or 0.83% of the ninhydrin-reactive material). Any increase in their
concentration during perfusion can be ascribed to protein degradation
(Section 5.2.3.2), and they are unlikely to have any large-scale
metabolic importance other than in protein metabolism. No
transamination of the branched-chain amino acids could be demonstrated
during perfusion (Section 5.2.3.2). In most future sections these
nine amino acids will be dealt with as a group ("other amino acids").
Another group comprises glutamate, aspartate, alanine and glutamine.
These constitute 36% of the total NRM, or 75% of the amino acids
which occur in proteins (cf Gail is and Benmouyal, 1973), and their
concentration in tissue exceeds that in plasma by a factor of ten
or more (Scharff and Wool, 1965a). They are closely related to
intermediates of energy metabolism. It is to this group that ammonia
metabolism is most likely to be related, through the action of
glutamate dehydrogenase or glutaminase. Relatively large amounts of
taurine, glycine, lysine, arginine and glutathione (Wendell, 1970) are
also present. "Peak (1)" is a large peak of unidentified material
eluting between taurine and glutathione. It was not identified,
although its chromatographic position shows it to be strongly acidic
in nature, possibly a sulphonated compound connected with taurine
metabolism. The high concentration of lysine, an essential amino acid,
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is remarkable, but it probably derives from the breakdown of muscle
proteins, in which it is a common residue (Kominz et al., 19S4;
Morgan et al., 1971; Elzinga and Collins, 1973). The absence of
a lysine tranaminase (Felig and Wahren, 1971; Felig, 1973) means that
it can only disappear from the tissue by diffusion out of the muscle
cells.
The analyses of Table L.5 show an interesting variation in
aspartate concentration between fed and fasted rats. According to
Bowman (1966), the aspartate content of rat heart falls on perfusion
with acetate, (3-hydroxybutyrate or octanoate. These substances increase
the level of acetyl CoA and accelerate its conversion to citrate.
Thus the requirement for oxaloacetate is increased and is satisfied
by aspartate. Low aspartate concentrations in hearts from fasted
rats may therefore indicate an increased dependence of these hearts
on the metabolism of fatty acids and ketone bodies.
5.2.3 The Effect of Perfusion on Myocardial Amino Acids
Perfusion for 75 minutes without an exogenous nitrogen source
led to an increase in ninhyarin-reactive material in the system
(Section 5.2.1). The effect of perfusion on the free amino acid
composition of rat heart is shown in Table 5.6. Values for glutamate,
aspartate, alanine, glutamine and ammonia are the means (+ standard
error) of enzymic measurements. Values for other compounds are the
means of total amino acid analysis of tissue and perfusate samples
from two hearts. Since protein turnover acts as a source and sink
of amino acids, an attempt will be made to estimate the extent of
net protein degradation, prior to evaluation of changes in amino
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5.2.3.1 Lysine and Protein Turnover
Heart muscle protein is in a state of continuous breakdown and
resynthesis (Manchester, 1970). During perfusion without an added
nitrogen source, the tissue Is in a state of negative nitrogen balance
and breakdown is more rapid than synthesis. A part of the increase in
free amino groups is due tc this (Section 5.2.1). Lysine is an
essential amino acid, a specific transaminase for which is absent in
peripheral tissue, so that the increase in lysine can be used as
an indication of net protein breakdown (Felig and Wahren, 1971;
Felig, 1973; Marliss et al., 1971). On a molar basis the lysine
content of muscle protein is approximately 8% (Black and Boiling,
1951, quote 8% in beef muscle; Morgan et al., 1971, 11.1% in rat
heart myosin; Kominz et al., 1954; 6.0% and 10.1% in actin and
•if
myosin respectively). Perfused rat hearts produced on average
0.21ymoles of lysine per g fresh weight in 75 minutes. This is
equivalent to an increase of 2.6ymoles per g in total free amino
acids due to protein breakdown.
Using this value, the contribution of protein breakdown lo the
increase in each amino acid on perfusion can be predicted and
the observed increase can be compared with it (Table 5.7). In the
Table, the approximate percentage composition of heart muscle
protein is calculated from the data of Morgan et_ al. (1971) and
Kominz et al. (1954), assuming equal amounts of actin and myosin.
The complete amino acid sequence of actin from rabbit skeletal muscle
has recently been published (Llzinga and Collins, 1973). The calculated
composition agrees well with that given by Kominz et_ (1954).
★
2 tissue samples, mean increase 0.02 ymoles per g, and 5 perfusate
samples, mean increase 0.19ymoles per g, were used to calculate the
average increase in lysine in the system.
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Ammo
. , proteinacid , . .
Average % Increase on perfusion (ymol/g)
in heart muscle
(residues per Corrected
100 residues) Predicted Observed (observed-predicted)
sparlate 6 0.16 -0.32 -0.48
lutamine 4 0.10 + 1.34 + 1.24
lutamate 11 0.29 -1.41 -1.70
lanine 9 0.23 + 1.13 *-0.90
lycine 6 0.16 -0.01 -0.17
ysine 8 0.21 +0.21 -
rginine 5 0.13 +0.14 +0.01
aline 5 0.13 +0.22 +0.09
ethionine 3 0.08 +0.09 +0.01
soleucine 6 0.16 +0.14 -0.02
eucine 9 0.23 +0.25 +0.02
yrosine 3 0.08 +0.16 +0.08
henylalanine 3 0.08 +0.25 +0.17
istidine 2 0.05 +0.08 +0.03
Table 5.7 Protein breakdown and amino acid changes on perfusion without
an added nitrogen source.
The increase in lysine is taken as an index of protein breakdown.
Using the composition of muscle prrteins given by Morgan et_ al. (1971)
and Kominz et_ al_. (1954), the predicted increase in each amino acid on
perfusion, due only to protein breakdown, is calculated. This value is
used to correct the observed amino acid changes for the effects of protein
turnover.
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The new data allow ciscrimation, hitherto impossible, between
glutamate, aspartate and their amides. Actin glutamate is 28%
amidated, aspartate 35%. At the present time only fragments of
the myosin sequence are known (Hodges and Smillie, 1972a,b; Huszar
and Elzinga, 1971; Huszar, 1972), but these give no reason to
doubt that the figures for amides in myosin are similar to those for
actin. The contents of aspartate, glutamate and glutami-e given
in Table 5.7 are calculated on this basis.
5.2.3.2 Metabolically Inert Amino Acids
Methionine, isoleucine, leucine and arginine showed increases
on perfusion which are identical, within the limits of experimental
error, to these predicted in Table 7. The increases can thus be
attributed to protein breakdown and strengthen confidence in the
use of lysine in the calculation of protein degradation. The
increases in tyrosine, phenylalanine, histidine and valine are greater
than predicted, although they are essential amino acids and synthesis
of their carbon skeletons cannot occur. The increases are, however,
quantitatively small, and probably do not differ significantly from
the predicted values. Proline and tryptophan were not measured in
the perfused heart. None of these amino acids is concentrated more
than fivefold from the plasma by the tissue (Scharff and Wool, 1965a),
and they are unlikely to have much metabolic importance other than
in the context of protein synthesis. It is interesting that no
disappearance of leucine, isoleucine or valine could be shewn,
despite reports thrt heart contains an active branched-chain amino
acid transaminase (Cammarata and Cohen, 1950) and readily oxidizes
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these amino acids if they are presented in the perfusing medium
(Clarke, 1957; Buse et al., 1972). Glycine docs not appear to be
oxidized by heart; it is not metabolized to CO^ (Lorber and Olsen,
1946), nor does it cause an increase in alanine production (Coulson
and Hernandez, 1968). It is possible that the small decrease observed
on perfusion represents some conversion to serine, which could not
be detected.
5.2.5.5 Metabolically Active Amino Acids:
Glutamate, Aspartate, Alanine and Glutamine
These four amino acids are closely related to the pathways of
energy metabolism, as the diagram shows (Fig 5.5). They showed
(M/e£ 7)
changes on perfusion^which differed greatly from the predicted increases
due to protein breakdown.
The decrease in glutamate is statistically significant (P<0.01)
and has been observed before (Hicks and Kerlv, 1960; Gailis and
Benmouyal, 1975). It could be a result of the recovery of the heart
from temporary anoxia after the onset of perfusion, since the
concentration of glutamate is reported to be high in anoxia
(Williamson, 1966). Bowman (i966) reported a fall in glutamate followed
by partial recovery during perfusion. The total asparatate concentration
also decreased significantly (P<0.01) if protein-derived aspartate,
is taken into account. This decrease was observed by Randle et_ al.
(1970) during 6 minutes perfusion. It is at variance with the results
of Bowman (1966) who found a marked rise in aspartate at the onset
of perfusion, falling later to the In vivo level, and Gailis and









Figure 5.3. The relationship of glutamate, aspartate,
glutamine, alanine and ammonia to energy metabolism.
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Time of perfusion (min)
Fig. 5.4 The appearance of alanine and glutamine in the perfusate of
hearts perfused without any additions.
Alanine and glutamine were measured in the perfusate of 4 hearts
perfused without any added nitrogen source. Points are means, ± S. E. M.
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guinea-pig heart. Hicks and Kerly (1960), on the other hand, found
a complete disappearance of aspartate measurable chromatographically
in two hours perfusion of rat heart.
In contrast to glutamate and aspartate, the total alanine
concentration increased significantly (P<0.01). An output of alanine
is characteristic of peripheral tissues, particularly muscle (see
Felig, 1973, for a review). The phenomenon is discussed in the context
of heart amino-group metabolism in the final section of this chapter.
The concentration of glutamine also increased on perfusion. Owing
to the large experimental error involved in glutamine measurement,
the increase was not statistically significant. It may not therefore
be real, especially since glutamine synthetase has not been conclusively
demonstrated in rat heart (see Chapter 1, Section 1.2). The fall in
glutamine demonstrated by Ottaway (1969a) and Gailis and Benmouyal
(1973) was not observed.
5.2.3.4 Perfusate Amino Acids
Analysis of the perfusate after 75 minutes (Table 5.6) showed
that very little ninhydrin-reactive mate-rial diffused out of the
heart other than ammonia, glutamine, alanine and taurine. Like
ammonia (Chapter 3, Section 3.2.2), the rate of production of glutamine
and alanine was linear, at least for the first 60 minutes of
perfusion (Fig 5.4).
5.2.3.5 Nitrogen Balance
If protein degradation is taken into account, and the statistically
insignificant increase in glutamine is ignored, the significant changes
are as follows:
Aspartate - 0.48 ymol/g
Glutamate - 1,70 ymol/g
(Total) - 2.18 ymol/g
Alanine + 0.90 ymol/g
Ammonia + 1.60 ymol/g
(Total) + 2.50 ymol/g
The appearance of alanine and ammonia is thus almost accounted for
by the disappearance of aspartate and glutamate. Considering the
large errors involved, the agreement is remarkably good.
(If the observed increase in glutamine is taken into account,
the nitrogen balance becomes seriously inexact, as can be seen from
the following calculation. The synthesis of 1.24ymoles of glutamine
from glutamate and ammonia means an increase in NH^ groups of 2.48
















This result lends support to the view that there is no synthesis
of glutamine in rat heart during perfusion, apart from that
derived from protein breakdown).
5.2.4 Perfusion with Ammonia
Hearts perfused with ammonia (300 ymol/l) in this series of
experiments took up 2.9ymoles of ammonia per g fresh weight from
the perfusing medium. Only O.27ymoles of this can be accounted for
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as an increase in the tissue concentration. The free amino acid
compositions of tissue and perfusate are shown an Table 5.8.
Total alanine in these hearts was rather higher than in hearts
perfused without ammonia, but it was not possible to show statistical
significance (P = 0.22). The elevated tissue lysine concentration
was probably due to chance biological variation. It is unlikely that
it indicates a disturbance of protein synthesis by ammonia, since
production of other "metabolically inert amino acids" (Section 5.2.3.2)
was unaltered by the presence of ammonia, and the lysine content of
the perfusate was similar to that found in the absence of ammonia.
The predicted values for amino acids derived from piotein breakdown
are therefore the same as those used in Section 5.3.3 (Table 5.7).
The comparison between the predicted values and the changes
observed on perfusion with added ammonia is given in Table 5.9.
Again the increases shown by the "metabolically inert" amino acids
differ little from the predicted values, whereas those shown by
glutamate, aspartate and alanine differ greatly from the latter.
Concentrations of these three amino acids in the system were
significantly different from these in the unperfused heart, but not
significantly different from those in the heart perfused without
an added nitrogen source. The increase in glutamine was not
significant, and indeed was loss than that measured in the absence of
added ammonia.
Nitrogen Balance
If, as before (Section 5.2.3.5), protein degradation is taken into
account, and the increase in glutamine is ignored, the changes in
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1.14 + 0.10 0.82 + 0.13 0.47 + 0.11 0.32 + 0.08 0.79 + 0.10 (4) -0.35 P = 0.06 -0.03 P >0.9
5.49 + 0.66 6.83 + 0.66 4.69 + 0.82 1.36 + 0.08 6.05 + 0.81 (8) +0.56 P = 0.6 -0.73 P =0.5
4.46 + 0.24 3.05 + 0.28 2.98 + 0.22 0.23 + 0.01 3.21 + 0.22 (8) -1.25 P < 0.01 +0.16 P> 0.6
0.99 + 0.12 2.12 + 0.25 1.04 + 0.25 1.63 + 0.17 2.67 + 0.38
*
-2.61
(4) + 1.68 P < 0.001 +0.55 P =0.2
0.43 + 0.03 2.02 + 0.24 0.70 + 0.08 -2.88 * (8) - - - -
0.82 0.81 0.33 0.41 0.74 -0.08 -0.07
1.07 1.31 1.69 0.27 1.96 +0.89 +0.65
0.33 0.47 0.57 0.06 0.63 +0.30 +0.16
acids 0.28 1.46 0.28 1.01 1.29 + 1.01 -0.17
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Table 5.8 Free amino acid content of rat heart after perfusion with 300 pmol/1 ammonia.
Total NRM, and compounds measured by enzyraic assays, are given as mean + S.E.M., with the number
of hearts in parenthesis. Other values are the means of two determinations by amino acid analyser. -These
figures are changes in concentration, not absolute values. Values for unperfused heart and heart perfused without
added nitrogen are taken from Tables 5.5 and 5.6, respectively.






Aspartate 0.16 -0.35 -0.51
Glutamine 0.10 +0.56 +0.46
Glutamate 0.29 -1.25 -1.54
Alanine 0.23 + 1.68 + 1.45
Glycine 0.16 -0.08 -0.24
Lysine 0.21 +0.89 +0.68
Arginine 0.13 +0.30 +0.17
Valine 0.13 +0.17 +0.04
Methionine 0.08 +0.08 0.00
Isoleucine 0.16 +0.11 -0.05
.Leucine 0.23 +0.19 -0.04
Tyrosine 0.08 +0.10 +0.02
Phenylalanine 0.08 +0.23 +0.15
Histidine 0.05 +0.13 +0.08
Table 5.9 Protein breakdown and amino acid changes on perfusion with
added ammonia.
The correction of observed amino acid changes is carried out
as described in the legend to table 5.7. The apparent increase
in lysine is due to high concentrations of lysine in the tissue









Alanine + 1.45 ymol/g
(Total) + 1.45 ymol/g










Alanine + 1.45 ymol/g
Glutamine + 0.92 ymol/g
(as amino
groups)
(Total) + 2.37 ymol/g
Thus in the presence of ammonia, nitrogen balance is inexact
whether glutamine is considered to increase or not. The net
disappearance of nitrogen represented by the discrepancy in the
first calculation is 3.21ymoles per g tissue. This problem is
discussed below (Section 5.3.2.3). The increases in lysine, taurine
and glutathione shown in Table 5.3 cannot be ascribed to any process
involving fixation of NH^.
5.2.5 Perfusion with Added Amino Acids
5.2.5.1 Perfusion with Glutamine
Fig 5.5 shows the uptake of glutamine by perfused rat heart
from a medium in which its concentration is 500 ymoles per litre.
The net uptake (1.5 + 2.1ymolts per g tissue) was small and seemed
to occur within the first 15 minutes of perfusion. Owing to the






Time of perfusion (min)
Fig. 5.5 The uptake of glutamine by perfused rat heart.
Points are means + S. E.M. of serial glutamine measurements in the
perfusate of 8 hearts.
Amino acid
Unperfus d, tissue (A)
Perfused,no addedN source, total (B)Concentration,,jmol/g
Significance of






Aspartate Glutamine Glutamate Alanine Ammonia
1.14+0 0 5.49+0 66 4.46+0 24 0.99+12 0.43+0
0.82+13 6.83+0 66 3.05+0 28 2.12+0.25 2.02+0 24





-1.08P<0.02 +2.51P<0 001 +3.10P<0.0 1
+0.33P>0.4 +1.38P<0 02 +1.50P<0 02
Table5.10Freminoacidcont ntfrahe rafterperfusionwith 500ymol/1glutamine. Valuesrmeans+S.E.M.,withthn mberofheartsi p re th sr:;. *-Thesefiguresarconcentrationhanges,otab oluvalues. Differencesw rcompar dusingStud t's-tes .




Aspartate 0.16 +0.64 +0.48
Glutamine 0.10 -0.56 -0.66
Glutamate 0.29 -1.08 -1.37
Alanine 0.23 +2.51 +2.28
Table 5.11 Protein breakdown and amino acid changes on
perfusion with added glutamine.
See legend to table 5.7.
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it was not possible to demonstrate that this value was significantly
different from zero. However, hearts perfused with glutamiue produced
significantly more alanine, ammonia and aspartate than those perfused
without an added nitrogen source (Table 5.10), and these changes
confirm that glutamine was taken up by the heart. The small change
in glutamate was not significant (P > 0.4). Perfusion with glutamine
was the only treatment which significantly increased the synthesis
of ammonia by the heart (P<0.02). It might be argued that ammonia
arose from the spontaneous conversion of glutamine to ammonium
pyrrolidonecarboxylate in the perfusate during the course of the
experiment (Hamilton, 1945). However, the tissue ammonia concentration
in hearts perfused with glutamine was three times that measured in
hearts perfused without any added nitrogen source (Table 5.6; signifi¬
cance of increase in tissue ammonia, P<0.01), and was indeed higher
than that in hearts perfused with 300ymol/l ammonia. These
observations clearly show that the increased ammonia is produced
in the tissue in response to the uptake of glutamine.
Using the values for the contribution of protein turnover to
amino acid metabolism derived in I able 5.7, the corrected amino acid
changes on perfusion can be calculated (Table 5.11) and the nitrogen
balance can be presented as follows:
Glutamate - 1.37 ymol/g Aspartate + 0.48 ymol/g
Glutamine - 1.32 ymoi/g Alanine + 2.28 ymol/g
(as amino
groups)
Ammonia + 3.10 ymol/g
(Total) - 2.69 ymol/g (Total) + 5.84 ymol/g
Figures are ymoles per g fresh weight.
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These figures show a discrepancy of 3.15 ymoles per g between
the synthesis of aspartate, alanine and ammonia and the disappearance
of glutamate and glutamine. In view of the biological variation in
glutamine uptake, and the analytical error involved in measuring
the small changes in perfusate glutamine concentration, some
discrepancy is perhaps to be expected.
5,2.5.2 Perfusion with Glutamate
In contrast to glutamine, the uptake of glutamate by perfused
rat heart was unequivocal and continued throughout the first hour of
perfusion (Fig 5.6), during which time approximately one quarter of
the added glutamate disappeared from the perfusate. The uptake from
the perfusate was 7.9 + 1.8ymoles per g fresh weight, and was
significantly greater than zero (P<0.02). Hence of the compounds
tested the uptake of glutamate was quantitatively the most important,
confirming the results of Keul and co-workers (1964, 1966) in human
heuxt.
Hearts perfused with glutamate produced more glutamine and
significantly more aspartate (P<0.02) than those perfused without
an added nitrogen source (Table 5.12). An increase in alanine
production was also noted in the one heart and two perfusates in which
it was measured. It was not possible to demonstrate a significant
increase in ammonia production by the whole system, although the tissue
ammonia concentration was significantly raised (P<0.01) over that
in hearts perfused without an added nitrogen source, as was the
tissue glutamine (1 '0.001).
Using the values for the contribution of protein turnover to
amino acid metabolism derived in Table 5.7, the corrected amino acid
Time of perfusion (min )
Fig. 5.6 The uptake of glutamate by perfused rat heart.
Points are means ± S. E.M. of serial glutamate measurements in the













Aspartate Glutamine Glutamate Alanine Ammonia
1.14+0 0 5.49+0 66 4.46+0 24 0.99+12 0.43+0
0.82+13 6.83+0.66 3.05+0 28 2.12+0 25 2.07+0 24
0.77+.140 93. 71 70.4( )0.56P=.0788P< .02 7.49+0 21.630990.51(3)3.80P<0.052 46P= .09 2.69+0 25-7.90* -9.67(5) 1.13( )2.5923.72( )2. 3-.62 0.57+061. 122 390. 7(4)1 96P<0.0010.36P> .4
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Aspartate 0.16 +0.56 +0.40
Glutamine 0.10 +3.80 +3.70
Glutamate 0.29 -9.67 -9.96
Alanine 0.23 +2.73 +2.50
Ta.ble 5.13 Protein breakdown and amino acid changes on
perfusion with added glutamate.
See legend to table 5.7.
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changes on perfusion were calculated (Table 5.13) and the nitrogen
balance expressed as follows:
Glutamate - 9.96 ymol/g











Figures are ymoles per g fresh weight. They show a discrepancy
of 2.30 ymoles per g between the nitrogen gained and the nitrogen
lost.
5.2.5.3 Perfusion with Aspartate
The aspartate concentration in the perfusate of 3 hearts
perfused with media containing aspartate (350 - 500 ymol/l)
remained constant for the first 60 minutes of perfusion, suggesting
that aspartate is not taken up by the perfused heart during this
period (Fig 5.7). The slight decrease in the perfusate aspartate
concentration in two experiments from 60 to 75 minutes is unlikely
to represent a sudden uptake of aspartate (see Section 5.3.5).
Some related metabolites were measured in these hearts (Table 5.14).
Hearts perfused with aspartate liberated more ammonia into the
perfusate than those perfused without any added nitrogen source, but
the increase in the perfusate ammonia concentration was not significant
(P>0.1). There was no evidence of any increase in alanine production
in the single hear* in which this amino acid was measured. It seems
unlikely therefore tiiat aspartate was taken up by the perfused rat
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heart, and extremely unlikely in the intact rat, where the plasma
aspartate concentration is much lower (38ymoles per litre as measured
by Scharff and Wool (1965a) in fed rats) than that used in the
experiments described in this section.
Time of perfusion (min)
Fig. 5.7 The concentration of aspartate added to the perfusate of
rat heart.
Points represent single determinations of aspartate in serial perfusate














Table5.14Ammoniaandlaninecha geso perfusionwithaspartate. Alimitednumberofheartswaperfusedithspartate.
Numbersareshowninparenthesis.
5 3 Discussion
The results reported in the preceding section of this chapter
describe an investigation into the changes in the amino acid content
of rat heart during perfusion, and the relation of the amino acids
with each other and with ammonia in heart metabolism. Many problems
and points of interest raised by the investigation are the subject
of discussion in the present section.
5.3.1 Amino Acid Metabolism in the Perfused Rat Heart
Total amino acid analysis has shown that the only amino acids
whose concentrations change significantly on perfusion are glutamate,
glutamine, aspartate and alanine (Section 5.2.3.3). Other amino
acids show smaller concentration changes which can be related to
protein breakdown in the tissue. The concentration of taurine, as
measured in the present study and by other authors (Table 5.5),
exceeds that of every other amino compound measured in rat heart.
Its function in this tissue is as yet unknown, although a transmittory
or excitavoxy role has been postulated for it (Huxtable and Brescler,
1972). It is unlikely to have any metabolic relationship with any
of the four amino acids named above, or to ammonia. Glutathione
was also present in relatively high concentration, but its concentration
could not be measured accurately since its peak was overlapped on
the chromatogram by those of taurine, which preceded it, and "peak 1",
which followed it. Changes in its concentration reported in Tables
5.6 and 5.8 are not mirrored by changes in the glycine concentration,
which suggests thau the glutathione concentration in fact remains
Fig.5.8
Concentrationsfamincidsam oniaiperfusedrhe rt.
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constant during perfusion. This discussion will therefore be
confined to glutamate, glutamine, aspartate, alanine and ammonia.
Figure 5.8 shows the concentration of these five compounds as
y mol/g fresh weight in the tissue of unperfused hearts, and in the
tissue and perfusate of hearts after perfusion with the media
described in the foregoing section.
5.5.1.1 The Metabolism of Endogenous Amino Acids
Perfusion without an added nitrogen source resulted in some
disappearance of glutamate and aspartate, with production of
alanine, ammmonia and possibly glutamine. (The calculation of
Section 5.2.3.5 shows that nitrogen balance is inexact, but the
discrepancy can be reduced if one assumes that no glutamine is
synthesized). A possible explanation is that the net conversion of
aspartate to alanine by the coupling of GOT to GPT results also in
a net conversion of pyruvate to oxaloacetate, and is a mechanism for
replenishing the tricarboxylic acid cycle in a tissue which lacks
pyruvate carboxylase (Safer and Williamson, 1973):
(1) Aspartate + cc-oxoglutarate ?■ oxaloacetate + glutamate
(2) Glutamate + pyruvate > oc-oxogluta'rate + alanine
Sum: Aspartate + pyruvate > oxaloacetate + alanine
In the perfused rat heart, however, this type of anaplerotic reaction
would seem to be unnecessary. In contrast to the substrate-depleted
hearts of Safer and Williamson (1973), hearts taken straight from
rats without anoxia and perfused with media containing glucose have
their full complement of tricarboxylic acid cycle intermediates
(Bowman, 1966). In fact, Bowman's results suggest that the utilization
of fat-related substances, as would occur during fasting, tends to
increase rather than deplete the concentrations of these intermediates.
The heart of a fasted rat, therefore, ought to have an excess rather
than a deficiency of tricarboxylic acid cycle intermediates.
Moreover, this conversion does not explain the net disappearance
of glutamate and the production of ammonia. Safer and Williamson
(1973) did not detect any ammonia production, since tissue ammonia
does not increase on perfusion (Chapter 3), and they did not measure
ammonia in the perfusate. An alternative explanation is that
glutamate and aspartate are oxidized to provide energy, the amino
groups leaving the heart as alanine and ammonia. The "alanine
cycle" (Felig, 1973) is discussed below (Section 5.3.3).
The nitrogen balance calculation of Section 5.2.3.5 shows a
disappearance of 1.70ymoles of glutamate and 0.48ymoles of
aspartate, and a production of 0.90ymoles of alanine and 1.6Cymoles
of ammonia per g fresh weight in 75 minutes of perfusion. If these
figures represent amino acids utilized as a source of energy, the
amount is insignificant in comparison with the utilization of carbo¬
hydrate energy sources. The hearts used in this study took up on
average 30.9ymoles of glucose per g per hour, producing 11.Sy moles
of lactate and 0.8y moles of pyruvate (Chapter 2) and presumably
oxidizing most of the remainder by the tricarboxylic acid cycle, since
no significant increase in tissue glycogen is seen on perfusion of
hearts from fasted rats (Mowbray, 1969) . Oxygen consumption was
3.61ymoles per minute, or 309ymoles per g per hour in a heart
weighing 0.7 g (Table 2.5). Thus endogenous amino acids are not an
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important source of energy in perfused rat heart which is supplied
with glucose, confirming the findings of Keul and co-workers (1964,
1966) in human heart.
5.3.1.2 The Metabolism of Amino Acids in the Perfusate
Hearts took up nitrogenous compounds selectively from the
perfusing fluid. No aspartate was taken up, at least in the first
hour of perfusion. The uptake of ammonia was small, and caused an
increase only in alanine production, but this increase was not
statistically significant. Ammonia uptake from media of varying
ammonia concentration has been fully documented in an earlier
chapter (Chapter 3). The uptake of glutamine was smaller than that
of ammonia, and was not easy to demonstrate in all hearts tested.
It did, however, result in a significant increase in the synthesis
of aspartate, alanine and ammonia compared with hearts perfused without
any added nitrogen source. The extra alanine and ammonia formed
were released by the heart into the perfusate. The extra aspartate,
however, did not leave the heart, but accumulated in the tissue: the
quantity of aspartate appearing in the perfusate was no different
from that in hearts perfused without any added nitrogen source.
Glutamate was the only compound tested which was metabolized
by the heart to an appreciable extent. Perfusion with glutamate
caused an increased production of aspartate and alanine. The
synthesis of glutamine by these hearts was significant, which suggests
that rat heart may not, after all, lack glutamine synthetase
(Iqbal and Ottaway, 1970). Ammonia production was not significantly
increased by perfusion with glutamate; this treatment did, however,
cause a significant increase (P<0.01) in the intracellular ammonia
concentration. It is probable therefore that the ammonia formed from
glutamate was used in glutamine synthesis and was not released into
the perfusate. Although the increase in aspartate synthesis was
almost identical to that caused by perfusion with glutamine, during
perfusion with glutamate the greater part of the aspartate was released
into the perfusate. Hence the output of aspartate into the perfusate
was significantly raised (P<0.01) by perfusion with glutamate, but
was unaffected by any other treatment described, which suggests that
aspartate was leaving the heart in exchange for some of the glutamate
taken up. Glutamate-aspartate exchange has been observed in mito¬
chondria (Chappell, 1968).
Work on human subjects shows that glutamate is taken up by the
heart from the circulation, but that it does not contribute significantly
to the heart's energy supply (Keul ejt aT., 1964). The present study
has shown that rat heart takes up glutamate from the perfusing medium,
in which its initial concentration is 370ymol/l. Although the
concentration of glutamate in the plasma of the fed rat is somewhat
lower (113ymol/l, Scharff and Wool, 196ba), it is likely that uptake
also occurs in the live animal. Hearts perfused with glutamate
metabolized 9.96ymoles of the amino acid per g tissue; although this
figure is nearly six times greater than the metabolism of endogenous
glutamate (1.70 ymol/g), it still represents an insignificant source of
energy when compared with the oxygen consumption of the heart (309ymol/g
per hour). Peripheral tissues in general consume glutamate and release
alanine; functions of this cyclic process will be discussed below
(Section 5.3.3).
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5.3.2 Amino Acid Metabolism and Ammonia
The production of ammonia from adenine nucleotides in rat heart
was discounted in section 5.1 of this chapter. In section 5.2, an
attempt was made to relate the synthesis or disappearance of ammonia
in perfused rat heart to changes in the concentration of glutamate,
glutamine, aspartate and alanine.
5.3.2.1 Ammonia Production
It was shown in section 5.2.5 that glutamine alone of the amino
acids tested caused a significant increase in the production of ammonia.
This does not necessarily mean that the ammonia produced in perfusion
without an added nitrogen source comes exclusively from glutamine.
It merely demonstrates the removal of an administered glutamine load,
as expected, by the action of glutaminase (Ottaway, 1969a,b).
Hearts perfused with glutamate did not produce any more ammonia
than those perfused with the control medium (containing no nitrogen
source). However, the tissue ammonia concentration was significantly
increased, and there was a significant synthesis of glutamine. This
implies that glutamate did cause an increase in ammonia synthesis, but
that the extra ammonia was used in the production of glutamine, instead
of appearing in the perfusate.
Hearts perfused with no added nitrogen source produced 1.6ymol
of ammonia per g tissue, but its source is more difficult to determine,
although the experiments described above showed that ammonia could
arise either from glutamate or from glutamine if these amino acids
were administered in excess. The decrease in gluconate on perfusion
with control media was 1.7ymol/g, which was almost identical to the
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amount of ammonia synthesized. However, the ammonia formed during
perfusion with the control medium appeared in the perfusate without
accumulating in the tissue, whereas perfusion with glutamate caused
no increase in the quantity of ammonia liberated into the perfusate.
Endogenous glutamate is therefore a possible source of ammonia only
if it is metabolized in a compartment different from that in which
exogenous glutamate is metabuliz*d. Glutamine has been proposed as
a source of ammonia in rat heart, since this tissue contains
glutaminase (Ottaway, 1969a,b) and the kinetic constants of this
enzyme can be used to predict, with some success, the behaviour of
isotopically labelled ammonia during perfusion (Chapter 4). This
could not be substantiated by the amino acid measurements described
here, since no decrease in glutamine was seen on perfusion with control
media.
5.3.2.2 Ammonia Uptake
In the "nitrogen balance" calculation of section 5.2.4 it was
not possible to account fo^ the uptake of ammonia by hearts perfused
with 300 ymol/l ammonia as an increase in bound amino groups, nor was
it possible to demonstrate significant increases in any amino acid
measured (although analysis of a greater number of hearts might
conceivably have shown a significant increase in alanine). The
problem of the fate of the ammonia nitrogen remains thus unsolved.
The end product is unlikely to be glutamate, since no increase in
the glutamate concentration of tissue or perfusate was caused by
perfusion with ammonia, and perfusion with ^N-labelled ammonia did
not result in glutamate becoming significantly labelled (Chapter 4,
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Section 4.3). Synthesis of adenine compounds is ruled out since there
is insufficient inosine and IMP in heart to react with all the ammonia
taken up (Gerlach et al., 1965). No significance can be attached to
the apparent increase in taurine (Section 5.2.4) in ammonia-perfused
hearts, since only two hearts were analyzed in each case, and it is
difficult to see what connection taurine might have with ammonia
metabolism. Metabolic uptake of ammonia by the heart has been
attributed to the synthesis of glutamine (Watanabe, 1968), despite
the failure of many authors to measure glutamine synthetase in rat
heart (Iqbal and Ottaway, 1970; see also Chapter 1). In the present
study, perfusion with ammonia did not increase glutamine formation
in the heart (Section 5.2.4); nevertheless, perfusion with
glutamate did lead to a significant production of glutamine which
implies that glutamme must indeed be formed from ammonia and glutamate
in rat heart.
5.5.2.3 Ammonia and Nitrogen Balance
In section 5.2 of this chapter, nitrogen balance calculations
were presented for hearts perfused with the control medium and with
media containing ammonia, glutamine or glutamate. Only those amino
acids which were considered metabolically important by virtue of
their high concentration in the tissue, significant concentration
change on perfusion, and direct relationship with energy metabolism,
were included in the calculations. All the calculations except that
relating to the control medium showed discrepancies. The control
calculation could be made approximately correct by assuming that no
glutamine synthesis took place, but the observation that glu^amine
MediumChangeinconcentration,syst m,pmol/gT tal
(excluding ammonia)


































Table5.15Nitrog nb lanceoperfusionwithvariousmedia. Figuresshowthainorlossfmetabolitefr mystem
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synthesis occurred in hearts perfused with glutamate suggests that
this assumption is invalid. On perfusion with added ammonia the
discrepancy involved a loss of nitrogen; perfusion with other media
resulted in a gain of nitrogen.
Table 5.15 shows that all the calculations can be made more
exact by omitting ammonia from the balance. This suggests that
the ultimate source or fate of ammonia may not lie in the four amino
acids measured, although it does not exclude any of these four amino
acids from being either the direct precursor of ammonia, or the
product formed directly from ammonia taken up by the heart.
5.5.5 Amino Acid Cycles in the Plasma of the Rat
Peripheral tissues, particularly skeletal muscle, release a
large number of amino acids into the plasma (Pozefsky et_ al_., 1969;
Felig and Wahren, 1971; Cahill et al., 1972), amongst which alanine
(Coulson and Hernandez, 1968; Pozefsky et al., 1968; Felig et al.,
1970; Felig and Wahren, 1971) ard glutamine (Marliss et al_. , 1971;
Ruderman and Lund, 1972) are released in the largest quantity.
Heart muscle likewise releases amino acids into the plasma (Keul et_ aT
1964); again alanine (Carlsten et al., 1961; Ottaway, 1969a) and
glutamine (Keul et al., 1964) are the most important. Glutamate,
in contrast, is taken up by forearm muscle (Marliss et al., 1971)
and heart (Keul et al., 1964). The splanchnic circulation conversely
removes alanine (Felig and Wahren, 1971), glutamine and other amino
acids from the blood and produces glutamate (Marliss et al., 1971).
Alanine (Mallette et al., 1969; Ishikawa et al., 1972) and glutamine
(Ross et al., 1967) have been shown to act as substrates for
gluconeogenesis in the liver, and the availability of alanine seems
to be rate-limiting for gluconeogenesis in this organ (Mallette et al.,
1969). The alanine output of muscle is correlated with muscle
activity and with the arterial pyruvate concentration (Felig and
Wahren, 1971), and is increased by the administration of amino
acids (Coulson and Hernandez, 1968). An "alanine cycle" has been
proposed (Mallette ert al., 1969; Felig et al., 1970; Felig and
Wahren, 1971; Felig, 1973). One of its functions is the return
of amino groups to the liver, following the oxidation by the muscle
of amino acids, either derived endogenously from protein degradation
or the ICF pool, or taken up from the plasma (as glutamate). In the
liver, the carbon skeleton is converted via pyruvate to glucose which
is returned to the plasma, the amino group being released as urea
or glutamate (Fig J.9). The cycle is completed by the return of
glucose to the heart; however, the output of glutamate by the liver
(Marliss ert al., 1971) and its uptake by the heart (Keul et_ al_., 1964)
and by muscle (Marliss et_ al., 1971) provide an additional link in
the cycle which is not discussed by the authors cited above. In
addition to glutamate, leucine is reportedly taken up by muscle and
metabolized, the nitrogen appearing as glutamine (Ruderman and
Lund, 1972).
Glutamine has also been proposed as a nitrogen transporter
(Braunstein, 1947; Ruderman and Lund, 1972), but its role is different
from that of alanine, firstly since splanchnic uptake of glutamine
is a function of the gut rather than the liver (Felig, 1973) and
secondly since its output by peripheral tissues does not increase
with activity (Felig, 1973) and is thus presumably unaffected by the
rate of amino acid oxidation. It can only be of importance in tissues
in which significant glutamine synthesis can occur, for example in
skeletal muscle and brain.
The metabolism of the perfused rat heart was in agreement with
the above scheme. Alanine, glutamine and ammonia were released into
the perfusate; other amino acids appeared in much smaller amounts
(Section 5.2.3.i). The relative importance of alanine, glutamine and
ammonia in disposing of amino groups added to the perfusing fluid
is shown in Table 5.16. Values represent the output of each compound
into the perfusate during perfusion, expressed asymol/g tissue.
Alanine synthesis seemed the most important mechanism for dealing with
a nitrogen load, since the output of alanine was increased in response
to the administration of amino compounds such as glutamate, glutamine
or ammonia. The glutamine output showed no such increase however, and
may represent merely a leakage of the amino acid from the large ICF
glutamine pool. Results reported in section 5.2.5.2 did suggest that
glutamine could be synthesized by the heart in response to the admini¬
stration of glutamate, but there was no resultant increase in the
output of glutamine into the perfusate under these conditions. Thus
the physiological significance of glutamine output by the heart is
uncertain. It does, however, constitute the major loss of amino acid
nitrogen from the heart, as it carries two amino groups per molecule.
Ammonia output has neve .- been considered as a significant method
of amino group disposal, in view of its supposed toxicity (see
Chapter 1, Section 1.3). Table 5.16 shews that it is quantitatively
as important as alanine in the removal of nitrcgen in control
perfusions. However, like glutamine, it shows no increase in output
in response to glutamate administration. The increase in output in
response to glutamine is due to the action of glutaminase (Ottaway,
1969a,b). Aspartate is included in Table 5.16, al .hough it does
not represent a significant loss of amino groups in perfusion with
ammonia, glutamine or the control medium. On perfusion with glutamate
however, the quantity of aspartate released into the perfusate increased
sign ificantly (P<0.01, compared to the aspartate output in control
perfusions). The increase in the efflux of aspartate from the heart
suggests that glutamate-aspartate exchange is involved to some extent
in the uptake of glutamate.
The large uptake of glutamate relative to the amounts of the
other compounds taken up (Section 5.2.5.2) is in agreement with the
observations of Keul et al_. (1964) in human subjects. Glutamate is
a readily available and easily taken up source both of nitrogen and
of carbon skeletons (Fig 5.9). It acts as a source of the amino
groups of non-essential amino acids which are not themselves taken
up from the plasma, for example aspartate. It acts as a source of
tricarboxylic acid cycle intermediates in a tissue which lacks
pyruvate carboxylase (Safer and Williamson, 1973) and so cannot
derive these intermediates from pyruvate. It can be oxidized to
provide energy, as long as the products, for example oc-oxoglutarate
or malate, can leave the heart at a rate sufficient to avoid accumu¬
lation. Such oxidation is accompanied by a stoicheiometric release
of nitrogen in the form of a] mine, aspartate and ammonia. It-has
been shown, however, (Section 5.3.1) that the energy provided by
glutamate oxidation does not constitute a significant part of the
heart's total energy requirement under normal circumstances, although
it may become important when other sources of energy are in short
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5.3.4 The Glutamate Concentration in Rat Heart
The glutamate concentration in the unperfused rat heart is
remarkably constant at approximately 4.5ymol/g fresh weight, as is
shown by the agreement between the values given by various authors
(Table 5.5, ignoring the value of Kuttner and Lorincz, 1969}, despite
variations in the concentrations of other amino acids such as alanine,
glycine or aspartate. On perfusion with no added nitrogen source
the tissue concentration fell to 2.75ymol/g (Section 5.2.3.3). This
value was not significantly affected by perfusion either with ammonia
or with glutamine, or even with glutamate itself, despite the uptake
of 7.9 ymol of glutamate per g of heart.
Thus there appears to be rigorous control of the glutamate
concentration in rat heart, and the concentration at which it is
controlled depends on the conditions: in these experiments there is
a distinction between hearts of intact starved rats and hearts
perfused with glucose medium. Williamson has observed that the
steady-state concentration of glutamate depends on the status of
the heart. The giutamate concentrations calculated from his data
asymol per g fresh weight were 4.5 in glucose perfusion and 1.4 in
substrate-free perfusion (Safer and Williamson, 1973), and 6.3 in
anoxia (Williamson, 1966). The value of 2.75 ymol per g reported here
after glucose perfusion is rather lower than that of Safer and
Williamson, who used fed rats and included insulin with glucose in
the medium. His hearts were-thus more dependent on glucose oxidation
than were those used in the present investigation, and took up
72 ymol of glucose per hour per g fresh weight (Safer and Williamson,
1973) compared with the value of 30.9 reported in Chapter 2. It is
possible therefore that the glutamate content of the heart i.^
affected in some way by the glycolytic flux. This does not. however,
explain the high glutamate concentration in the unperfused heart,
since one would expect the glycolytic flux to be relatively low in
the starved animal.
It is more probable that the glutamate concentration in heart
muscle reflects the mitochondrial NAD+/NADH ratio, as it does in
rat liver (Krebs, 1967; Williamson et al., 1967). Hence the
high glutamate concentration in hearts perfused with fat-like
substances such as acetate or octanoate (Bowman, 1966) or in anoxia
(Williamson, 1966) may be due to a decrease in the NAD+/NADH ratio.
The decrease seen on perfusion could therefore represent recovery
of the heart either from mild anoxia or from a fasting type of
metabolism. However, the literature values of Table ££"are too
uniform to suggest anoxia; and the values for hearts from fed rats
are as high as those from fasted rats.
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5.3.5 A Note on the Final Perfusate Sample
Reference has been made occasionally to anomalous concentrations
of metabolites in the 75 minute perfusate sample. Ammonia sometimes
showed a rise during the last 15 minutes of perfusion (Chapter 3),
as did glutamine in hearts perfused with it (Chapter 5, Section
5.2.5.1), whereas aspartate in two aspartate-perfused hearts showed
a slight drop in concentration. These changes did not occur in all
hearts, and might be attributed to incipient heart failure. However,
some hearts were maintained for longer periods without any continued
increase in the perfusate ammonia concentration, and hearts which
showed a rise in ammonia concentration in the last 15 minutes included
hearts perfused for 60, 75, 90 or 120 minutes. Attempts to trace an
artefact connected with the taking of the final sample were unsuccessful.
In most cases the increases were small and within the limit of
experimental error. An uptake of aspartate in the final 15 minutes
was not supported by any significant increase in alanine or ammonia
production..
CHAPTER 6
THE LOCALIZATION IN RAT HEART OF SOME ENZYMES
RELATED TO GLUTAMATE METABOLISM
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Chapter 6. The Localization in Rat Heart of Some Enzymes Related To
Glutamate Metabolism
There are two major approaches to the intracellular localization
of enzymes in a tissue. The first involves physical disruption of
the tissue and the separation of subcellular organelles by
appropriate methods, for example, differential centrifugation; the
enzymes are measured in the resultant fractions by standard techniques.
This approach is limited by the number of fractions which can be
separated: usually only nuclei, mitochondria and microsomes are
segregated from the soluble components of the cytoplasm. The
microsome fraction is itself heterogeneous, containing ribosomes,
endoplasmic reticulum and other membranes, fragments of which may
roll up in such a way as to enclose enzymes which are actually
cytoplasmic. Cross-contamination between fractions is a further
disadvantage of this method, but can be reduced by employing
gentler methods. One of these is the fractional extraction technique
of Pette and co-workers (Pette, 1966, 1968). This method permits
gentle but efficient washing-out of cytoplasmic enzymes so that it is
no longer so necessary to depend on the measurement of compartment-
specific "marker" enzymes. The standardization of all steps in the
procedure leads to excellent reproducibility. The laboratory method
has been described (Chapter 2, Section 2.4.2.1). Fractional
extraction has been successfully applied to a wide range of problems
(Pette et_ al^., 1962a,b; Pette and Luh, 1962; Klingenberg and Pette,
1962; Pette, 1966; Goebell and Pette, 1967; Pette, 1968; Brdiczka
et al_., 1969; Brdiczka and Pette, 1971). Its particular disadvantage
is that the centrifugation steps precipitate nuclei and other
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subcellular organelles in addition to mitochondria, all of which
can be seen microscopically to be intact after the first sucrose
wash (Pette, 1968). Hence homogenization of the suspended pellet
yields a supernatant (S4) containing nuclear and microsomal, as
well as mitochondrial enzymes. All membrane-bound enzymes appear
in the final pellet, whether they are attached to the inner mito¬
chondrial membrane (as is SDH) or to the outer membrane (as is
monoamine oxidase) or to other membranes such as the endoplasmic
reticulum.
The second approach permits the direct observation of enzyme
distribution ini situ without tissue disruption, achieved by the
histochemical staining of the enzyme in a thin section of rapidly-
frozen tissue. A reaction catalyzed by the enzyme under investigation
results in the deposition of a detectible product at the site of
the enzyme. The product is coloured in light-microscope work, or
electron-opaque for electron microsocpy. Tetrazolium salts have
been widely used in the light-microscopic study of enzymes in
tissue slices; the staining reaction involves the reduction of a
soluble, pale yellow tetrazolium salt to a densely-coloured formazan.
Ditetrazolium salts yield dark blue insoluble formazans and are
used in preference to monotetrazolium salts which yield more readily-
diffusible red formazans. Nitro-blue tetrazolium is most widely
used as it is easily reduced in the standard technique, wivhout
significant non-specific reduction (known as the "nothing dehydrogenase"
reaction), and produces a small-grained formazan suitable for
accurate enzyme localization. In dehydrogenase localization reducing
equivalents are pro 'ided (via a reduced coenzyme) by the substrate
of the dehydrogenase. Other enzymes can be localized if they can be
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coupled to a suitable dehydrogenase.
Tetrazolium salts react directly with reduced flavoproteins.
Thus the first enzymes to be studied by tetrazolium staining were
succinate dehydrogenase and the flavoprotein diaphorases (Seligman
and Rutenberg, 1951; Farber and Louviere, 1956; Farber and Bueding,
1956; Farber et al_., 1956; Nachlas et^ al., 1957). Diffusion of
these enzymes during the staining period was not a problem in
their localization, since they are membrane-bound. NADH does not
reduce tetrazolium at an appreciable rate, so that the localization of
an NAD+-linked dehydrogenase requires an electron-transfer intermediate
between NADH and tetrazolium. In earlier experiments endogenous
tetrazolium reductases fulfilled this function, with the disadvantage
that their distribution, as well as that of the enzyme under
investigation, was reflected in the formazan pattern obtained. This
problem was overcome in later work by the incorporation of soluble
redox dyes in the staining medium (Farber and Bueding, 1956; Nachlas
et al., 1957); phenazine methosulphate is generally used. A
further consequence of the use of PMS was a reduction in staining
time which allowed the local1 ization of soluble dehydrogenasespresent
in sufficient activity without much diffusion of the enzymes during
staining. However, soluble enzymes tended to diffuse out of the
tissue with the result that much of the formazan was deposited m
the liquid medium, staining in the tissue slice being weak and diffuse.
Leakage of enzyme was greatly reduced by incorporating the staining
reagents in a slice of gelatine (Fahimi and Amarasingham, 1964) o± of
agarose gel (Pette and Brandau, 1962) which was applied the
tissue slice. An agarose gel staining system has been used
successfully in the localization of dehydrogenases and other enzymes
in several tissues (Pette and Brandau, 1962, 1966; Brandau and
Pette, 1966; Sigel and Pette, 1969). Histochemical localisation
in heart muscle, however, has been confined to structure-bound
enzymes such as succinate dehydrogenase, glycerophosphate oxidase
and adenosine triphosphatase (Niles et asl., 1964; Morales and Fine,
1965; Chayen et_ al^., 1966; Niles et_ aK, 1966; Pette and Brandau,
1966).
The patterns produced by staining skeletal muscle are very
clear. Mitochondrial enzymes such as succinate and glutamate
dehydrogenases cause formazan deposition only in the mitochondria
opposite the I-bands (Brandau and Pette, 1966). The I-bands of
adjacent fibrils coincide in the muscle studied by these authors,
resulting in a striated pattern in which the narrow stained bands
are composed of individual mitochondria. Lactate dehydrogenase is
an extra-mitochondrial enzyme, but it appears not to be homogeneously
distributed throughout the system since formazan is deposited in the
I-bands of the fibrils. This gives a striated distribution in which
the stained bands are wider than those of mitochondrial enzymes, and
in which individual mitochondria cannot be seen (Brandau ana Pette,
1966). It is inferred that the enzyme occurs only in the I-bands of
the fibrils. Malic enzyme catalyzes formazan deposition between and
parallel to the fibrils, suggesting that it is located in vhe i.iter-
fibrillar spaces. Enzymes found in two compartments give a composite
formazan distribution, for example, glyceraldehyde phosphate dehydro¬
genase stains heavily in the I-band mitochondria; this pattern is
superimposed on a higher staining of the I-band cytoplasm. Malate
dehydrogenase stains lightly in the interfibrillar spaces and heavily
in the interfibrillar mitochondria (Brandau and Pette, 1966).
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Skeletal muscle contracts when removed from its attachment
in the animal, and only shows striations if it is frozen while
held in a stretched position. Since the muscle fibrils run
parallel to the axis of the muscle, striated fibrils will be seen
in a longitudinal section of a muscle prepared in this manner. Heart
muscle differs in that the orientation of the fibres does not
conform to any regular pattern; sections cut from it generally
show a mixture of fibres cut in transverse, longitudinal and
oblique section. Further, it is technically difficult to stretch
heart muscle during freezing. In the present investigation, some
relaxation was induced by soaking small pieces of heart muscle in
isotonic KC1 solution before freezing, and striations were visible
in such preparations. Heart muscle also differs from skeletal muscle
in its cellular organization. The fibres are shorter, so that
coincidence between the I-bands of adjacent fibrils is unlikely to
persist beyond a few sarcomere-lengths. The mitochondria are
larger, and have a more complex structure than those of skeletal
muscle and they practically fill the interfibrillar spaces (Klingenbeig,
1964).
In the present chapter the activity and intracellular distribution
in heart muscle of three key enzymes concerned in nitrogen metabolism,
GluDH, GOT and GPT, are investigated and discussed. The methods used
are tetrazolium staining (Brandau and Pette, 1966) and fractional
extraction (Pette, 1968). The distributionsof the enzymes under
study are compared with those of marker enzymes. Control experiments
are described in an attempt to assess the contribution to the stain
distribution of artifactual adsorption of enzymes to histological
structures. Reports of this work have already appeared (Jarvie
Figs. 6.1 - 6.6 Distribution of enzymes in sections of rat cardiac
muscle stained as described in the text. Staining times (in
parenthesis) and magnifications are given.
I
Fig. 6.1 Lactate dehydrogenase, tetrazolium method (10 min)
x 1100.
Fig. 6.2 Succinate dehydrogenase, tetrazolium method (10 min)
x 1100.
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Fig. 6.3 Succinate dehydrogenase, tetrazolium method (10 xnin)
x 450.




Fig. 6.5 Glutamate dehydrogenase, tetrazolium method (30 min)
x 1100.
Fig. 6.6 Glutamate oxaloacetate transaminase, tetrazolium method
(30 min), x IjlOO.
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(a) Enzyme Figure L (ym) R
LDH 1 2.3 0.81
GluDH 5 2.3 0.86
GOT 6 2.3 0.78
ADH, added 7 2.3 0.91
Cytochrome oxidase 4 2.3 0.98
SDH 2 4.3 1.32
SDH 3 4.1 1.32
(b) Literature values (for SDH)
R Reference
0.86 Cnayen et al., 1966
1.39 Burstone; 1962
1.40 Nachlas et al., 1957
1.43 Nachlas et al., 1957
1.54 Novikoff, 1959
Table 6.1 Dimensions of banding patterns in
heart myofibrils stained by the techniques described.
L is the distance between successive dark striations; R is
the ratio of L divided by the distance between adjacent fibrils. L was
obtained by measuring 10 consecutive striations along a fibril and
dividing by 10; this procedure was repeated at least 5 times for each
photograph and the mean was calculated. The mean distance between
fibrils was obtained in an analogous manner. Literature values were
obtained by making similar measurements on published photographs. For
these only the ratio is reliable, since in many cases the actual magni¬
fication of the published picture is uncertain.
et al_., 1971; Jarvi.- and Ottaway, 1975).
6.1 Histochemical Localization of Enzymes in Rat Heart
Definition: In the present chapter the phrase "soluble
enzymes" denotes enzymes which are water-soluble and free to
diffuse in the aqueous medium created on disruption of the tissue.
Such enzymes may or may not diffuse freely within the cellulai
environment, and the phrase covers cytoplasmic and mitochondrial
enzymes. It also includes enzymes which may be loosely adsorbed
in vivo to structures such as fibrils, but which are released by
standard extraction methods. "Insoluble enzymes" denotes enzymes
firmly bound to membranes, from which they can only be released by
special solubilization techniques. Examples are SDH and monoamine
oxidase. A list of enzyme abbreviations can be found in Chapter 2,
Section 2.1.3.
Thin sections were cut from rapidly-frozen rat heart as
described in Chapter 2 (Section 2.4.1.1). In most sections, phase-
contrast microscopy revealed areas of transversely cut fibrils and
areas of longitudinally cut fibrils. Some longitudinally" cut fibrils,
but not all, showed striations visible in polarized light. The
potassium chloride treatment thus relaxed many of the fibres, but
its effect on the rest of the fibres was limited by the extent of
diffusion of K+ ions through the tissue. All striated fibres,
however, were completely relaxed, and showed a sarcomere-length of
2.3 ym (see Table 6.1).
The stain distributions given by five enzymes in sections of rat
heart were photograpned (Figs 6.1 - 6.6). The contrast is not so
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sharp as in the photographs of Brandau and Pette (1966) or Sigel
and Pette (1969), possibly because longer staining times were
required for heart muscle enzymes (other than SDH and LDH) than
those recommended for skeletal muscle enzymes (Sigel and Pette, 1969),
so that some diffusion of enzyme or of reaction intermediates may
have occurred during the staining period. Control sections incubated
in the absence of substrate did not stain to any extent: there was
no "nothing dehydrogenase" reaction.
6.1.1 Lactate Dehydrogenase
The staining pattern of LDH is characterised by formazan
deposition in the fibrils (running from bottom to top, Fig 6.1);
some fibrils are more heavily stained than others. The fibrillar
staining is crossed by striations (left to right, Fig 6.1) which
are "in register" for about 35 fibril widths in the section photo¬
graphed. Whereas the striations observed with skeletal muscle LDH
are continuous across adjacent fibrils, giving the picture a "banded"
appearance (Brandau and Pette, 1966), these of LDH in heart muscle
are broken so as to give a "blotched" appearance. This may be due
to the presence of bulky unstained mitochondria between the fibrils
of heart muscle (Klingenberg, 1964). Calculation of the distance
along the fibril between successive striations gives a value of
2.3 ym (Table 6.1), which is approximately equal to the quoted
sarcomere-length of 2.5 ym (Bloom and Fawcett, 1968). The striations
probably correspond to a concentration of the enzyme in the I-band
cytoplasm. Calculation of the sarcomere-length f.om the photographs
requires accurate knowledge of the absolute magnification. This is
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not necessary if the length is measured in terms of a quantity which
is assumed to be constant in all photographs. Hence the ratio R
given in Table 6.1 is the mean distance between striations divided
by the mean distance between fibrils in each photograph.
6.1.2 Succinate Dehydrogenase and Cytochrome Oxidase
The pattern given by SDH also shows striations (Figs 6.2 and 6.3),
but these are much coarser in appearance than those given by lactate
dehydrogenase. (Figs 6.1 and 6.2 are at the same magnification;
Fig 6.3 shows staining of SDH at rather less than half of the
magnification of Fig 6.2). Fig 6.3 shows parallel bands of stain
running from left to right which may represent staining of inter-
fibrillar mitochondria. The striations superimposed upon them
(running from bottom to top) are not "in register" for more than
5-6 fibril widths (compare LDH), and the distance between adjacent
striations is 4.2 pm (Table 6.1). This distance is rather shorter than
two sarcomeres, and the basis of the periodicity is not known. The
pattern resembled that observed by Chayen et al. (1966), but lacked
the granular texture described by Niles et_ al. (1966) in the presence
of FMS.
Cytochrome oxidase, like SDH, is bound to the inner mito¬
chondrial membrane. It was localized by diaminobenzidine staining
(Chapter 2), in an attempt to eliminate any possible artifacts of
the tetrazolium technique. The resultant pattern (Fig 6.4) can be
compared with figure 6.3, which was taken at the same magnification.
The bands of stain -running from left to right probably represent
interfibrillar mitochondria. With a few exceptions, there are no
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svriations, and where striations occur, they are weak and show
a periodicity corresponding to the sarcomere-length (Table 6.1).
The staining time was necessarily much longer (40 minutes) than
that required for the staining of SDH by the formazan technique, and
the stain deposition is weaker and more diffuse.
6.1.3 Glutamate Dehydrogenase
GluDH is generally regarded to be a mitochondrial enzyme
(de Duve et al., 1962). This is supported by fractional extraction
(see below). The stain ought therefore to be deposited in and around
the interfibrillar mitochondria. However, the staining pattern observed
(Fig 6.5) is superficially similar to that of lactate dehydrogenase
(Fig 6.1). Fibrils run from left to right, and striations cross them
at right angles and are in register for many fibril widths. Dark
spots of heavy formazan deposition are also visible. These are
unlikely to be fibrils cut in cross-section, since some of them
occur singly in the area of longitudinal section. They may represent
the position of structures rich in GluDH, possibly discrete mito¬
chondria or larger T-tubules.
6.1.4 Glutamate Oxaloacetate Transaminase
GOT (Fig 6.6) yields a similar pattern to that of GluTH. The
striated fibrils run from left to right, and a few dark spots are
visibl°. The greyness of the picture is due to the thickness of
the section. In both GOT and GluDH patterns diffuse bands of
stain run parallel the fibrils, which may represent an underlying
formazan deposition in interfibrillar mitochondria. They are not
shown by lactate dehydrogenase.
6.1.5 Control Tests
The similarity of the staining pattern of soluble intra-
mitochondrial enzymes to that of LDH raises the possibility that
these enzymes leak from mitochondria ruptured in the freezing and
thawing of the tissue, and selectively adsorb to fibrillar elements
in the cytoplasm. It has been shown that aldolase and other
glycolytic enzymes bind to muscle proteins, particularly to actin
(Arnold and Pette, 1968, 1970; Arnold <rt al_., 1969, 1971). This
affinity may be responsible for the I-band distribution of soluble
enzymes stained in muscle slices. It is therefore important to
test the adsorption of enzymes to heart muscle fibres, both in vitro
in a heart homogenate and microscopically in a tissue slice. An
enzyme not naturally present in rat heart was used in these tests
in order to avoid interference by endogenous enzyme.
Alcohol dehydrogenase is absent from rat heart (Morales and
Fine, 1965") , but can be stained by the tetrazolium technique in
muscles which possess it (de Pereda and Rebollo, 1967), and is
therefore an appropriate enzyme to test for adsorption to heart
myofibrils. A solution of yeast ADH was applied to tissue slices
and stained as described in Chapter 2 (Section 2.4.1.6). The
resultant pattern (Fig 6.7) showed that selective adsorption of the
enzyme to elements of the muscle tissue had indeed occurred. The
stain distribution resembles that of SDH (Fig 6.3) rather more
closely than that c>p LDH (Fig 6.1), suggesting that the enzyme is
taken up by the interfibrillar spaces, although the abundant striations
Figs. 6.7 and 6.8 Control experiments to test for adsorption of
components of the staining system to elements of the tissue siice.
Magnification x 450.
Fig. 6.7 The formazan distribution obtained on staining a tissue,
pieviously suffused with alcohol dehydrogenase, with a staining gel
for localization of this enzyme (5 min). Some striations are
visible, suggestive of fibrillar adsorption, but the predominant dark
bands suggest that much of the enzyme assumes a location in the
interfibrillar spaces.
Fig. 6.8 The pattern obtained on staining a tissue previously
suffused with NADH solution (10 : nin). There are no formazan
granules or striations in the tissue: all the formazan is deposited
in the gel-slice. Thus adsorption of NADH or other components
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Table6.2AdsorptionfyeastADHth rthomogenate. 0.5grathe rtwashomogenizedin10mlofsucrosemedium(Chapt r
2,Section.4.2.238 40unitsofADH(1u it=ymolfethanolperinat25°C)wereaddedanthmixturewasstirredg ntlyt0°Cfor20min.Centri- fugationyieldedsupernatanta llet,whichsesuspendedu rose mediumandstirredfor15min.Theresultants pernatantw sS2.Asubsequent15minwashofthepelletwith0.1mol/1phosphatebuffer,pH7.2,yield d supernatantS3a dtheelletP.
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have a periodicity corresponding to the sarcomere-length (Table 6.1).
The distribution was unaffected by the ionic strength of the
solution in which the enzyme was dissolved and applied.
If NADH solution was applied to the tissue slice in analogous
manner and stained with a gel containing Nitro-BT and PMS, all the
formazan was precipitated in the staining gel, and none was deposited
in the tissue (Fig 6.8). This result shows that there is no
binding of NADH or other components of the staining system to the
tissue.
In_ vitro adsorption of alcohol dehydrogenase to elements of a
heart muscle homogenate was also tested (Chapter 2, Section 2.4.2.2).
However, all the enzyme activity added to such homogenates could be
extracted by a medium of low ionic strength (Table 6.2), indicating
that no enzyme is adsorbed to the disrupted tissue under these
conditions.
6.2 Enzyme Localization by Fractional Extraction
The result of the fractional extraction of enzymes in a rat
heart by the method of Pette (1968) (Chapter 2, Section 2.4.2.1) is
shown in Table 6.3 and Fig 6.9. Three enzymes concerned with
nitrogen metabolism, GluDH, GOT and GPT, are compared with marker
enzymes having four types of distribution: soluble-cytoplasmic
(LDH, pyruvate kinase, adenylate kinase); soluble-intramitochondrial
(citrate synthetase); mixed (malate dehydrogenase); and mitochondrial
membrane-bound (SDH).
Glutamate pyruvate transaminase is present in low activity, and
its measurement is thus less accurate than that of the marker
Legend to Tables 6.3 and 6.4
0.5 g of tissue was analyzed by fractional extraction as
described in Chapter 2, Section 2.4.2.1. Fractions were obtained
as follows. Si, 15 min gentle stirring of suspension in sucrose
medium, low ionic strength. S2, 15 min repeat of this procedure.
S3, 15 min gentle stirring in 0.1 mol/1 phosphate. S4, homogeni-
zation followed by 10 min stirring. P, resuspended pellet.
Enzyme
Totalactivity, ymol/min/g freshweight













































































































































































































rigs. 6.9 and 6.10 Fractional extraction of enzymes in tissue.
0,5g of rat tissue was analyzed by the fractional extraction technique
(see Chapter 2, Section 2.4.2.1). Fractions were obtained as follows:
S^, 15xnin gentle stirring of suspension in sucrose medium, low ionic
strength; S2> 15min repeat of this procedure; S^, 15 min gentle
stirring in 0.1 mol/1 phosphate; S , homogenization followed by 10 min
stirring; P, resuspended pellet.




d glutamate pyruvate transaminase
e malate dehydrogenase




Fig, 6.9 Fractional extraction of enzymes in rat heart.
245.
Fraction
Fig. 6.10 Fractional extraction of enzymes in rat liver.
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enzymes. The fractional extraction pattern, however, shews that
this enzyme is entirely cytoplasmic. GOT in heart is more
active than either GPT or GluDH, and can be separated into two
fractions: soluble-cytoplasmic and soluble-intramitochondrial. Its
distribution resembles that of malate dehydrogenase, although the
proportion of cytoplasmic to mitochondrial is lower in the case of
GOT. GluDH is more active in heart than it is in skeletal muscle
(Lowenstein, 1972), and its distribution is that of a soluble-intra¬
mitochondrial enzyme such as citrate synthetase.
In the fractional extraction of rat liver or rabbit muscle
(Pette, 1968), no more than 5% of the total activity of soluble-
intramitochondrial enzymes is released in the washing stages prior
to homogenization. In the present investigation on the other hand,
12.5% of the total activity of GluDH is liberated prior to
homogenization. The parallel release of citrate synthetase suggests
that some of the mitochondria are ruptured during the sucrose and
phosphate washes. These data thus provide ro evidence of any
extramitochondrial glutamate dehydrogenase. As a control of the
technique, a fractional extraction of rut liver was carried out in
which less than 4% of the GluDH was released prior to homogenization
(Table 6.4 and Fig 6.10), comparable with the results of Pette (1968).
6.3 Discussion
The photographs comprising Figs 6.1 - 6.6 show that the enzymes
studied conform to specific distributions throughout rat cardiac
muscle, as they do in skeletal muscle. The more diffuse nature of
formazan deposition in cardiac muscle makes it rather difficult to
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deduce with certainty to which cellular structures the staining
corresponds, whereas the clear staining pattern given by skeletal
muscle allows much greater precision in allocating formazan deposition
to fibrils, I-bands, mitochondria or interfibrillar spaces
(Brandau and Pette, 1966; Sigel and Pette, 1969). In heart muscle
it is often hard to decide whether bands of stain represent fibrils
or the interfibrillar spaces running parallel to the fibrils. The
presence of striations with a r-eriodicity of one sarcomere-length,
dividing the band of stain into a row of dark spots, suggests
fibrillar staining. The soluble enzymes showed such a pattern, and
the dark spots presumably indicate a concentration of enzyme in
the I-bands. More continuous bands of stain can be seen in the
SDH and cytochrome oxidase distributions (Figs 6.3 and 6.4); similar
though fainter bancs underly the GluDH and GOT distributions
(Figs 6.5 and 6.6). These may represent interfibrillar mitochondria.
Exogenous ADH (Fig 6.7) gives similar bands though they are thicker
and more distinct, corresponding to interfibrillar spaces which have
soaked up the added enzyme.
In view of this difficulty in relating the histochemicar
pattern of heart tissue to known cellular structures, it is more
useful to compare the patterns given by the different enzymes, and
to relate these to the distributions of the enzymes revealed by
tissue fractionation. The most striking feature of figures 6.1 - 6.6
is the similarity in the formazan distribution given by all the
soluble enzymes, irrespective of their extra- or intramitochondrial
location as shown by the extraction technique (Fig 6.9) The
similarity in appearance is reflected by the similarity of the tissue
dimensions: the distance between striations is equal to the sarcomere
length (2.3 ym) and the ratio R (Table 6.1) is the same in all
cases. Membrane-bound enzymes alone gave a different pattern.
The distance between SDH striations was 4.2 ym, and R was
correspondingly greater. The basis of the 4.2 ym periodicity,
presumably a mitochondrial feature, is unknown. Comparison with
cytochrome oxidase stained with diaminobenzidine (Fig 6.4) suggests
that an artifact of the tetrazolium system may be involved.
Although an I-band location of heart LDH and cytoplasmic GOT
is feasible and is analogous to the distribution of LDH and many
glycolytic enzymes in skeletal muscle (Brandau and Pette, 1966;
Sigel and Pette, 1969), the similar distribution of GluDH is
unexpected. Apart from the faint and rather ambiguous bands already
pointed out, neither GluDH nor GOT were associated with significant
formazan deposition in mitochondria. The possibility was considered
that the GluDH stained in the cytoplasm originated from mitochondria
ruptured in the freezing and thawing process, and became adsorbed
to actin in the myofibrils. This hypothesis was supported by the
finding that exogenous ADH added to the tissue assumed a striated
iistributicr.. However, the pattern obtained with ADH v as more like
that of SDH than that of the soluble enzymes, and a large amount of
stain was deposited in the interfibrillar spaces: this was not seen
with either GluDH or GOT. Furthermore, adsorption of ADH to actin
did not occur ill vitro in a heart muscle homogenate.
The oompartmentation of ammonia metabolism in heart has already
been iiscussed (Chapters 3 and 4). The small and metabolically
active exchangeable ammonia pool would be associated with a separate
fraction of glutamcte dehydrogenase. Location of this fraction in
the sarcotubular system would be in agreement with the observed
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findings. It would be separated from the rest of the cyfoplasm by
a membrane, maintaining physical separation of rhe ammonia pools.
It would be easily accessible to substrates such as external ammonia,
hence the speed at which added ammonia appears to be metabolized by
a small pool of enzyme. It would stain as a fibrillar enzyme; being
more accessible than mitochondrial GluDH to exogenous substrate, it
might well stain whilst the latter remained unstained. (Tager (1966)
suggested that mitochondrial GluDH might be NADP+-specific, a
further possible reason for non-staining of the mitochondrial enzyme
by an NAD+-containing staining medium). Finally, it would appear
in fractional extraction as a mitochondrial enzyme, since the tubular
membrane would be unbroken until the final homogenization step which
opens the mitochondria. In addition, factors such as the small size
of the enzyme pool or special lability of the enzyme might have
prevented its previous discovery.
CHAPTER 7
GENERAL DISCUSSION AND CONCLUSIONS
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Chapter 7 General Discussion and Conclusions
The study presented here has several aspects. The ammonia
concentration has been measured in rat heart and is similar to
concentrations reported both in skeletal and in cardiac muscle by
other authors. It has been shown that rat heart produces ammonia
during perfusion with media to which none has been added, and
conversely that ammonia added to the perfusing medium can be taken
up and metabolized by the heart. A distribution ratio is maintained
by the perfused heart, in which the concentration in the tissue can
be up to twenty times as high as that in the medium. The effect
on this ratio of varying the perfusate ammonia concentration has been
described. Transport of ammonia across the plasma membrane has
been investigated by measuring the ammonia distribution under
different conditions and also by the use of isotopically-labelled
ammonia. The relationship of ammonia metabolism to that of free
amino acids in heart has been investigated, and the localization of
some of the enzymes involved in ihis metabolism has been studied.
7.1 Source of Ammonia
In skeletal muscle, the production of ammonia is well-documented
(see Chapter 1) and derives from the breakdown of adenine nucleotides
(Lowenstein, 1972). For the reasons discussed earlier (Chapter 5,
Section 5.1), however, adenine nucleotides cannot be a significant
source of ammonia in rat heart, and one is led to presume that
ammonia is formed in this tissue from the intracellular pool of free
amino acids. Both glutamate and glutamine can give rise to ammonia
by simple hydrolytic reactions: both enzymes are present in rat
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heart (glutamate dehydrogenase, Lowenstein, 1972; glutaminase,
Ottaway, J969a,b). At first sight glutamate is the more likely
precursor: on perfusion a decrease in tissue glutamate occurs which
is equal to the amount of ammonia produced (Chapter 5, Section 5.2.3.3).
The liberation of ammonia from glutamate is a final step in the
deamination of all amino acids which can transaminate with ac-oxo-
glutarate, allowing their carbon skeletons to be used in energy
metabolism. However, hearts perfused with added glutamate took up
glutamate from the medium but did not produce significantly more
ammonia although the tissue ammonia concentration was significantly
raised. (These hearts did, however, produce more glutamine than those
perfused without a nitrogen source. The net reaction 2 moles
glutamate —> 1 mole glutamine + 1 mole oc-oxoglutarate could occur
without any increase in net ammonia production. This pathway requires
glutamine synthetase and is discussed further in the following section).
Finally, the equilibrium of glutamate dehydrogenase in rat heart
mitochondria (Chapter 1, Section 1.1) suggests that the enzyme
functions in the synthesis rather than in the degradation of glutamate.
If the enzyme is to catalyze the release uf ammonia from glutamate,
compartmentation of the enzyme substrates would be required, for example
a high concentration of glutamate at the site of the enzyme, or a
mechanism whereby the relatively high concentration of ammonia in
the tissue is prevented from reaching the enzyme.
In contrast, perfusion of hearts wich added glutamine did
lead to a significant increase in ammonia production, although
hearts perfused without an added nitrogen source produced ammonia
without any detectable disappearance of glutamine. The metabolism
of ^N-ammonia by the heart (Chapter 4) is in accordance with ammonia
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production from glutamine, with kinetic constants as determined by
Ottaway (1969b) for heart glutaminase. On balance it seems likely
that glutamine is the major source of the ammonia formed by perfused
rat heart.
7.2 Fate of Ammonia
There are three main reactions by which ammonia can enter into
combination with organic molecules in higher animals: carbamyl
phosphate synthesis, glutamine synthesis and the glutamate dehydrogenase
reaction. Of these, only glutamate dehydrogenase has been conclusively
demonstrated in rat heart, although glutamine synthetase appears to
be present in some other mammalian hearts (Chapter 1, Section 1.2),
and possibly also in rat heart (Trush, 1963b).
On perfusion with 300 ymol/l ammonia the concentrations of alanine,
glutamine, glutamate and aspartate were not significantly higher
than those in hearts perfused without added ammonia, nor could nitrogen
balance calculations using these four amino acids account for the
ammonia metabolized by the hear;,. The b&ois of this discrepancy could
not be ascertained. The likely explanation is that a compound not
measured in these experiments represents the ultimate fate of the
ammonia. Adenine nucleotides are not a possibility since their
synthesis requires amination of IMP by aspartate, and there is no
measurable IMP in a properly-oxygenated heart (Chapter 5, Section 5.1).
In theory increased protein synthesis could account for the lost
nitrogen, though it is difficult to see why protein synthesis should
increase in response to an increase in free amino acids caused by
ammonia perfusion, but not when the increase in amino acids is caused
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by perfusion for instance with glutamine, in which case there is no
lost nitrogen (Chapter 5, Section 5.2.5.1). Furthermore, incorporation
of the nitrogen either into adenine nucleotides or into the peptide
backbone of protein requires synthesis of glutamate as the primary
event. One would expect this to lead to an increase in tissue
glutamate, and a labelling of tissue glutamate from ^N-ammonia,
neither of which occurred (Chapter 4, Section 4.3). These observations
could only be explained if it is assumed that glutamate, like ammonia
(Chapter 4), exists in two intracellular pools, one large and
relatively inert, the other small and metaboiically active. The
concept of compartmentation is further developed belw.
Glutamine synthetase has been demonstrated in human, rabbit
and guinea-pig heart (Chapter 1, Section 1.2); its absence from rat
heart would represent an unusual species-specificity. Perfusion with
ammonia caused no increase in glutamine, but this does not exclude
the presence of glutamine synthetase since an increase in glutamine
was seen on perfusion with glutamate (Chapter 5, Section 5.2.5.2).
Possibly net glutamine synthesis can only occur if both the nitrogen
and tne carbon skeleton are presented at the same time, as is the case
with glutamate perfusion:
GluDH
Glutamate + NAD+ + H^O
+






2 Glutamate + NAD
+
v Glutamine oc-oxoglutarate + NADH
Further information could be gained by perfusing *■;: th a medium
containing both glutamate and ammonia. It might also be possible to
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demonstrate glutamine synthesis conclusively by measuring the
labelling of glutamine after perfusion with ammonia, with or
without the addition of glutamate. Until such experiments can be
performed, the fate of the assimilated ammonia remains uncertain.
7.5 Transport of Ammonia
Transport of ammonia across cell membranes has generally been
considered as one of two processes: the simple diffusion either of
uncharged ammonia or of ammonium cation. The present investigation
shows that neither of these simple processes satisfactorily explains
the observed distribution of ammonia between the tissue and the
perfusate. The possibility of a carrier mechanism in addition to one
of the simpler diffusion processes was therefore proposed (Chapter 3,
Section 3.4.3). A model developed on the basis of work with "^N-ammonia
suggested that ammonia entered the tissue by a process displaying
saturable kinetics, presumably a carrier (Chapter 4). A carrier
mechanism would enable a high tissue ammonia concentration to be
maintained even though the blcoa concentration is considerably lower.
A carrier would be a protein molecule, possibly specific to ammonia
as may be the case in some lower organisms (Pribil and Kotyk, 1970;
Hackette et al., 1970), or possibly also transporting other small
cations such as sodium and potassium (Post and Jolly, 1957). In either
case the uptake of ammonia against a concentration gradient would
require energy. Energy can be provided directly if the transport of
cations is coupled to the hydrolysis of ATP, transport and ATPase both
being functions of the same protein (Post and Joj.iy, 1957). Ammonia then
enters the cell in exchange fo^ sodium. The physiological role of the
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carrier is the maintenance of a high intracellular potassium concen¬
tration. Ammonia and potassium thus compete for the same carrier; the
effect on such a system of altering the perfusate porassium concentration
has already been discussed (Chapter 3, Section 3.4.3). The existence
and importance of a carrier mechanism could be further investigated
by the addition of the glycoside ouabain to the perfusing fluid. In
theory if an ATPase is involved in ammonia transport, its effect
should be abolished by this treatment and the resultant ammonia
distribution should reflect simple diffusion across the membrane.
Variation of the pH or potassium concentration of the perfusing fluid
should then give a clearer picture, enabling the mechanism of diffusion
to be distinguished either as NH^ or as NH^+ permeability. Alterna¬
tively, uncoupling the oxidative phosphorylation of the heart by
means of dinitrophenol should abolish all energy-dependent processes
including the active transport of ammonia.
Further experiments could be devised to assess the role of
organic anions in ammonia permeability. Ammonium salts of certain
weak organic acids have been shown to permeate the mitochondrial
membrane readily (Chappell, 1968) and there is no reason to suppose
that this is any less true of the less specialized plasma membrane.
Thus perfusion with media containing acetate, or more physiologically
citrate malate or lactate, might accelerate the rate at which ammonia
enters the tissue.
Finally, valinomycin is a carrier of potassium ions across cell
membranes. It might be used in perfusion as a means of altering
the potassium distribution across the membrane, and hence the membrane
potential, when any resultant change in ammonia distribution might be
observed.
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7.4 Compartmentation of Ammonia
Experiments with isotopically labelled ammonia (Chapter 4)
suggested that there was a large pool of ammonia which was prevented
from exchanging rapidly with the extracellular medium and a smaller
pool whose function was to exchange ammonia relatively rapidly with
the extracellular fluid, and through which the metabolic formation or
disappearance of ammonia occurred. The smaller pool therefore responds
to changes in extracellular ammonia, and also deals with any excess
tissue ammonia forming for example as a result of hypoxia. The
larger pool exchanges very slowly with the smaller. It may be capable
of losing ammonia into the external medium, but it cannot take up
ammonia from the ECF to any significant extent since this would result
in its size being dependent on the external concentration. If it
loses ammonia to the ECF it will also require "topping-up" by
synthesis from a precursor in the intracellular pool.
The arrangement shown in Fig 7.1 is in accordance with the results
of isotopic labelling experiments (Chapter 4). Rate constants derived
from these experiments suggest that the precursor (X) of ammonia
liberated into perfusate to which none has been added is glutamine,
and that most of this ammonia comes from the larger pool (A). Thus
on perfusion with glutamine (Chapter 5, Section 5.2.5.1), there is
an increased synthesis of ammonia which diffuses cut into the
perfusate. On perfusion with glutamate there is a significant
increase in tissue ammonia, but no increase in perfusate ammonia. It
is possible therefore that ammonia is formed from glutamate in the
metabolic pool (x), and that glutamine is synthesized from it without
any release of ammonia into the perfusate. Compartmentation of tissue
ammonia has three implications: firstly, enzymes concerned in ammonia
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Perfusate NH4 Tissue NH4 Metabolites
Figure 7.1. Ammonia pools in perfused rat heart.
^ = passive diffusion
$—> active transport
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and amino-group metabolism may also be compartmentally or non-homo-
geifeously distributed; secondly, related metabolites such as glutamate
or glutamine may also bo compartmental ized; and finally, the
compartmental distribution should be related to the known structure
of the muscle.
The distribution of GluDH and GOT, the most active enzymes of
amino-group metabolism in heart, has been investigated and discussed
(Chapter 6). Both enzymes appear to be associated with the I-bands
of the myofibrils. GPT was demonstrated in the cytoplasm of the
heart, but its activity was too low to permit staining. The
possibility of artifacts in the cytoplasmic staining of GluDH and
GOT has been discussed; it was suggested alternatively that this
staining might represent a small pool of enzyme in the sarcotubular
system which in unaisrupted tissue is more accessible to external
substrates than is the intramitochondrial enzyme, but which on
fractional extraction of disrupted tissue would remain with the
mitochondrial fraction.
It has been suggested (Chapter 1, Section 1.3) that, if the
substrates of the GluDH rcac+ion were homogeneously distributed
throughout the cells, the ammonia concentration in the heart would be
maintained at a very low level by the action of mitochondrial GluDH,
and an ammonia load would cause a toxic depletion of °c-oxog.utarate.
Compartmentation of tissue ammonia would ensure that at least part
of the tissue ammonia did not come into contact with mitochondrial
GluDH. If this fraction is located in the cytoplasm, where the
NAD+/NADH ratio is 100 times higher than it is in the mitochondria,
it could exist in equilibrium with glutamate, even if it is accessible
to a cytoplasmic form of GluDH. It is possible that other substrates
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Fig. 7.2 Diagrammatic representation of the T- and L-systems in_a
concerned in amino-group metabolism, for example amino acids and
oxo--acids, occupy a similar compartment. This could be a reason
why the labelling of glu.tamate from ^N-ammonia is less than would
be expected if giutamate were formed from ammonia (Chapter 4,
Section 4.3).
The location of such a compartment must be related to the
structure of the muscle. The simplest form of compartmentation
involves a membrane across which ammonia cannot pass. The inner
mitochondrial membrane is presumably not such a barrier, since ammonia
can cross it easily in the presence of weak organic acids, at least
in isolated mitochondria (Chappell, 1968). Muscle, however, has
a highly-developed membranous reticulum, consisting of two systems
(Chapter 1, Section 1.8). The T-tubules are continuous with the
extracellular space (Forssman and Girardier, 1966, 1970; Raynes and
Simpson, 1967), and the L-tubules are continuous with the outer
mitochondrial membrane (Forssman and Girardier, 1966). The two
systems are not themselves continuous, but at defined interfaces or
triads the lumen of one is separated from the lumen of the other by
a double membrane. The systems may form a route whereby substrates
can reach the mitochondria without passing through the cytoplasm
(Forssman and Girardier, 1966, 1970). In an active muscle solutes
can be moved easily along the lumen of the tubules, the only barrier
being diffusion across the membrane at the triadic junctions. Hence
a possible basis for the compartmentation of tissue ammonia is shown
in Fig 1.2.
The lumen of the L-system is a possible site for the small,
actively-metabolized ammonia pool (x). It could exchange readily
with the extracellular medium (with which it communicates via the
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T-system), and also with the intramitochondrial space. One would
expect the metabolism of ammonia catalyzed by mitochondrial GluDH
to lead to a production of glutamate when the extracellular ammonia
concentration was high, and a labelling of glutamate from ^N-ammonia,
neither of which was seen however. It might be that the inner
mitochondrial membrane in the intact cell is less permeable to
ammonia than the swelling experiments in isolated mitochondrit suggest.
If this is the case the metabolism of ammonia and related compounds
in this compartment could be brought about by small quantities of
enzyme in the tubules themselves, probably bound to the membrane, as
has already been suggested (Chapter 6, Section 6.3).
The larger, non-exchangeable ammonia pool (A) could be located
in the cytoplasm. The rather polar environment of the myofibrillar
proteins would tend to hinder the diffusion of ammonia ions through
the cytoplasm. Thus the reactivity of pool "x" would be associated
with the ease of movement of NH^+ in the tubular system, whereas
the non-reactivity of pool 'A' would be a consequence of the reduced
mobility of NH^+ in the cytoplasm. Mowbray and Ottaway (1973) have
observed that pyruvate does not mix completely in perfused rat hevrt.
This finding may have a similar structural basis to the compartmentation
of ammonia here described.
7.5 Functions of ammonia in heart muscle
In general, ammonia has only been considered as a waste material
in higher animals, formed as a by-product of amino acid or nucleotide
metabolism. Free ammonia was held to be toxic, so that it must be
removed from the tissue as rapidly as possible into the bloodstream,
from which it is extracted by the liver and formed into the relatively
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harmless urea. Thus high tissue ammonia levels represented a
potentially toxic state where the rate of ammonia production exceeded
the rate of its elimination. Several properties of ammonia were said
to be responsible for its toxicity, chief being its effect on
tricarboxylic acid metabolism (Chapter 1, Section 1.3). In the brain
it was so toxic (James et_ aiL , 1972) that it required removal in situ
b) glutamine formation. If urea synthesis was insufficient, for
example in liver failure, skeletal muscle could take up and metabolize
ammonia in order to keep the blood concentration from rising too high
(Bessman and Bessman, 1955), thus protecting the brain from damage.
Ammonia was supposed to be of no use to the body, except that it
formed the basis of a mechanism for hydrogen ion excretion in the
kidney (Van Slyke e_t al., 1943).
However, the high ammonia concentration in the heart is not
a consequence of uptake from the blood, as it can be maintained in
a rat heart perfused without any added ammonia. Nor did ammonia at
the tissue concentrations measured have any demonstrable toxic
effect on perfused rat heart, as judged by beating, appearance and
oxygeo consumption (Chapter 2). Moreover, a tenfold change in extra¬
cellular ammonia concentration caused only a twofold change in tissue
concentration (Chapter 3). The tissue concentration was kept within
limits of 0.3 - 0.7 ymol/g, apparently by three processes: by the
synthesis or metabolism of ammonia within the tissue; by active
uptake of ammonia from the extracellular medium in which its
concentration is much lower; and possibly also by intracellular
compartmentation which provided a "store" of ammonia in the tissue.
Thus one is led to believe that the ammonia in he^rt muscle may have
some function, and is not merely a waste-product of muscle metabolism.
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Ammonia production from adenine nucleotides in skeletal
muscle is related to muscle activity (Lowenstein, 1972). The
activation by ammonia of enzymes including phosphofructokinase has
been discussed (Chapter 1, Section 1.5), and it is feasible that the
tissue ammonia concentration plays a role in the regulation of
glycolysis in skeletal muscle. However, heart muscle contains
relatively more mitochondria than skeletal muscle (Klingenberg, 1964)
and its metabolism is more aerobic. It does not have the same
requirement to adapt to sudden strenuous bursts of activity by a
huge increase in anaerobic glycolysis. Moreover, ammonia in heart
muscle is not formed from adenine nucleotides (Chapter 5, Section 5.1),
so that ammonia production is not related to the tissue's energy
metabolism so closely as it is in skeletal muscle. Hence ammonia
in heart muscle may play a part in phosphofructokinase activation,
but is of less consequence in regulating the glycolytic flux in this
tissue as compared to skeletal muscle.
Nevertheless, there was some evidence that perfusion with
300 ymol/1 ammonia caused a slight increase in the oxygen consumption
of the perfused heart. It is possible tnat ammonia aids the
mobilization in the cell of weak acid substrates with which it can
form poorly-dissociated ammonium salts. Thus it could aid the passage
of substrates such as pyruvate and fatty acids across the mitochondrial
membrane. Mitochondria have been shown to swell in the presence of
ammonium salts of weak acids (Chappell, 1968; Brierley et al., 1970).
A similar mechanism could be involved in the diffusion out of the
mitochondria of citrate for fatty acid synthesis, and in the diffusion
of lactate across the plasma membrane.
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There is the further possibility, analogous co events in the
kidn?y, that ammonia is formed by heart glutamf.iase (Otta'\ay, 1969a,b)
in response to acids such as lactic acid generated by heart metabolism,
and that one of its functions is to take up the excess hydrogen ions
and prevent the intracellular pH from falling too low. However, no
correlation between ammonia and lactate production was found, at least
in frog muscle (Embden and Wassermeyer, 1928a). Several methods
exist by which the work done by a perfused beating rat heart may
be varied (Neely et al., 1967; Krebs, 1970; Opie et^ aK, 1971).
In view of the possible relationship of myocardial ammonia to substrate
mobilization, it would be of interest to study the effect on ammonia
production of varying the work done by the heart.
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Histochemical Localization of Enzymes in
Heart Muscle
By D. R. Jarvie and J. H. Ottaway (Department
of Biochemistry, University of Edinburgh Medical
School, Teviot Place, Edinburgh EH8 9AO, U.K.)
and J. Nolte and D. Pette. (Fachbereich Biologie
der Universitdt Konstanz, Jakob-Burckhardt Strasse,
7750 Konstahz, West Germany)
Histoohemical localization by formazan deposi¬
tion, in an agarose gel-film medium, by using
phenazine methosulphate to reduce interference
from tetrazolium reductases, has been used for
extensive studies on the localization of mito¬
chondrial and cytoplasmic enzymes in rat liver
(Pette & Brandau, 1966), rabbit skeletal muscle
(Sigel & Pette, 1969) and insect flight muscle
(Brandau & Pette, 1966). This variant of the
tetrazolium localization method has not been used
to study the distribution of soluble enzymes in
heart muscle.
We now report the results of studies on the dis¬
tribution of succinate dehydrogenase (EC 1.3.99.1),
glutamate dehydrogenase (EC 1.4.1.2), glutamate-
oxaloacetate transaminase (EC 2.6.1.1) and lactate
dehydrogenase (EC 1.1.1.27) in rat heart muscle.
The muscle fibres were caused to relax by soaking
the organ in iso-osmotic potassium chloride solution
before freezing and sectioning. This pretreatment
made it possible to detect the striations of the
myofibrils, normally invisible in freshly excised
heart tissue. All the enzymes showed a banded
distribution, but that for the purely mitochondrial
enzymes succinate dehydrogenase and glutamate
dehydrogenase was coarser and more irregular,
in keeping with the expected localization of these
enzymes in mitochondria, which are concentrated,
but not exclusively located, opposite the I-bands of
the fibrils (Klingenberg, J 964). The picture for
glutamate-oxaloacetate transaminase, which is
known to occur in both cytoplasm and mito¬
chondria in this tissue, was similar to that for the
purely cytoplasmic enzyme lactate dehydrogenase.
It cannot at present be proved conclusively that
the 'soluble' enzymes are located within the myo¬
fibrils, but the localization pattern appears to be
in accord with the hypothesis of a concentrated
distribution of many glycolytic and related enzymes
around the isotropic zone of skeletal-muscle fibres,
which has been put forward by Brandau & Pette
(1966) and Sigel & Pette (1969).
This work was carried out in Konstanz as the result of
an invitation from D. P., and financial support was pro¬
vided by the Science Research Council.
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Localization in cardiac muscle of some enzymes
related to glutamate metabolism
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Synopsis. A tetrazolium staining medium incorporated in a gel has been used in a
histochemical study of enzymes in thin sections of heart muscle. Formazan distribution
patterns given by mitochondrial enzymes were inconsistent with the location of these
enzymes revealed by the extraction of whole tissue. Similar stain distributions were
given by lactate dehydrogenase, glutamate oxaloacetate transaminase and glutamate
dehydrogenase. The distribution given by succinate dehydrogenase was not the same as
that given by cytochrome oxidase stained by a different technique. Alcohol dehydro¬
genase added to the tissue assumed a distribution which suggested some adsorption of
the enzyme to the tissue, but experiments suggested that this enzyme was not firmly
bound to muscle proteins in the manner of some glycolytic enzymes.
Introduction
Ditetrazolium salts have been an important biochemical tool in the study of dehydro¬
genases in mammalian tissue since the work of Seligman & Rutenberg (Rutenberg et al.,
1950; Seligman & Rutenberg, 1951) on succinate dehydrogenase, firstly in tissue homo-
genates and later in tissue slices. The ease of reduction of the salts and the physical pro¬
perties of the formazan deposited were improved until the method had become suitable
for the accurate localization of insoluble dehydrogenases in tissue slices at the light-
microscope level (Farber & Bueding, 1956; Farber& Louviere, 1956; Farber et al., 1956;
Nachlas et al., 1957). At that time, however, the technique did not permit the certain
localization of freely-diffusible enzymes. Two advances made the study ofsuch enzymes
possible. First, the use ofsoluble redox dyes in the staining medium accelerated hydrogen
transfer to the tetrazolium salts and markedly reduced the staining time. This also
eliminated the requirement for endogenous tetrazolium reductases, so that the formazan
pattern reflected the enzyme studied, irrespective of the distribution of such reductases.
A number of these dyes were investigated (Nachlas et al., 1957); phenazine metho-
* Present address: Department of Clinical Chemistry, Royal Infirmary of Edinburgh, Edinburgh,
UK.
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sulphate is now almost universally used. Secondly, incorporation of the staining system
into a gel-film which was applied to the tissue slice reduced the leakage of soluble
enzymes out of the tissue. Gelatine was first used (Fahimi & Amarasingham, 1964), but
is now generally replaced by agarose. Using this latter technique a series of studies has
been made on soluble enzymes in rat liver (Pette & Brandau, 1966), insect striated
muscle (Pette & Brandau, 1962; Brandau & Pette, 1966) and rabbit skeletal muscle
(Sigel & Pette, 1969). The gel-film method has not been used to study the distribution
ofsoluble enzymes in heart muscle, although structure-bound enzymes such as succinate
dehydrogenase and ATPase have been studied in some detail (Niles et al., 1964; Morales
& Fine, 1965; Chayen et al., 1966; Niles et al., 1966). The present work represents a
study of the distribution of succinate dehydrogenase, glutamate dehydrogenase, lactate
dehydrogenase and glutamate-oxaloacetate transaminase in rat heart muscle. For
glutamate-oxaloacetate transaminase a method has been evolved in which reaction is
coupled to the production of formazan in the reaction catalysed by glutamate dehydro¬
genase. A preliminary report of this work has already appeared (Jarvie et a/.,i97i).
Materials and methods
The following biochemicals were obtained from Boehringer und Soehne GmbH,
Mannheim: enzymes and nucleotides, cytochrome c, sodium L-lactate, and sodium
succinate, L-aspartic, L-glutamic and a-oxoglutaric acids and triethanolamine hydro¬
chloride. Phenazine methosulphate, nitro-BT, diaminobenzidine tetrahydrochloride,
and agarose were obtained from Sigma Corporation. Other reagents and inorganic
chemicals were obtained either from BDH biochemicals, Poole, Dorset, or from
E. Merck, Darmstadt, Germany. Lyophilized alcohol dehydrogenase was obtained from
BDH biochemicals.
Preparation of tissue
The procedure was based on the method of Pette (Pette & Brandau, 1966; Sigel & Pette,
1969). Rats (laboratory strain) were fed on a normal diet and killed by cervical fracture
and exsanguination. The heart was removed as quickly as possible and transferred to ice-
cold isotonic potassium chloride solution; when contraction ceased, the heart remained
in a relaxed state. The organ was cut into strips ofabout 2 mm cross-section and returned
to the KC1 for a further 1 min. The strips were then rapidly blotted and frozen in iso-
pentane precooled in liquid nitrogen. No contraction was apparent on freezing. Sections
of 10 u.m thickness were cut at -20°C with a microtome mounted in a cryostat (W.
Dittes, Heidelberg, Germany), as described by the above authors. Suitable sections for
staining were selected by examination in the phase-contrast microscope. In one experi¬
ment, the hearts were perfused (10 min) with an ice-cold Ringer in which the NaCl
(138 mM) had been replaced by an equivalent concentration of KC1. The resultant tissue
sections presented an identical microscopic appearance to those prepared by soaking the
whole organ in the solution.
Preparation ofgel-films
Gel-films were prepared and stored as described by Pette & Brandau (1966). Gel media
(1.5% agarose) were used for all enzymes, including succinate dehydrogenase. The com-
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position of staining media was as follows (values refer to the final concentrations of
reagents in the gel-film). Test media for lactate, glutamate and succinate dehydrogenases
are as follows:
Lactate dehydrogenase (1.1.1.27). Triethanolamine/triethanolamine hydrochloride
buffer (TRE) 50 mM, pH 7.6; EDTA 1 mM; nitro-BT 1.5 mM; NAD + =
2.3 mM; L-lactate = 24 mM and phenazine methosulphate (PMS) = 0.3 mM.
Glutamate dehydrogenase (1.4.1.2). TRE = 50 mM; pH = 7.6; EDTA — 5 mM;
nitro-BT = 1.5 mM; NADH+ = 2.3 mM; L-glutamate = 50 mM; ADP = 2 mM;
PMS = 0.15 mM.
Succinate dehydrogenase (1.3.99.1). Sodium phosphate = 100 mM; pH = 7.6;
EDTA 5 mM; nitro-BT — 1.5 mM; PMS = 0.15 mM; succinate = 80 mM; KCN =
1 mM.
Glutamate-oxaloacetate transaminase (2.6.1.1). The staining medium involved the
coupling of transamination to glutamate reduction by the reactions:
Test reaction: a-oxoglutarate + aspartate-> glutamate + oxaloacetate.
Auxiliary reaction: glutamate + NADP+ + H.,0 —*■ NH4+ + a-oxoglutarate +
NADPH.
Glutamate dehydrogenase is incorporated in the gel as the auxiliary enzyme, and
formazan deposition occurs at the site of the transaminase in the tissue.
Appropriate concentrations of reagents were found by tests in solution, the relative
rates of tetrazolium reduction being followed spectrophotometrically. a-Oxoglutarate
is a substrate of the test-reaction and a product of the auxiliary reaction. Its optimal con¬
centration was found to be 1.5 mM. ADP was added as an activator ofglutamate dehydro¬
genase: it had no effect on the transaminase reaction in vitro. NADP + was used as the
coenzyme for the auxiliary reaction, since NADH is reoxidized by the oxaloacetate
formed in the test reaction (rat heart contains a high concentration of malate dehydro¬
genase). Glutamate dehydrogenase was dialysed before addition to the gel, to remove
ammonium sulphate. Staining was complete in 30 min. Control gels lacking aspartate did
not stain.
Medium: TRE = 5omM;pH = 7.6; EDTA = 5 mM; nitro-BT = 1.5 mM;NADP+ =
5 mM; a-oxoglutarate =1.5 mM; L-aspartate = 50 mM; glutamate dehydrogenase =
iooi.u./ml; ADP 2mM;PMS — o.2mM.
Gel slices were applied to tissue sections as described by Pette & Brandau (1966), and
incubated at 37°C in the dark until sufficient colour had developed, as judged by rapid
inspection under the microscope. On average, this required 10 min for succinate and
lactate dehydrogenases, and 30 min for glutamate oxaloacetate transaminase and gluta¬
mate dehydrogenase. After removal of the gel slice, the sections were fixed in 4%
formaldehyde solution, dried and mounted in glycerol-gelatine.
Localization of cytochrome oxidase
Cytochrome oxidase was localized using the technique of Seligman (1968). Tissue
sections were prepared on microscope slides by the technique described above, and
100-200 ;rl staining medium was pipetted on to each. After 40 min incubation at 25°C,
the section was carefully blotted, fixed in 5% acetic acid, dried and mounted in glycerol-
gelatine.
The medium was made up as follows: sodium phosphate = 0.05 M, pH 7.4; diamino-
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benzidine tetrahydrochloride (Sigma) = 0.5 mg/ml; catalase = 2 |j.g/ml; cytochrome c
= 1 mg/ml; sucrose = 75 mg/ml (0.22 m). Control gels contained in addition 10 mm
potassium cyanide to inhibit cytochrome oxidase. Colour developments in control
sections were not completely prevented unless the tissue sections were preincubated for
5 min in a medium containing buffer, 75 mg/ml sucrose and 10 mm KCN (Nir & Selig-
man, 1971).
Adsorption test with exogenous enzyme
In experiments designed to study the possible adsorption ofexogenous alcohol dehydro¬
genase to tissue, slices were cut and transferred to microscopic slides in the normal
manner. Before application of the staining gel, a 5 ul drop of solution containing yeast
alcohol dehydrogenase (or a similar drop of a control solution) was placed on the tissue
slice. After 3 min incubation at room temperature, excess liquid was soaked away with
tissue and a staining gel for visualization of alcohol dehydrogenase was applied to the
slice. Staining was sufficient in 10 min at room temperature (or in 5 min at 37°C). Since
the technique loosens the tissue from the slide, it was no longer possible to remove the
staining gel and to fix and mount the section. Sections were, therefore, photographed
immediately on development of the stain, with the gel slice in position. Alcohol dehydro¬
genase solutions contained 10 mg protein per ml and were applied at two different ionic
strengths: (1) in 0.8 M ammonium sulphate solution and (2) after overnight dialysis
against two changes of 2 mM phosphate, pH 7.0. In control experiments, drops of dis¬
tilled water or drops of 0.8 M ammonium sulphate were applied to the tissue slices.
A further experiment tested for the adsorption of non-enzymic components of the
staining system to the tissue. In this test, a 5 [A drop of NADH solution (15 mM) was
applied to the tissue slice for 3 min and then soaked away with tissue paper before
application of the appropriate staining gel.
The staining gels required were as follows:
Alcohol dehydrogenase (i.i.i.i). TRE = 50 mM, pH = 7.6; nitro-BT = 1.5 mM;
NAD = 3.0 mM; Ethanol = 44 mM; PMS = 0.15 mM.
NADH stain. TRE = 50 mM; pH = 7.6; EDTA = 5 mM; nitro-BT = 1.5 mM;
PMS ^0.15 mM.
Enzyme localization in disrupted tissue
In this investigation, the 'fractional extraction' technique of Pette (1968) was used.
Freshly-excised heart was minced in a specially constructed micro-meat-mincer. The
tissue was gently extracted in two changes of sucrose medium (0.3 M sucrose, 10 mM
TRE, 2 mM EDTA, pH 7.4), yielding supernatants A and B, followed by one extraction
in 0.1 M phosphate buffer, pH 7.2, giving supernatant C. Finally, the solid material was
homogenized in the same buffer (Polytron PT 10 Homogenizer, Kinematic, Luzern,
Switzerland), yielding supernatant D and the pellet S. Enzyme activities were measured
in standard spectrophotometric assays (Biicher et al., 1964).
In vitro extraction pattern of exogenous alcohol dehydrogenase
In testing for adsorption of alcohol dehydrogenase in soluble components of a rat heart
homogenate, a freshly excised heart was washed for 10 min by coronary perfusion with
ice-cold Ringer (Krebs & Henseleit, 1932). Tissue (0.5 g) was homogenized (Ultraturrax
Localization ofglutamate metabolism enzymes
homogenizer, Janke & Kunkel) in a medium of low ionic strength similar to that used in
the fractional extraction of endogenous enzymes (0.3 m sucrose, 5 mm TRE, 0.5 mm
MgS04, pH 7.4). Yeast alcohol dehydrogenase was added (0.1 mg of lyophilized
powder, containing 8.40 enzyme units as assayed), and the total volumes were made up
to 10 ml with sucrose medium. The mixture was stored for 20 min at o°C to allow bind¬
ing of ADH to take place before centrifuging at 2,6000 g for 25 min. The sediment was
washed with a second 10 ml portion of sucrose medium, then with 0.1 m phosphate
buffer (high ionic strength), pH 7.2. In each case 15 min stirring preceded the centri-
fugation. Alcohol dehydrogenase activity in all fractions was assayed by the method of
Racker (1950), with the addition of semicarbazide hydrochloride (7.5 mm) and gluta¬
thione (0.98 mm).
Results
The method of tissue preparation produced relaxed fibres, as evinced by the striation
seen on staining (Figs. 1-3), which were also seen when viewed by polarized light.
Regions of fibrils without striations may have been due to incompleteness of relaxation
though all fibres which showed striations seemed to be relaxed to the same extent as
judged by the distance between striations (Table 1).
Staining patterns for the endogenous enzymes are shown in Figs. 1-6. Formazan was
not deposited in control sections incubated in the absence of substrate. All the enzymes
Figures 1-4. Distribution of enzymes
in sections of cardiac muscle
stained by the tetrazolium technique
as described in the text. Staining
times are given in parentheses. X 760
Figure 1. Lactate dehydrogenase
(10 min).
Figure 2. Glutamate dehydrogenase
(30 min).
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Figure 3. CrlUtatriafe oxalnaretate
transaminase (30 min).
Figure 4. Succinate dehydrogenase
(10 min). Note the similarity in the
patterns given by the first three
enzymes, and the anomalous pattern
given by succinate dehydrogenase.
Figures 5 & 6. Comparison of the
stain distribution given by two
structure-bound enzymes, x 310
Figure 5. Succinate dehydrogenase,
stained by the tctrazolfum techniaue
(10 min)
Figure 6. Cytochrome oxidase,
stained by the diaminobenzidine
technique (40 min). Cytochrome
oxidase gives a pattern consistent
with localization of the enzyme
in the interfibrillar mitochondria;
succinate dehydrogenase does
not yield the expected pattern.
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Figure 8. The pattern obtained on staining a
tissue previously suffused with NADH
(10 min). There are no formazan granules or
striations in the tissue; thus adsorption of
NADH or other components of the staining
system can be excluded.
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Figures 7 & 8. Controls to test for possible
adsorption of enzyme and components of
the staining system to elements of the tissue.
X 270
Figure 7. The pattern of formazan obtained
on staining a tissue, previously suffused with
alcohol dehydrogenase, with a staining gel for
localization of this enzyme (3 min). Some
striations ate visible, suggestive of fibrillar
adsorption, but the predominant dark bands
suggest that much of the enzyme assumes a
location in the interfibrillar spaces.
except succinate dehydrogenase and cytochrome oxidase gave a similar pattern,
characterized by fibrillar staining with distinct transverse striations. Succinate dehydro¬
genase (Figs. 4, 5) gave a markedly different distribution, with significantly wider
striations (Table 1). The pattern of this enzyme was similar to that observed by Chayen
and his group (Chayen et al., 1966; Niles et al., 1966), though the granular stain distri¬
bution observed by these authors in the presence of PMS was not found. Cytochrome
oxidase gave a pattern in which very few striations were discernible (Fig. 6), consistent
with location of the enzyme in the interfibrillar mitochondria.
Fig. 7 shows the formazan deposition in a tissue slice treated with exogenous alcohol
dehydrogenase in a medium of low ionic strength. A similar pattern was obtained when
the enzyme was applied in a medium of high ionic strength. The formazan distribution
is superficially similar to that given by endogenous lactate dehydrogenase, glutamate
dehydrogenase and glutamate oxaloacetate transaminase; some striations are visible,
suggestive of limited fibrillar adsorption. However, the predominant dark bands suggest
that most of the enzyme assumes a location in the interfibrillar spaces. Treatment of
tissue slices with NADH (Fig. 8) did not give rise to any specific tissue staining: formazan
was deposited homogeneously in the staining gel and in the section. Control experiments
in which water or 0.8 M ammonium sulphate was used in place ofalcohol dehydrogenase,
produced no stain.
The dimensions of the patterns were measured in half-plate prints and compared with
measurements made in photographs published by other authors (Table 1). The ratio r
in Table 1 is the ratio of the average striation width to the average distance between
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Table I. Dimensions of banding patterns in heart myofibrils stained by the
tetrazolium technique.
(a)
Enzyme Figure I (pm) r
Lactate dehydrogenase 1 2-3 0.81
Glutamate dehydrogenase 2 2-3 0.86
Glutamate oxaloacetate transaminase 3 2-3 0.78
Alcohol dehydrogenase (added) 7 2-3 0.91
Succinate dehydrogenase 4 4-3 1.32
Succinate dehydrogenase 5 4-1 1.32
Sarcomere length = 2.5 [tm. (Bloom & Fawcett, 1968)
(b) Literature values (for succinate dehydrogenase)
r Reference
0.86 Chayen et al., 1966
1-39 Burstone, 1962
1.40 Nachlas et al., 1957
1.43 Nachlas et al., 1957
1-54 Novikoff, 1959
I is the distance between successive dark striations, r is the ratio of I divided by
the distance between adjacent fibrils. I was obtained by measuring 10 consecu¬
tive striations along a fibril and dividing by 10; this procedure was repeated at
least 5 times for each photograph and the mean was calculated. The mean dis¬
tance between fibrils was obtained in an analogous manner. Literature values
were obtained by making similar measurements on published photographs. For
these only the ratio is reliable, since in many cases the actual magnification of the
published picture is uncertain.
adjacent fibrils, and enables comparison with photographs in the literature whose exact
magnification is uncertain. The length I is the actual width of the striations in microns,
which corresponds to the sarcomere length (given as 2.5 urn by Bloom & Fawcett, 1968)
for all the enzymes except succinate dehydrogenase.
Fractional extraction of heart muscle according to the method of Pette (1968) gave the
results shown in Table 2. Lactate dehydrogenase is wholly cytoplasmic, glutamate
dehydrogenase wholly intramitochondrial, whereas glutamate oxaloacetate transaminase
is distributed between both compartments. This is comparable to the findings of Pette
(1968) in insect flight muscle. Succinate dehydrogenase is bound to structural protein
and sediments with the final pellet.
The results of extraction of alcohol dehydrogenase, by a method analogous to frac¬
tional extraction, from a homogenate to which it has been added are shown in Table 3.
The whole of the enzyme activity added was extractable by a medium of low ionic
strength, and thus no binding of the enzyme to insoluble components could be demon¬
strated.
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Table 2. Fractional extraction of enzymes in rat heart. See Pette (1968) and Table 3 for explanation
of fractions.
Total activity
{[tmoljminlg Cumulative percentage of total activity extracted
fresh weight
Enzyme af 25°C) St S., S3 St P
Lactate dehydrogenase 478.4 96.7 98.3 98.7 99-9 IOO.0
Glutamate pyruvate
transaminase 0.78 68.7 100.0 100.0 100.0 100.0
Malate dehydrogenase I309-5 33-9 36.9 43.0 95-7 100.0
Glutamate oxaloacetate
transaminase 196.8 25.0 28.2 3i-4 93.8 100.0
Citrate synthetase 56.6 4-9 5-2 9-7 87.5 100.0
Glutamate dehydrogenase 12.9 5.0 7-5 12.5 88.2 100.0
Succinate dehydrogenase 26.7 0.0 0.0 O.I I.I 100.0
Protein 118.5 mg g 23.4 26.5 30.0 42.5 100.0
Table 3. Adsorption of yeast alcohol dehydrogenase to a rat heart homogenate. 0.5 g rat heart was
homogenized in 10 ml sucrose medium (see text). 8.40 units of alcohol dehydrogenase (1 unit
1 irmol of ethanol per min at 25°C) were added and the mixture was stirred gently at o°C for 20 min.
Centrifugation yielded supernatant S, snd a pellet, which was resuspended in sucrose medium and
stirred for 15 min. The resultant supernatant was S2. A subsequent 15 min wash of the pellet with
0.1 M phosphate buffer, pH 7.2, yielded supernatant S;1 and the pellet P.
Alcohol dehydrogenase activity extracted % of total activity
{•j.mol mm at 25°C) added




Total activity recovered 8.46 —
Recovery (%) — 100.7
Discussion
The purpose of this investigation was to localize, if possible, in mammalian heart
muscle, glutamate oxaloacetate transaminase and glutamate pyruvate transaminase.
The other enzymes were stained for as controls to check the validity of the results for
glutamate oxaloacetate and glutamate pyruvate transaminases, de Duve et al. (1962) have
already recorded that lactate dehydrogenase is always a purely cytoplasmic enzyme,
whereas succinate dehydrogenase and glutamate dehydrogenase are mitochondrial
enzymes, and both have been used as markers for mitochondria in biochemical separa¬
tion procedures. Like malate dehydrogenase, glutamate oxaloacetate transaminase has
t>een detected both in mitochondria and in cytoplasm of various animal tissues, and this
I
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dual localization is an essential part of a mechanism currently proposed for the transfer
of reducing equivalents into mitochondria (see, for example, Safer & Williamson, 1973).
Glutamate pyruvate transaminase was found to be solely localized in the cytoplasm
by the fractional extraction technique (Table 2), thus confirming Pette's (1962) results for
beef heart. Unfortunately, its concentration in heart muscle is too low to give staining
by the method successfully developed for glutamate oxaloacetate transaminase.
The distribution of dehydrogenases, and of those glycolytic enzymes which may be
coupled to them, have been extensively studied by the tetrazolium gel-staining tech¬
nique (Pette & Brandau, 1962, 1966; Brandau & Pette, 1966; Sigel & Pette, 1969). In
striated muscle from several sources the distribution of many glycolytic enzymes has
been found to be banded, with heavy staining at the level of the I-bands of the muscle
fibrils. Lactate dehydrogenase is the type enzyme showing this distribution pattern. In
some instances, this banding can be correlated with demonstrable physical binding of
the enzymes to fibrillar components, notably actin (Arnold & Pette, 1968, 1970; Arnold
et al., 1969, 1971). These studies have not previously been extended to cardiac muscle,
but the banded distribution of lactate dehydrogenase which we observed in rat heart
muscle (Fig. 1) agrees in every particular with that found by Pette's group for other
muscle types.
In some skeletal muscles, the interfibrillar mitochondria tend to be arranged in pairs
at the level of the I-bands, but in heart muscle they form continuous columns completely
filling the interfibrillar space (Klingenberg, 1964). Thus it would be expected that the
stain produced in heart muscle sections by a completely intramitochondrial enzyme
would be distributed as lines of dots, perhaps even largely fused together, running
parallel to the direction of the fibrils, which can be distinguished by phase-contrast
microscopy. With cytochrome oxidase, stained by the diaminobenzidine technique, this
was the case (Fig. 6), but the two other mitochondrial marker enzymes succinate and
glutamate dehydrogenases, did not give the expected pattern (Figs. 5, 2). Succinate
dehydrogenase appeared to be located in granules somewhat clumped together, and
separated by blank spaces. These quasi-uniform regions were only in register over short
distances and the repeat distance was almost twice the distance between the I-bands in
relaxed muscle (see Table 1). The significance of this observation cannot at present be
assessed, but we are confident that it is not due to overstaining (see below). Similar find¬
ings have been reported by Chayen et al. (1966) and Niles et al. (1966).
The staining pattern found for glutamate dehydrogenase (Fig. 2) differed considerably
from this. It was surprisingly similar to the banded distribution characteristic of lactate
dehydrogenase, with scattered granules which might be identified with mitochondria
superimposed on it. The bands were in register over several fibril widths for long dis¬
tances, and the spacing of the bands corresponds to the relaxed sarcomere length
(Table 1). The staining pattern for glutamate oxaloacetate transaminase was not dis¬
similar, but with fewer scattered granules. These results were so surprising that a test
was made by flooding the section, before applying the gel, with a solution of alcohol
dehydrogenase, a soluble enzyme not found in heart muscle (Morales & Fine, 1965).
A weak, but distinct, banded pattern was also found for this enzyme (Fig. 7), with a
repeat distance of 2.3 u.m.
The four enzymes (succinate, alcohol and glutamate dehydrogenases, and glutamate
oxaloacetate transaminase) which gave unexpected staining patterns, were all localized by
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the tetrazolium technique, and this inevitably casts some suspicion on the method. The
possibility that the results are an artefact of formazan deposition, as opposed to produc¬
tion, can almost certainly be set aside. The deposition of non-specific granules seems
from inspection of the photomicrographs, most likely to have occurred with staining for
succinate dehydrogenase (Fig. 4). However, visual control of staining enabled us to
check that the pattern did not alter significantly over the total staining time. It is difficult
to explain the regularity with which the granules appear at least over short distances in
terms of non-specific deposition, or the fact that very similar ratios of repeat distance to
interfibrillar space to those found by us have been reported by several other workers
(Table 1). Table 1 also shows that the repeat distance for succinate dehydrogenase
does not correspond with the sarcomere length, as it did for the other enzymes which we
investigated. We are unable to explain this.
We also found that when a section was flooded with NADH, the formazan was sub¬
sequently deposited uniformly (Fig. 8), in distinction to the pattern found when it was
flooded with alcohol dehydrogenase and ethanol (Fig. 7). Moreover, Pette and co¬
workers have demonstrated very strict mitochondrial localization of succinate and gluta¬
mate dehydrogenases in locust muscle (although admittedly not in columnar mito¬
chondria), and, on the other hand, have shown that malate dehydrogenase, 'malic
enzyme' and NADP-linked isocitrate dehydrogenase, which are all thought to be both
cytoplasmic and mitochondrial, show an interfibrillar distribution in locust flight muscle
which is quite different from the striated appearance of Figs. 2 & 3. Much of the study
reported here was carried out in Pette's laboratory, and it is unlikely that it departed
much from his own workers in points oftechnique. Thus we may accept that striations at
the I-band level are not an inevitable consequence of the tetrazolium gel slice procedure.
It is also possible that the treatment of the tissue in some way damaged the mito¬
chondria, and that the enzymes released from the matrix as a result of the damage,
instead of diffusing throughout the cytoplasm, attached themselves to some insoluble
component of the I-band structure. The experience with alcohol dehydrogenase shows
that this may be possible, although it is evident that the binding of this enzyme to a
fibrillar structure is different from the binding of the glycolytic enzymes studied by
Arnold et al. (1971), since the latter were not bound at high ionic strengths, whereas
alcohol dehydrogenase binding to the section was unaffected by 0.8 M ammonium sul¬
phate. Moreover alcohol dehydrogenase, unlike glycolytic enzymes, does not appear to
bind to any component of disrupted muscle.
Although it is possible that the banded patterns found with glutamate dehydrogenase
and glutamate oxaloacetate transaminase were artefacts of preparation of the heart sec¬
tions, the proposition is not easy to believe. It implies that almost all the mitochondria
were disrupted, that almost all of them lost the major portion of their contents, and that
the glutamate oxaloacetate transaminase and glutamate dehydrogenase (and perhaps
other matrix enzymes) became overwhelmingly attached to an I-band component. In the
present state of our knowledge, these premises cannot be ruled out, but the first two at
least seem rather unlikely. There is no reason to suppose that soaking the heart in iso¬
tonic KC1 damages the mitochondria, since this medium is used by some biochemists to
study their permeability, and heart mitochondria are particularly resistant to freezing
and thawing. Moreover, the fact that sections stained with diaminobenzidine had to be
pre-incubated with KCN suggests that the mitochondrial membrane was well preserved.
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The possibility must, therefore, be at least considered that the histochemical studies
are correct, and that the purely biochemical data are, to some extent, misleading. Two
consequences may be induced.
(a) Impressive evidence has been accumulated that many enzymes of the Embden-
Meyerhof pathway, and also enzymes of glycogen metabolism, are concentrated in the
I-band region of striated muscle (Arnold & Pette, 1969). It seems not unreasonable that
a fraction of the glutamate oxaloacetate transaminase and glutamate dehydrogenase of
heart muscle could also be located here, since glutamate and aspartate have been impli¬
cated in transfer of reducing equivalents between the glycolytic system and the electron
transport chain. If this non-mitochondrial fraction of the two enzymes is located in the
T-tubules or in the sarcoplasmic reticulum, rather than being bound to F-actin, it would
be possible for it to be spun down with the mitochondria in the differential extraction
procedure, and assumed to have arisen from the latter source.
(b) The staining patterns shown in Figs. 2 & 3 imply that the mitochondrial glutamate
dehydrogenase and glutamate oxaloacetate transaminase are not equally distributed
among the mitochondria filling the interfibrillar spaces in cardiac muscle (unless some
mitochondria are impermeable to PMS or nitro-BT). Unequal distribution is a very
unorthodox proposal; since mitochondria are thought to reproduce themselves by
budding, they are all likely to have identical enzymic complements. There is, however,
a certain logic about the supposition that the paired mitochondria opposite the I-bands
in skeletal muscles (Klingenberg, 1964), whose primary function in this tissue may well
be the oxidation of pyruvate and NADH arising from glycolysis, retain this position and
function in cardiac muscle, while the regions opposite the A-bands have become filled
with mitochondria specialized for fat oxidation and longer-term energy provision for the
heart muscle as a whole. As these mitochondria need not respond to the large flux of
pyruvate which follows the increased glucose utilization of exercise, their content of
pyruvate oxidase, and perhaps of enzymes of amino acid metabolism, might be lower
than normal. They might indeed have a reduced content of enzymes of the tricarboxylic
acid cycle, since 40% of the energy released in the oxidation of fatty acids appears in the
^-oxidation steps, and not in the oxidation of acetyl residues. These speculations might
explain the banded pattern seen in Figs. 2 & 3. Mowbray & Ottaway (1973, and in press)
have shown, from a study of isotopic labelling patterns in rat hearts perfused with radio¬
active lactate, that pyruvate does not mix completely within the heart, and that there
appear to be some mitochondria oxidizing pyruvate which does not derive from lactate.
These ideas can only be tentatively put forward at present, because the experimental
evidence is far from complete. Until both a dehydrogenase known to be restricted to
mitochondria, and a dehydrogenase at least partially cytoplasmic (perhaps malate
dehydrogenase) can be shown to give a columnar (interfibrillar) staining pattern in heart
muscle sections with the tetrazolium gel slice technique, the possibility must remain that
the results reported here are technical artefacts. If this proves to be the case, all the
evidence for the location ofglycolytic enzymes in the I-bands ofstriated muscle will have
to be closely re-examined.
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